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Abstract 
 
Tuberculosis (TB) is a leading cause of death from a single infectious agent 
and infects one third of the world’s population in a latent form. Latent TB is 
characterised by presence of TB antigens but a lack of symptoms of TB. Latent TB is 
associated with the persistent form of Mycobacterium tuberculosis, and is a reservoir 
from which symptomatic infection arises. Non-replicating persistence (NRP) is 
postulated to be a reversible state characterised by lack of replication, decreased 
metabolic activity and increased antimicrobial resistance.  
To achieve viable persistence, NRP cells have been postulated to require 
stabilisation of cellular structures needed for stress tolerance and for the transition 
from NRP to active replication. This study investigates the hypothesis that ribosome 
stabilisation assists in mycobacterial stress tolerance and persistence. RafS is a 
novel mycobacterial ribosome associated factor and putative ribosome stabilisation 
factor. The physiological roles and functional characteristics of RafS are investigated 
in this study. 
The role of RafS in M. smegmatis (Msm) and M. tuberculosis (Mtb) physiology 
were investigated. Competitive survival assays between wild type and ΔrafSMtb 
illustrated that RafSMtb confers a competitive advantage during survival under 
nutrient limitation. RafSMsm and RafHMtb were found to significantly inhibit in vitro 
translation. Furthermore, RafSMsm and RafHMtb inhibited in vitro translation of mRNA 
with and without Shine Dalgarno sequences. It was determined that RafSMsm is 
dispensable for growth and survival in several conditions and also for mature biofilm 
and pellicle formation. Also, RafSMsm is dispensable for tolerance of heat, acid and 
antibiotic stress. Ribosomal profiling indicated no significant effect of rafSMsm deletion 
on ribosomal subunit association in log phase and stationary phase rich media 
cultures. These findings are discussed in the context of mycobacterial growth, 
survival, stress tolerance and persistence mechanisms. 
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1.1 Scope of the Introduction 
 
The introduction aims to provide an overview of Mycobacterium tuberculosis, 
aspects of tuberculosis (TB) pathology, latent TB and in vitro stress models. 
Subsequently, bacterial translation, Escherichia coli ribosome stabilisation and 
putative mycobacterial ribosome stabilisation factors (Raf proteins) are described. 
Finally, the main research objectives of the project are outlined.  
 
1.2 Mycobacterium tuberculosis and tuberculosis (TB) 
 
1.2.1 Mycobacterium tuberculosis, TB and latent TB  
 
Mycobacteria belong to the phylum Actinobacteria, which is known for its high 
morphological diversity (Servin et al., 2008). Actinobacteria are found in aquatic and 
terrestrial habitats worldwide and produce a variety of extracellular enzymes and 
secondary metabolites (Falkinham et al., 2009, Ventura et al., 2007). The genus 
Mycobacterium includes the pathogens, Mycobacterium tuberculosis and 
Mycobacterium leprae which are causative agents of TB and leprosy, respectively 
(Henriques et al., 2000).   
During the industrial revolution, TB was responsible for 1 in 4 deaths 
(Donoghue, 2009). In 2010, an estimated 1.3 million people died from TB and an 
estimated 8.6 million new TB cases arose (WHO Report 2013). Biological and 
socioeconomic factors contribute to the spread of TB, such as HIV-related 
immunodeficiency, prevalence of drug-resistant TB, poor sanitation and 
overcrowding (Rustad et al., 2009). Furthermore, the current Bacillus Calmette- 
18 
 
Guerin (BCG) vaccine primarily protects young children and leprosy patients from 
TB, but provides variable protection (0 – 80%) against infectious pulmonary TB in 
adults (Singh et al., 2014). 
Latent TB is defined by the absence of clinical TB symptoms along with a 
positive reaction to the purified protein derivative (PPD) skin test (Barry et al., 2009). 
Globally, an estimated 1.8 billion people are PPD+. The actual value may be lower 
than estimated due to false positive results if an immune response to PPD is elicited 
by antigens from other mycobacteria, such as Mycobacterium bovis in the BCG 
vaccine. A more specific latent TB diagnostic test which detects interferon-γ (IFN-γ) 
produced in vitro in response to M. tuberculosis antigens has been developed (Barry 
et al., 2009). 
Current antibiotics target actively replicating bacteria and are not effective 
against latent stage TB. The current first-line regimen for treating active TB consists 
of isoniazid, a rifamycin, pyrazinamide and ethambutol and the length of treatment (6 
months) reflects the difficulty of eradicating M. tuberculosis. Factors such as reduced 
patient compliance or antibiotic inefficacy contribute to the formation of genetic 
antibiotic resistance. Koul et al. highlighted that a drug regime of reduced duration 
and lower dosing frequency is needed (Koul et al., 2011). 
Latent TB and TB reactivation are major public health concerns and new 
antimicrobial strategies are needed to target latent TB bacilli, whose antibiotic-
tolerance is phenotypic in nature and distinct from genetic antibiotic resistance. 
Latent bacilli act as a reservoir from which actively replicating transmissible bacilli 
can arise and the emergence of bacilli from latency to active TB is known as 
reactivation. TB reactivation occurs mostly in highly oxygenated regions, while 
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latency is associated with reduced oxygen. Immunodeficiency and diabetes are risk 
factors which increase the chances of reactivation (Barry et al., 2009).  
 
1.2.2  M. tuberculosis lung pathogenesis and granuloma formation 
 
M. tuberculosis is well-adapted for lung pathogenesis and a single bacterium 
is sufficient to cause infection (Russell et al., 2007). M. tuberculosis is a facultative 
intracellular parasite of macrophages and bacilli undergo an elaborate struggle with 
the immune system in order to gain a stronghold in infected lungs. M. tuberculosis 
exploits immune-mediated damage to spread within infected lungs, which show a 
gradation of stages in which calcified tuberculous lesions with few viable bacteria 
become caseous lesions which themselves become sources of actively replicating 
bacteria (Barry et al., 2009). 
When aerosols carrying TB bacilli are inhaled into the lungs, the bacilli 
undergo internalisation by macrophages. Here, M. tuberculosis undergoes rapid 
replication, arrests phagosome maturation and prevents phagosome acidification 
and accumulation of hydrolytic enzymes (Rengarajan et al., 2005). In quiescent 
macrophages, M. tuberculosis bacilli are retained in the recycling endosomal 
pathway, a state protected from lytic enzymes of the lysosome, where iron is 
accessible for incorporation into several enzymes and proteins. In the presence of 
activating cytokines, macrophages can deliver the bacilli to acidic lysosome-like 
vacuoles.  
Activated macrophages exhibit low oxygen levels and produce nitric oxide and 
related radicals, conditions that are unfavourable for M. tuberculosis active 
20 
 
replication and metabolism. However, latent TB bacilli are postulated to result from 
M. tuberculosis entering a non-replicating persistent state for survival in the stressful 
environment of granulomas. Granulomas are avascular lesions that suppress 
bacterial growth due to oxygen and nutrient deprivation, acidic pH and nitric oxide 
production.  Several types of granulomas have been identified which suggests that a 
spectrum of pathology is characteristic of pulmonary TB infections (Table 1.1) 
(Russell et al., 2007). 
 
Table 1.1. Types and features of TB granulomas suggest that a spectrum of 
pathology is characteristic of pulmonary TB infections (Barry et al., 2009). 
 
Type of  
granuloma 
Features 
Most prevalent 
in active and/or  
latent TB 
Composition 
M. tuberculosis  
bacilli primary 
location 
Non-
necrotising 
granuloma 
Active TB 
mostly macrophages with 
some lymphocytes 
macrophages 
Caseous 
granuloma 
Active and  
latent TB 
epithelial macrophages, 
neutrophils, lymphocytes, 
sometimes surrounded by 
peripheral fibrosis; 
centre is caseous and 
hypoxic and contains dead 
host cells 
macrophages, in 
the centre and 
possibly in the 
fibrotic rim  
 
Fibrotic 
granuloma 
Latent TB 
mostly fibroblasts, with 
minimal macrophages 
 
Unknown 
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Granulomas aid in limiting the spread of M. tuberculosis, and yet also harbour 
latent bacilli for decades. Several immune factors contribute to granuloma formation, 
such as activating cytokine TNFα (tumour necrosis factor alpha) which mediates 
phagocyte migration and aggregation to form granulomas. Mycobacteria themselves 
produce a potent initiator of granuloma formation, cord factor, suggesting that they 
are well adapted to and may even benefit from survival within granulomas.  
Zebrafish embryos are employed for investigating Mycobacterium marinum 
infections due to their transparency during the first 3 weeks of development which 
allows real-time monitoring of host-pathogen interactions and fluorescent transgenic 
immune cells within the host. Studies of M. marinum infections have revealed 
mechanisms of bacterial spread within granulomas, such as uninfected macrophage 
attraction to infected macrophage aggregates and inter-macrophage bacterial 
transfer (Pozos et al., 2004). During reactivation, granulomas caseate and cavitate, 
releasing viable bacilli into the lung. Reactivated bacilli can induce a productive 
cough that facilitates dissemination to new hosts (Höner zu Bentrup et al., 2001). 
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1.3 M. tuberculosis stress adaptations 
 
1.3.1 M. tuberculosis non-replicating persister (NRP) cells tolerate 
unfavourable conditions 
 
Non-replicating persister cells (NRP cells) are postulated to be responsible for 
the latent asymptomatic phase in TB-infected individuals. NRP is postulated to be a 
reversible state characterised by (i) lack of replication (ii) decreased metabolic 
activity and (iii) increased antimicrobial resistance. It has been suggested that the 
use of the term ‘dormancy’ to refer to the NRP state is inappropriate because 
bacterial mRNA transcripts are found in lung tissue in the latent stage of disease, 
indicating that latent bacilli retain some metabolic activity. Unfavourable conditions in 
granulomas are postulated to encourage the development of stress-resistant NRP 
cells. (Höner zu Bentrup et al., 2001). 
The Cornell mouse model is an example of an animal model that was 
designed to isolate M. tuberculosis persister cells. In this model, after infecting mice 
with M. tuberculosis, chemotherapy was administered and the infection was thus 
reduced to a point at which no bacterial colonies were isolated when tissue 
homogenates were plated on nutrient agar. From these samples, persistent bacteria 
were retrieved by spontaneous reactivation of the infection or by immuno-
suppressive corticosteroid therapy (Guirado et al., 2013). 
Persistence mechanisms are widely investigated using in vitro models due to 
cost effectiveness, rapidity and reproducibility of preliminary results. M. bovis (BCG), 
M. smegmatis and M. marinum predominate in the literature as models for studying 
M. tuberculosis. The use of M. tuberculosis in growth-based experiments is limited 
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by its slow growth and it being a biosafety level 3 human pathogen (Shiloh et al., 
2010).  
The mechanisms by which actively growing mycobacteria undergo a shift to 
become NRP cells and maintain viability remain to be understood. Several 
processes have been identified that are essential for NRP bacteria viability, including 
NAD+ and ATP synthesis and maintenance of the proton motive force. While protein 
synthesis is greatly reduced, expression of genes encoding several alternative sigma 
factors is greatly enhanced, suggesting that these genes may be involved in 
mediating adaptations to persistence (Rustad et al., 2009). 
The majority of sporulation genes are not required for mycobacterial virulence 
in macrophages and to date, sporulation has not yet been conclusively demonstrated 
in M. tuberculosis (Russell et al., 2007). However, spore-like forms were reported by 
Ghosh et al. (Kirsebom lab), who suggested that sporulation occurs at a low rate in 
M. marinum and M. bovis BCG (Ghosh et al., 2009). Traag et al. conducted similar 
experiments but did not detect spores in M. marinum cultures (Traag et al., 2010). 
Singh et al (Kirsebom lab), suggested that since the signal that triggers sporulation is 
not yet known, the existence of spore-like forms is not easily reproduced (Singh et 
al., 2010). 
Ovoid forms were also suggested to be an NRP cell morphology. Anuchin et 
al. observed non-plateable ovoid forms in M. smegmatis cultured under nitrogen-
limitation. Ovoid forms showed increased antimicrobial and heat resistance, 
diminished metabolic activity and diminished colony forming unit (CFU) viability. 
Ovoid forms could be stored for up to 5 months and recovered to become rod-
24 
 
shaped cells (Anuchin et al., 2009). To date, these NRP cell morphologies have not 
been conclusively accepted. 
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1.3.2 In vitro mycobacterial stress mechanisms  
 
1.3.2.1 Coping with reduced oxygen: M. tuberculosis hypoxic stress tolerance 
and the DosR regulon 
 
Bacterial cells employ respiratory reactions to oxidise metabolites for 
generating energy. Oxygen is important for the functioning of the electron transport 
chain, where the energy generated from the transfer of electrons across a series of 
cytochromes is coupled to ATP synthesis and oxygen is the terminal electron 
acceptor for this process (Cecchini et al., 2003). As described in section 2.2, hypoxia 
is an important stress condition which M. tuberculosis faces in the environment of the 
granuloma. This leads to the question as to how does M. tuberculosis survive 
hypoxia? 
Several models have been developed for investigating mycobacterial stress 
mechanisms. According to the Wayne hypoxia model, NRP cells can be obtained by 
culturing M. tuberculosis in a sealed vessel with a defined culture-to-headspace ratio 
with gentle mixing. This model is convenient for investigating genes involved in 
stress adaptation, due to gradual oxygen depletion and nutrient starvation during 
extended stationary phase (Wayne et al.,1996).  
Regarding the metabolic pathways used to generate energy in hypoxic M. 
tuberculosis, many genes predicted to be involved in M. tuberculosis anaerobic 
respiration are surprisingly repressed or not induced, suggesting that much remains 
to be understood as to how M. tuberculosis remains viable during persistence 
(Rustad et al., 2009). Key regulons involved in hypoxic adaptation are the DosR 
(dormancy survival) and EHR (enduring hypoxic response) regulons (Leistikow et al., 
2010, Rustad et al., 2008). Blocking expression of the DosR regulon had little effect 
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on subsequent expression of the EHR. The EHR regulon contains 230 genes and is 
important for the long-term maintenance of the hypoxic response (Rustad et al., 
2008). 
The DosR regulon is a set of 48 coregulated genes which is induced by three 
factors which inhibit aerobic respiration: hypoxia, NO, and CO. Control and induction 
of the DosR regulon is mediated by a three-component regulatory system composed 
of DosS and DosT, two sensor histidine kinases that bind NO and CO, and a 
response regulator, DosR (Honaker et al. 2009, Leistikow et al,. 2010). The genes of 
the DosR regulon contain a consensus sequence to which DosR binds, known as 
the DosR binding motif (Gautam et al., 2011). DosR genes upregulated during M. 
tuberculosis persistence include universal stress proteins, nitroreductases, 
diacylglycerol acyl transferases, heat shock proteins, and ferredoxins.  
The DosR regulon is primarily involved in the M. tuberculosis initial hypoxic 
response where it is responsible for (i) mediating a shift away from oxygen 
consumption which is necessary for optimal transition of M. tuberculosis to aerobic 
growth from an anaerobic or an NO-induced NRP state and (ii) maintenance of ATP 
levels and balancing of the redox state (NAD/NADH ratio) under hypoxic conditions 
(Gerasimova et al., 2011). It has also been suggested that the DosR regulon plays 
an important role in reducing growth prior to transitioning to the NRP form (Hett et 
al., 2008). Deletion of DosR was associated with a reduction in the abundance of 
70S associated ribosomes in hypoxic M. smegmatis cultures (Trauner et al., 2012). 
This is described further in section 1.3.6. 
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1.3.2.2 M. tuberculosis nutrient starvation stress tolerance: investigating 
energy-limitation responses 
 
Given that M. tuberculosis undergoes nutrient starvation in granulomas and 
that metabolites are important for generating energy in bacteria, mechanisms of 
nutrient starvation stress tolerance are of significant interest in the study of 
mycobacteria. The Loebel model investigated survival of NRP bacilli in general 
nutrient starvation in oxygen-rich conditions (in phosphate-buffered saline, where 
nutrients were absent).  
Loebel et al. found that nutrient-starved M. tuberculosis bacilli survive for long 
periods of time in vitro and undergo a drastic reduction in respiration over the first 96 
hours of starvation (Loebel et al., 1933). Betts et al. adapted the Loebel model to 
investigate changes in M. tuberculosis gene expression under general nutrient 
starvation using microarray analysis and found that 279 genes were upregulated and 
323 genes were downregulated after 96 hours of culture (Betts et al., 2002).  
This study provided evidence for the slowdown of the transcription apparatus, 
energy metabolism, lipid biosynthesis and cell division in addition to induction of the 
stringent response and other genes that may play a role in maintaining long-term 
survival (Betts et al., 2002). It also leads to further questions as to the effectors of 
slowdown of these essential cellular processes. 
Smeulders et al. showed that M. smegmatis remained viable over 650 days 
after a reduction in viability under carbon, nitrogen and phosphorous starvation 
(Smeulders et al., 1999). A study investigating M. smegmatis survival under nutrient 
starvation in a chemostat model found three mechanisms that the bacteria employed 
(i) alteration of metabolism to minimise waste (ii) production of new compounds to 
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scavenge resources and (iii) utilisation of alternative energy sources (Berney et al. 
2010). 
 
1.3.2.3 The stringent response is a bacterial amino acid starvation response 
that is induced in nutrient-starved M. tuberculosis 
 
The stringent response is an amino acid starvation response that has been 
studied extensively in E. coli and other gram negative bacteria. As mentioned in 
section 1.3.2.2, induction of the stringent response was observed in a study of the 
differential expression of M. tuberculosis genes in general nutrient starvation (Betts 
et al., 2002) 
The stringent response is regulated by the alarmone guanosine 
tetraphosphate (ppGpp), a small molecule regulator of transcription of genes 
regulating growth and survival. ppGpp is produced from pppGpp, which itself is 
produced from ATP and GTP by the enzymes RelA and SpoT of the RelA/SpoT 
(RSH) family. RelA is bound to a subset of ribosomes and is activated in response to 
uncharged tRNA in the ribosomal A-site during amino acid starvation. SpoT is 
activated by a range of other starvation stresses.  
ppGpp binds near the active site of RNA polymerase (RNAP) and plays a role 
in repressing rRNA synthesis and ribosome production. Genes negatively regulated 
by ppGpp include genes involved in DNA replication, ribosome assembly, 
translation, fatty acid production and cell wall synthesis. Genes positively regulated 
by ppGpp include genes involved in amino acid biosynthesis and proteolysis and 
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stress tolerance genes, such as osmotic and oxidative stress genes and genes 
encoding universal stress proteins (Magnusson et al., 2005).   
In M. tuberculosis, RelA and SpoT have a single homologue, RelMtb, which 
catalyzes (p)ppGpp synthesis and hydrolysis (Avarbock et al. 2005). Loss of RelMtb 
was associated with impaired survival under nutrient starvation and under extended 
anaerobic incubation. Also, the stringent response is essential for M. tuberculosis 
long term survival in a TB mouse model (Primm et al., 2000) (Dahl et al., 2003).  
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1.4 Bacterial ribosome structure and translation  
 
1.4.1 Bacterial ribosome structure 
 
Protein synthesis, also known as translation, is the process by which the 
message encoded by mRNA is translated into specific amino acids that comprise 
proteins. Given the vast changes in transcription observed in nutrient-starved M. 
tuberculosis described in section 1.3.2.2 and the hypoxic and stringent stress 
responses described in sections 1.3.2.1 and 1.3.2.3 respectively, it is apt to 
investigate whether further regulation occurs at the translation level in M. 
tuberculosis  as a result of energy limitation stresses.  
Ribosomes are structures that mediate translation and comprise ribosomal 
RNA (rRNA) and proteins (r proteins). The majority of ribosomal proteins are less 
than 20 kDa in molecular weight. Ribosomal subunits contain rRNA molecules that 
form a scaffold upon which r proteins bind (Broderson et al. 2005). The subsequent 
information presented in section 1.4 is based on a text by Anders Liljas unless 
otherwise indicated (Liljas, 2004). 
Ribosomes are RNA-protein structures that mediate translation or protein 
synthesis. Bacterial ribosome subunits are named according to their sedimentation 
coefficients; the large subunit is termed the 50S subunit and the small subunit is 
termed the 30S subunit. The two subunits when bound together form the 70S 
ribosomal subunit. These sizes are shared by chloroplast, archaea and plant 
mitochondrial ribosomes, whereas eukaryote ribosomes are composed of the 60S 
large subunit and the 40S small subunit, which together form the 80S ribosome. 
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The 50S ribosomal subunit contains 23S and 5S rRNA whereas the 30S 
subunit contains 16S rRNA. The rRNA molecules provide bindings sites to r proteins, 
which in turn stabilise the rRNA structure. Ribosome crystal structures indicate 
extensive rRNA interactions with r proteins. rRNA molecules form double-stranded 
helices, which themselves form secondary structures comprising kinks and turns 
stabilised by hydrogen bonds. Kink-turn structures have been associated with 
binding to r proteins. Notably, the region of the small subunit that interfaces the large 
subunit is distinctly protein-poor. 
The r proteins are primarily globular and exhibit acidic surface and internal 
basic regions that neutralize the negative charge of rRNA. A repeatedly occurring 
motif, the RNA recognition motif (RRM) is composed of alternating β strands and α 
helices in a pattern known as “split β-α-β”. Also common are OB-fold (oligonucleotide 
binding) domains which contain β sheets. Some proteins also bind zinc, magnesium 
and monovalent ions. 
Arrangement of rRNA helices in the small (30S) subunit allows flexibility which 
is important for its functionality. The large subunit mediates peptidyl transfer in the 
peptidyl transfer centre. Large subunit 23S rRNA contains 6 interwoven domains that 
form a stable core. Interactions between rRNA and r proteins in the large subunit are 
more extensive than those of the small subunit. Two flexible side protuberances, L1 
and the L12 stalk, are functionally important. The entry site of the incoming amino 
acid is known as the A site and the site of polypeptide chain formation is known as 
the P site. The polypeptide exit tunnel allows passage of the nascent polypeptide 
chain to the exterior and its external side is protein-rich.  
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In the 70S ribosome, translational activities mainly occur at the subunit 
interface and ribosome dynamic properties depend on inter-subunit bridges that hold 
ribosomal subunits together. 12 intersubunit bridges have been mapped to specific 
proteins and helices in the 30S and 50S subunits. The bridges are dynamic and 
change or break in response to the changes that occur at the subunit interface.  
 
1.4.2 Bacterial translation 
 
During translation, ribosomes select amino acids in the order needed to form 
the primary structure of polypeptides which form proteins. Ribosome association 
refers to the joining of 50S and 30S subunits to form 70S ribosomes. Ribosome 
dissociation refers to the separation of 70S ribosomes into 50S and 30S subunits. 
Ribosome association and dissociation are key processes in the ribosome cycle. 
Translation takes place in three main stages;  
1. Initiation, the process of mRNA recognition and mRNA positioning. 
2. Elongation, the process of polypeptide chain building based on codon-
anticodon recognition. 
3. Termination, the conclusion of polypeptide building and ribosome recycling. 
During initiation, messenger RNA (mRNA) is threaded through two tunnels, 
which are responsible for: 
(i) binding mRNA  
(ii) decoding the mRNA message. 
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1.4.2.1 Translation initiation 
 
Initiation begins with the 30S subunit recognising the mRNA molecule; the 
Shine-Dalgarno (A- and G- rich) sequence of the mRNA 5’ end is recognized by the 
anti-Shine-Dalgarno sequence of the 30S subunit’s 16S rRNA 3’ end. Recognition 
between these sequences anchors the mRNA to the 30S subunit. In a process 
known as mRNA adaptation, the initiator codon, an RNA triplet found in mRNA, 
positioned in the P-site is recognized by the initiator tRNA anticodon.  
Subsequent codons are recognized by complementary anticodon RNA triplets 
in tRNA carrying specific amino acids. tRNAs bound to rRNA at the A and P sites 
base pair to mRNA for mRNA decoding. Codon-anticodon recognition produces 
small subunit anti-codon stem loop conformation changes, which mediates a 
movement known as “closure”. Initiation factors IF1, IF2 and IF3 mediate fMet-tRNA 
positioning in the P site and IF2 catalyses subunit association. Functions of initiation 
factors are shown in Table 1.2.  
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Table 1.2. Functions of translation initiation factors. (Liljas, 2004). 
 
Initiation factor 
 
 
Function 
 
IF1 
 
 stimulates ribosome subunit dissociation  
 stimulates IF2 binding 
 assists in directing the initiator tRNA to the P site 
IF2  associates the pre-initiation complex (mRNA+30S 
subunit+ IFs) to the large subunit 
IF3  prevents association between the two ribosomal subunits 
before initiation is complete (interaction site with 
intersubunit bridge has been confirmed) 
 promotes 70S ribosome dissociation and maintains a pool 
of free 30S ribosomal subunits 
 directs initiator tRNA to the P-site 
 influences kinetics and fidelity of codon-anticodon 
recognition 
 
 
1.4.2.2 Elongation 
 
Subsequently, the large ribosomal subunit binds and elongation begins. The 
sites at which tRNA interact with the large subunit are present in a tunnel at the 
subunit interface known as the peptidyl transferase centre. These sites, in order of 
tRNA migration during translation are as follows;  
1. T-site: entry site where tRNA bound with elongation factor EF-Tu is located  
2. A-site: site for aminoacyl tRNA complexes  
3. P-site: site for peptidyl tRNA complexes  
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4. E-site: exit site where deacetylated tRNA is located before exiting the 
ribosome. 
The A, P and E sites are the tRNA binding sites of the ribosome. Of these, the 
A and P sites play a significant role in elongation and reactions in these sites are 
catalysed by the rRNA component of the ribosome (Broderson et al., 2005). During 
elongation, each amino acid is added to the growing polypeptide chain after codon-
anti-codon interaction, in a process known as decoding.  
The aa-tRNA amino acid end contacts the 50S subunit peptidyl transferase 
centre. The aa-tRNA anticodon end contacts the mRNA decoding site of the 30S 
subunit, where it is bound to its corresponding mRNA codon in the A site (Fig. 1.2). A 
peptide bond then forms between the amino acid of the tRNA in the A site and the 
amino acid of the charged tRNA in the P site. The growing polypeptide chain is 
transferred to the tRNA in the A site. This tRNA is then known as the peptidyl tRNA. 
Elongation factors EFTu and EFG assist in this process and their main features are 
included in Table 1.3. 
The peptidyl-tRNA in the A site carrying the nascent polypeptide chain is to be 
shifted to the P site so that another aatRNA can bind at the A-site, in a process 
known as translocation. To achieve this, the ribosome undergoes a “ratchet-like” 
movement, an approximately 10o anticlockwise rotation of the 30S subunit relative to 
the large subunit induced by EF-G:GTP. This mediates (i) tRNA shifting from the A- 
and P- sites to the P- and E-sites respectively and (ii) movement of mRNA to expose 
the next codon in the A-site (Fig. 1.2), allowing entry of the next aa-tRNA and mRNA 
codon. Upon dissociation of EF-GDP, the ribosome returns to its original subunit 
orientation.  
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Table 1.3. Features of key translation elongation factors. (Liljas, 2004). 
 
Elongation factor 
 
 
Features 
 
EF-Tu 
 
 binds aminoacyl tRNAs to the A site and protects 
aminoacyl tRNAs from hydrolysis 
 GTP hydrolysis induces a conformational change to 
activate EF-Tu. EF-Tu mediates removal of GDP from 
the ribosome 
EF-G  translocase; mediates translocation of peptidyl tRNA 
and mRNA after peptidyl transfer (“ratchet-like” 
movement) 
 GTP hydrolysis induces a conformational change to 
activate EF-G 
 
1.4.2.3 Termination 
 
Translation is terminated when a stop codon is encountered. The stop codon 
is recognized by class 1 termination factors which hydrolyse the polypeptide from the 
tRNA. Ribosome recycling allows binding of new mRNA to the ribosome, since the 
previous mRNA and deacetylated tRNAs exit the ribosome and the ribosomal 
subunits are dissociated from each other. This process is mediated by ribosome 
recycling factor, RRF, which binds across the A and E sites. Ribosomes interact with 
membrane proteins via the 50S subunit which contains a polypeptide exit tunnel, a 
non-polar tunnel in which the nascent polypeptide chain travels out of the ribosome, 
and is protected from digestion by proteolytic enzymes. Protein folding occurs when 
polypeptide chain emerges from the ribosome (Broderson et al., 2005). 
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1.5 Bacterial ribosome stabilisation 
 
1.5.1 Ribosome stabilisation is a form of bacterial translational regulation 
associated with nutrient starvation 
 
Studies of ribosomal heterogeneity and specialisation in bacteria and 
eukaryotes refuted the view that ribosomes and translation are unchanging entities 
(Gilbert et al., 2010). An example of a specialised ribosome is the stabilised 
ribosome. Ribosome stabilisation is defined as the association of ribosomal subunits 
or ribosomes which renders them translationally inactive. Ribosome stabilisation is a 
means of exit from the ribosome cycle and is a form of translational regulation found 
in several bacterial and eukaryotic species (Ortiz et al., 2010, Krokowski et al., 
2011).  
E. coli stationary phase ribosomes were found to have lower affinity for 
ribosome initiation and dissociation factors compared to log phase ribosomes, 
suggesting that ribosome stabilisation and translation inhibition may be important 
adaptations during stationary phase (Yoshida et al., 2009). Evidence describing 
ribosome stabilisation in E. coli is described in sections 1.5.2 and 1.5.3.  
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1.5.2 Escherichia coli stabilised ribosomes exist as both 70S monomers and 
100S dimers 
 
In Escherichia coli (E. coli), ribosome stabilisation results in the formation of 
both 70S ribosome monomers and 100S ribosome dimers. The 70S monomer is 
formed by the association of the 50S and 30S ribosomal subunits. The 100S dimer is 
a higher order ribosomal structure that is formed when two 70S ribosomes are joined 
together via their 30S subunits. It has been shown to be translationally inactive 
(Wada et al., 1995). The 30S subunits contact each other in two regions (Fig. 1.3) 
(Ortiz et al., 2010).  
Ortiz et al. investigated 100S dimer formation and distribution in different 
growth phases. Cryoelectron tomography indicated that an estimated 10% to 20% of 
stabilised ribosomes formed 100S dimers in minimal media stationary phase. The 
cellular distribution of the 100S dimers indicated that in this condition, they cluster 
together. The proportion of 100S dimers was lower in exponential phase and 
clustering of 100S dimers was not observed. Furthermore, addition of amino acids 
resulted in reduction of 100S dimers in stationary phase cells (Ortiz et al., 2010). 
Taken together, these data suggested a role for 100S dimer formation in tolerance of 
stationary phase nutrient starvation in E. coli. 
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Figure 1.3. Cryo-electron tomography-derived structure of the E. coli 100S dimer, a 
stabilised ribosomal form of E. coli found most abundantly in minimal media 
stationary phase cultures. (A) Averaged 100S ribosome density map based on cryo-
electron tomograms of E. coli grown to stationary phase in minimal media with 70S 
ribosome crystal structure docked into the density map. 50S ribosome subunits are 
shown in blue and 30S subunits are shown in yellow. (B) Cross-section of the 100S 
ribosome density map from (A). Two major contact regions between the 70S 
ribosome particles (I and II) were identified. Ribosomal proteins S9, S10, and the 
16S rRNA helix 39 were located near region 1 and protein S2 was located near 
region 2. Imaged adapted from Ortiz et al., 2010. 
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1.5.3. E. coli ribosome stabilisation factors 
 
1.5.3.1 E. coli ribosome stabilisation factors affect ribosomal subunit 
association 
 
Since 100S dimers are translationally inactive ribosomal forms, 100S 
dimerisation is an example of ribosome stabilisation (see section 1.5.2). Given that 
100S dimers and 70S monomers potentially play a role in nutrient starvation 
tolerance, their discovery led to further questions regarding the factors responsible 
for ribosome stabilisation. Three ribosome stabilisation factors (RSFs) are 
responsible for E. coli ribosome stabilisation; protein Y (also known as YfiA) (PY), 
ribosome modulation factor (RMF) and hibernation promoting factor (HPF).  
The effect of RSFs on ribosome subunit association suggested a role for 
these proteins in ribosome stabilisation. Ribosome profiling indicated that RMF and 
HPF are involved in the sequential conversion of 70S monomers to 100S dimers as 
follows: 
1. RMF causes dimerisation of 70S ribosome monomers to form 90S dimers. 
(Wada et al., 1995). 
2. HPF, also known as Yhbh, binds to 90S dimers and converts them to 100S 
dimers. (Ueta et al., 2008). 
Polikanov et al. determined high resolution crystal structures of RMF, HPF 
and YfiA in complex with the Thermus thermophilus ribosome. The structures 
indicated the binding sites of these proteins and mechanisms by which they inhibit 
translation. The findings regarding RMF, HPF and PY are described sections 1.5.3.2, 
1.5.3.3 and 1.5.3.4, respectively (Polikanov et al., 2012).  
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Compared to ribosome stabilisation in E. coli, in Lactococcus lactis, YfiA is 
necessary and sufficient for 100S ribosome dimerisation. Furthermore, yfiA deletion 
diminished survival in energy starving conditions (Puri et al., 2014). This indicates 
that in some organisms, ribosome stabilisation can be mediated by a single factor. 
Since the docking sites of E. coli ribosome stabilisation factors have been 
characterised and this gives insight into their mechanism, the remainder of this 
section describes the ribosome stabilisation factors of E. coli. 
 
1.5.3.2 E. coli RMF (Ribosome Modulation Factor) prevents mRNA binding to 
the ribosome, inhibits translation and promotes 90S ribosome dimer formation 
 
RMF was found to bind to stationary phase ribosomes in E. coli and was 
associated with ribosome dimer formation. RMF is synthesised prior to stationary 
phase and also in a slowly growing nutrient-starved state. Deletion of rmf was 
associated with decreased survival of E. coli in 5 hours of acid stress culture at pH3 
(El-Sharoud et al., 2007). Also, deletion of rmf was associated with decreased 
survival of E. coli in 100 minutes of heat stress at 50oC. 
This viability defect in heat stress was more pronounced for E. coli stationary 
phase cells lacking rmf, whose ribosomes also showed a defect in thermal stability 
as shown by differential scanning calorimetry. Deletion of rmf was also associated 
with a decrease in the abundance of 100S ribosome dimers under heat stress in 
stationary phase. Taken together, the data indicated a significant role for rmf in 
tolerance of acid and heat stress during stationary phase (Niven et al., 2004). 
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Furthermore, RMF is a significant inhibitor of in vitro translation; RMF inhibited 
both phage MS2 and polyU mRNA in vitro translation (Wada et al., 1995 and 
Yoshida et al., 2009). The gene encoding RMF is widely present in 
gammaproteobacteria, but is not present in any other bacteria (Ueta et al., 2013). 
Polikanov et al. later showed that RMF binds to 3 nucleotides of 3’ end 16S rRNA at 
the anti-Shine-Dalgarno region (Fig. 1.4).  
By occupying this position, RMF blocks access of the mRNA Shine-Dalgarno 
(SD) sequence to the 30S ribosomal subunit, thus preventing translation initiation. 
Furthermore, RMF involvement in the dimerisation of 30S subunits is supported by 
the observation that 30S subunits dimerise in vitro upon the addition of RMF 
(Polikanov et al., 2012). 
Polikanov et al identified the two points of contact between the 30S subunits 
that had been described previously by Ortiz et al. (Polikanov et al., 2012, Ortiz et al., 
2010). RMF-induced 30S subunit dimerisation was not a result of RMF proteins 
contacting each other, suggesting that 30S subunits directly contact each other 
during dimerisation. Polikanov et al. hypothesised that the binding of RMF to two 
30S subunits induces a conformational change which allows the 30S subunits to 
contact each other and that binding of HPF further stabilises 100S dimer formation 
(Polikanov et al., 2012). 
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Figure 1.4. E. coli RMF blocks access of mRNA to the 30S ribosomal subunit, 
preventing translation initiation. RMF mediates dimerisation of 70S ribosomes to 
form 90S stabilised ribosome dimers, a process which is mediated by joining of 30S 
subunits. RMF (blue) binds to 3 nucleotides of 3’ end 16S rRNA at the anti-Shine-
Dalgarno region and prevents recognition of the Shine-Dalgarno sequence of mRNA 
by the ribosome. The image shown is based on a high resolution crystal structure of 
RMF in complex with the Thermus thermophilus ribosome. Figure adapted from 
Polikanov et al. 2012. 
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1.5.3.3 E. coli HPF (Hibernation Promoting Factor) promotes 100S ribosome 
dimer formation whereas PY inhibits 100S ribosome dimer formation 
 
According to Polikanov’s HPF-ribosome and PY-ribosome crystal structures 
(described in section 1.5.3.1), HPF and PY both bind at the channel of the 30S 
subunit that lies between the head and body, where tRNAs and mRNA bind during 
protein synthesis. Although their binding sites overlap, they have opposing roles; 
HPF promotes 100S dimer formation whereas PY inhibits its formation.  
 
 
Figure 1.5. PY (YfiA) (yellow) and HPF (green) bind at the channel between the head 
and body of the 30S subunit, where tRNAs and mRNA bind during protein synthesis. 
HPF promotes 100S dimer formation whereas PY inhibits 100S dimer formation. The 
image shown is based on high resolution crystal structures of PY and HPF in 
complex with the Thermus thermophilus ribosome. Figure adapted from Polikanov et 
al. 2012. 
 
  
47 
 
In E. coli, HPF is a significant inhibitor of phage MS2 mRNA translation (SD 
present) but is not a significant inhibitor of polyU mRNA translation (Ueta et al., 
2008). On the other hand, PY inhibits translation of both GFP (SD present) and 
polyU mRNA (Agafonov et al., 2001). In E. coli, RMF and HPF together are 
responsible for mediating ribosome dimerisation.  
IF3 is an initiation factor that dissociates 70S ribosomes into individual 
subunits. Although IF3 is capable of removing HPF from the ribosome, 100S dimers 
stabilised by both RMF and HPF were found to be unaffected by incubating with IF3 
(Yoshida et al., 2009). However, 100S ribosome dimerisation is rapidly reversed by 
adding nutrients. Upon transferring E. coli cells from nutrient starvation to fresh 
medium, RMF and HPF exit 100S dimers within 1 minute of transfer and cells start to 
proliferate within 6 minutes (Aiso et al., 2005). 
E. coli HPF is known as a “short HPF” since it lacks a long C-terminal 
extension. Short HPFs are predominantly present amongst gammaproteobacteria 
(e.g. E. coli, Salmonella Typhimurium, Yersinia pestis, Klebsiella pneumonia, 
Pseudomonas fluorescens and Vibrio cholerae). “Long HPFs” had longer C-terminal 
extensions and did not require RMF for 100S ribosome formation.  
“Long HPFs” were characteristic of non-gammaproteobacteria (e.g. Bacillus 
subtilis, Staphylococcus aureus, Streptococcus pyogenes, M. tuberculosis and 
Borrelia burgdorferi)  (Ueta et al., 2008, Ueta et al., 2013). In Staphylococcus 
aureus, SaHPF is a homologue of HPF but no RMF homolog exists. Unlike in E. coli 
where 100S dimers are found exclusively in stationary phase, 100S dimers exist in 
all growth phases of S. aureus and the highest levels of 100S dimers are found at 
the transition from exponential phase to stationary phase. 
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Given that 100S ribosome dimer formation is not a feature of mycobacterial 
ribosome stabilisation (Trauner, 2010), the promotion of 70S ribosome monomer 
formation is a putative ribosome stabilisation mechanism in mycobacteria. Since PY 
promotes 70S ribosome monomer formation, the findings regarding PY are 
addressed in the subsequent section (1.5.3.4). 
 
1.5.3.4 PY (E. coli) promotes 70S ribosomal monomer formation and inhibits 
100S ribosome dimer formation. 
 
PY, also known as YfiA, is an RSF and S30AE protein of 70S E. coli 
ribosomes. S30AE proteins are prevalent amongst several bacterial and 
cyanobacterial species (see section 4.1). Agafonov et al. carried out studies 
regarding PY’s effect on in vitro translation and determined that PY inhibited GFP 
mRNA translation and polyU mRNA translation (Ribosome: PY 1:1 and 1:4 
respectively) (Agafonov et al., 2001). Deletion of yfia did not affect growth and 
viability in 8 days of culture (Ueta et al., 2005). 
PY is bound to ribosomes during stationary phase at 37°C (Maki et al. 2000; 
Agafonov et al. 2001). When initially discovered, PY was shown to increase the 
proportion of 70S monomers (Agafonov et al., 1999). Deletion of yfiA was associated 
with an increase in 100S dimer formation; ΔyfiA (RMF and HPF present) showed a 
higher proportion of 100S dimers than wild type, whereas 100S dimers were not 
isolated from Δhpf (RMF and YfiA present) (Ueta et al., 2008). These findings 
suggested that PY activity is anti-ribosome dimerisation.  
Supporting this anti-dimerisation role, PY was suggested to block the binding 
of RMF and HPF to the ribosome. The long C-terminal extension of PY has been 
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shown to overlap with the binding site of RMF (Figure 1.6). Thus, prevention of RMF 
binding is a suggested mechanism that explains the anti-dimerisation effect of PY 
(Polikanov et al., 2012). Furthermore, PY also occupies the same binding site as 
HPF and stabilises the 30S subunit in its apo-conformation i.e. the 30S subunit 
conformation without RMF bound.  
 
 
 
Figure 1.6. The binding site of PY which overlaps with that of RMF supports its anti-
ribosome dimerisation role in E. coli. The long C-terminal extension (red) of PY 
(yellow) is shown to overlap with the binding site of RMF (blue). Prevention of RMF 
binding to the 30S ribosome is suggested to explain the anti-dimerisation effect of 
PY. The image shown is based on high resolution crystal structures of PY and RMF 
in complex with the Thermus thermophilus ribosome. Figure adapted from Polikanov 
et al. 2012. 
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1.5.3.5 PY (E. coli) is an auxiliary factor in cold acclimation 
 
The binding of PY at the 30S ribosomal subunit mRNA channel and PY’s 
inhibition of GFP and polyU mRNA translation were established (sections 1.5.3.3 
and 1.5.3.4. Here, I review the findings of Di Pietro et al. which challenge the 
previous hypothesis that PY is a central regulator during cold shock tolerance 
(Wilson et al. 2004).  
During cold shock at 15oC, E. coli cells are known to undergo transient growth 
arrest and an acclimation phase characterised by bulk protein synthesis repression 
and expression of cold shock genes. Cold shock mRNA regulatory elements render 
cold shock mRNAs suitable for translation in cold conditions (Di Pietro et al. 2013). 
Although it had been suggested that PY may play a central role in repressing bulk 
protein synthesis during cold shock– in particular repression of non-cold shock 
protein synthesis (Wilson et al, 2004),  
Di Pietro’s findings indicated that in cold acclimation, PY does not play a 
central regulatory role in growth, in maintaining viability or in repressing bulk protein 
synthesis. The following findings regarding PY illustrate its non-central role during 
cold shock: 
1. PY was dispensable for growth at 37oC and at 10oC.  
2. PY was dispensable for viability in cold shock after growth at 37oC.  
3. At 15oC, translation assays indicated partial inhibition of translation achieved 
at the highest amounts of PY added (80 pmol) and that inhibition varied 
depending on the mRNA employed.  
4. Translation of several cold shock mRNA was strongly inhibited. With cspA 
cold shock (cs) mRNA, strong inhibition of translation (80%) was seen when 
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PY was pre-incubated with 50S and 30S subunits, prior to the addition of 
initiation factors. At 15oC, inhibition of translation of cspA mRNA (cs) was 
55%. At 37oC, inhibition of translation of cspG mRNA (cs) was 45% (Di Pietro 
et al. 2013). 
 
PY acts as an auxiliary factor in cold acclimation: 
1. PY played a partial role in reducing bulk protein synthesis, as was determined 
by investigating the effect of yfiA deletion on cell lysate protein content in cells 
undergoing cold shock; For in vitro translation at 15oC versus at 37oC, 
translation inhibition was higher at 40 – 50% versus at 20 – 30%, respectively.  
2. PY appeared to increase translation resumption efficiency upon exiting the 
cold acclimation phase (Di Pietro et al. 2013).  
 
Taken together, Di Pietro’s findings suggest a non-central role for PY in 
protein synthesis regulation during cold acclimation and that PY-mediated inhibition 
of translation is mRNA-specific and temperature-specific.  
 
1.5.3.6 PY stabilisation of 70S ribosome monomers is most effective when 
ribosomes are dissociated and when initiation factors are absent 
 
Further to Polikanov’s findings regarding PY’s docking site at the 30S 
ribosomal subunit and Agafonov’s findings regarding PY-mediated in vitro inhibition 
of translation, Di Pietro’s findings indicated that (i) the translation inhibition 
mechanism of PY involves PY binding 30S ribosomal subunits to prevent initiation 
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complex formation and that (ii) PY binding to the ribosome is most effective when 
ribosomes are dissociated and when initiation factors are absent (Polikanov et al., 
2012, Agafonov et al., 2001). 
The findings of Di Pietro et al. indicated that: 
 
1. PY bound rapidly and tightly to 30S subunits and slowly and weakly to 50S 
subunits as shown by fluorophore tagging and binding affinity studies of PY-
ribosome interaction. This agrees with PY’s known binding site as 
determined by Polikanov (Polikanov et al., 2012). 
2. PY accelerated the kinetics of idle 70S ribosome formation by approximately 
two-fold. This agrees with PY’s known activity in promoting 70S ribosome 
monomer formation (Ueta et al. 2005). 
3. PY did not destabilise fMet-tRNA once it was correctly positioned on the 
ribosome, suggesting that PY does not compete effectively with initiation 
factors for binding to the 30S subunit. 
4. When pre-incubated with 30S subunits without initiation factors, PY was 
associated with a two-fold reduction in fMet-tRNA and initiation factor binding 
to the 30S subunit (Di Pietro et al. 2013). 
Without pre-incubating PY with dissociated ribosomes in the absence of 
initiation factors, PY-mediated inhibition of initiation complex formation is scarce. 
This suggests that it is worthwhile to investigate PY’s inhibitory activity in conditions 
where initiation factors are less abundant, such as in energy-limiting conditions when 
the nutrient supply is low. This may lead towards a better understanding of the 
conditions contributing to ribosome stabilisation and how PY is regulated 
accordingly.  
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Furthermore, studies that investigate the ribosome stabilisation activity of PY 
in conditions of nutrient starvation are lacking, and based on the mechanistic model 
presented, further investigations of the role of PY in translation inhibition during 
starvation stress tolerance is warranted. 
 
1.6 Investigating mycobacterial ribosome stabilisation  
 
1.6.1 The mycobacterial ribosome stabilisation hypothesis 
 
The mycobacterial ribosome stabilisation hypothesis states that in 
mycobacteria, the association of 50S and 30S ribosomal subunits results in the 
formation of inactive 70S stabilised ribosomes (Trauner et al., 2010). 70S stabilised 
ribosomes were postulated to be the sole stabilised form of ribosomes since higher 
order ribosomal structures such as 100S dimers were found to be absent in M. 
smegmatis and M. bovis.  
The mycobacterial ribosome stabilisation hypothesis stated above is a general 
hypothesis that is not limited to a specific condition. A more specific hypothesis was 
postulated to address mycobacterial ribosome stabilisation in NRP cells (see section 
1.6.2). M. smegmatis ribosome subunit composition was investigated in hypoxic 
stasis by investigating changes in RNA biosynthesis levels, rRNA stability and 
ribosomal sucrose gradient profiling. The 70S ribosome was shown to be the 
predominant form in normoxic, hypoxic and carbon starved M. smegmatis stasis 
(Trauner, 2010). Also, the DosR regulon was shown to play a role in ribosome 
subunit association in hypoxic stasis. These findings are described in section 1.6.2. 
54 
 
1.6.2 The mycobacterial ribosome stabilisation NRP hypothesis  
 
M. tuberculosis NRP cells are in a state of non-replicating persistence as 
described in section 1.3.1 and the mechanisms that allow NRP persistence and 
survival despite unfavourable conditions in granulomas are being investigated. The 
general hypothesis of macromolecular stability in NRP cells is that the stabilisation of 
essential cellular structures is needed for the transition from NRP to active 
replication (Leistikow et al., 2010).  
More specifically, the mycobacterial ribosome stabilisation hypothesis states 
that ribosomes must be stabilised in NRP cells in order to be available during active 
replication, when conditions are favourable for return to active growth.  In addition to 
the ribosome stabilisation hypothesis, it has been postulated that the ability to sense 
and respond to environmental stimuli is needed so that entry into and exit from the 
NRP state is regulated according to conditions present (Dworkin et al., 2010). Thus, 
putative ribosome stabilisation factors are postulated to mediate ribosome 
stabilisation and assist in regulating mycobacterial stress tolerance and persistence.  
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1.6.3 DosR is necessary and sufficient for M. smegmatis ribosome subunit 
association in hypoxic stasis 
 
The DosR regulon plays a role in the initial hypoxic response in M. 
tuberculosis and is described in section 1.3.2.1. Trauner determined that the DosR 
regulon plays a role in promoting 70S ribosome monomer formation in M. smegmatis 
hypoxic stasis cultures. Although dosR deletion did not appear to affect the level of 
70S ribosomes in normoxic stasis, 50S ribosomes were the predominant form 
isolated from ∆dosR mutant hypoxic stasis cultures (Trauner et al., 2010, Trauner et 
al., 2012). This suggested that DosR is necessary and sufficient for M. smegmatis 
ribosome subunit association in hypoxic stasis. 
In M. smegmatis, the transition from active growth to hypoxic stasis is 
characterised by a decrease in rRNA biosynthesis levels, suggesting that ribosome 
assembly is reduced in stationary phase. In ∆dosR mutants, the decrease in rRNA 
levels during prolonged hypoxia was more rapid, suggesting that DosR plays a role 
in maintaining rRNA levels in hypoxic stasis (Trauner et al., 2010). The role of DosR 
in 70S ribosomal subunit association supported the mycobacterial ribosome 
stabilisation NRP hypothesis (see section 1.6.2). 
During hypoxic stasis in M. smegmatis, a marked decrease in the proportion 
of 30S subunits compared to 50S subunits was observed. In ∆dosR mutants, this 
effect was more pronounced, suggesting that DosR plays a role in maintaining 30S 
subunit levels in hypoxic stasis. Given that E. coli RSFs bind at the 30S subunit (see 
section 1.5.3), the role of DosR is maintaining 30S subunit levels led to the question 
as to whether a putative RSF in M. smegmatis was regulated by DosR (see section 
1.6.4). 
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1.6.4 RafS and RafH are putative mycobacterial ribosome stabilisation factors 
 
Given that DosR was found to play a role in mycobacterial ribosome subunit 
association in hypoxic stasis (section 1.6.3) and ribosome 100S dimerisation in E. 
coli occurs in minimal media (section 1.5.2), proteomic analysis was conducted on 
ribosomes obtained from hypoxic and carbon-starved stasis M. smegmatis cultures 
to investigate whether putative ribosome stabilisation factors were bound to the 
ribosomes. 
Two hypothetical proteins were found to bind to M. smegmatis ribosomes 
under hypoxic and carbon-starved stasis. MSMEG_3935 and MSMEG_1878, were 
bound to ribosomes in hypoxic stasis. MSMEG_1878 was also bound to ribosomes 
in carbon-starved stasis. In active normoxic growth, these proteins were not bound to 
ribosomes in significant amounts (Trauner, 2010).  
MSMEG_3935 and MSMEG_1878 were found to be S30AE proteins 
containing the S30AE domain, a ribosome-binding domain, and are homologous to 
M. tuberculosis S30AE proteins Rv3241c and Rv0079, respectively (95% and 80% 
protein sequence identity with their respective M. tuberculosis homologues, NCBI 
blastp). The S30AE domain contains two alpha helices and a four-stranded beta 
sheet (Zhukov et al., 2007). This domain is also present in PY (section 1.5.3). 
Further details of the bioinformatic characteristics of these proteins are described in 
section 4.1. 
The mycobacterial S30AE proteins were named ribosome associated factors 
(Raf proteins). MSMEG_1878 and Rv3241c were named RafSMsm and RafSMtb and 
MSMEG_3935 and Rv0079 were named RafHMsm and RafHMtb, respectively. The 
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role of RafSMsm and RafSMtb in ribosome stabilisation was the main hypothesis 
investigated in this project and research aims are outlined in section 1.8. 
 
1.6.5 M. smegmatis RafHMsm is a putative ribosome stabilisation factor that 
plays a role in maintaining rRNA stability and viability in hypoxic stasis and in 
maintaining viability in heat stress 
 
RafHMsm was found to be a member of the DosR regulon, since its upstream 
region contained an element that is regulated by DosR. Furthermore, RafHMsm was 
absent from ∆dosR mutant ribosomes (Trauner, 2010). Phenotypic and 
complementation analysis of ∆rafHMsm and ∆dosR mutants indicated that rafHMsm 
contributes to ∆dosR mutant phenotypes (Trauner, 2010, Trauner et al., 2012). 
1. ∆rafHMsm rRNA stability is compromised during prolonged hypoxic stasis, 
suggesting that RafHMsm plays a role in maintaining rRNA stability in hypoxic 
stasis. 
2. ∆rafHMsm viability is impaired during prolonged hypoxic stasis, but to a lesser 
extent than for ∆dosR, suggesting that RafHMsm plays a role in maintaining 
viability in hypoxic stasis. 
3. ∆rafHMsm viability is impaired in heat stress at 55oC to a similar extent as for 
∆dosR. Provision of rafHMsm in trans fully restored the ∆dosR phenotype  
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1.7 Investigating RafS, a putative ribosomal stabilisation factor in 
mycobacteria 
 
1.7.1 Gene environment of RafS 
 
Notably, the genome of M. leprae was found to contain rafS, but not rafH, 
suggesting that investigation of a role of RafS in non-tuberculous mycobacteria is 
also warranted. Miotto et al identified the presence of a small RNA at the negative 
strand of the 5’ untranslated region ≤ 80 bp upstream of the Rv3241c gene by global 
RNA-seq analysis of exponentially growing cultures of M. tuberculosis H37Rv. The 
presence of a -10 consensus sigma factor a promoter sequence was also found to 
be associated with this sRNA.  
Also, the sRNA was visualised by northern blot analysis of exponential and 
stationary phase cultures. Sig a is a primary sigma factor associated with regulation 
of gene expression during the exponential growth phase. Regulatory RNA species 
function via a range of mechanisms and the function of the sRNA upstream of 
Rv3241c is yet unknown (Miotto et al., 2012). 
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Figure 1.7. Gene environment of rafSMtb (Rv3241c) in the M. tuberculosis genome 
(Tuberculist). Available gene annotations are indicated. SecA is involved in protein 
export across the cytoplasmic membrane (Hou et al., 2008). 
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In the same model, rafSMtb was also significantly upregulated after 24 hours of 
stationary phase general nutrient starvation (PBS) (p = 3.3 x 10-4) and rafSMtb 
expression was 2.07 fold higher than in active growth in rich media. At 96 hours, no 
significant difference in rafSMtb gene expression was observed. The data suggested 
the role of RafSMtb in tolerance of early nutrient starvation in 2 to 24 hour standing 
cultures is worth further investigation. 
In comparison, expression of rafHMtb was significantly down-regulated (10.2 
fold) in general nutrient starvation (Figure 1.8). Also down-regulated at 96 hours 
were several genes involved in energy metabolism, lipid biosynthesis, polyketide and 
non-ribosomal peptide synthesis and genes encoding ribosomal proteins. Among the 
characterised genes that were upregulated at 96 hours were transcriptional 
regulators of the GntR, ArsR, Lrp/AsnC families (Betts et al., 2002).  
However, Beste et al. detected that transposon mutant ΔrafHMbo was one of 29 
mutants with reduced fitness in fast growth (doubling time = 23 days) in a carbon-
limited chemostat (probability of false prediction <0.1), suggesting a role for rafHMtb in 
carbon starvation in a continuous culture fast growth M. bovis BCG chemostat model 
(Beste et al. 2009). 

 
 

)LJXUH0WXEHUFXORVLV5DISURWHLQH[SUHVVLRQ LVDOWHUHGGXULQJJHQHUDOQXWULHQW
VWDUYDWLRQLQVWDQGLQJFXOWXUHV$5DI60WEH[SUHVVLRQLVVLJQLILFDQWO\XSUHJXODWHGLQ
HDUO\QXWULHQWVWDUYDWLRQ3%6%5DI+0WEH[SUHVVLRQLVVLJQLILFDQWO\GRZQUHJXODWHG
LQWRKRXUQXWULHQWVWDUYDWLRQ3%6,PDJHJHQHUDWHGEDVHGRQGDWDIURP%HWWV
HW DO  )ROG FKDQJH LQ JHQH H[SUHVVLRQ ZDV FRPSDUHG LQ 0 WXEHUFXORVLV
VWDWLRQDU\SKDVHJHQHUDOQXWULHQWVWDUYDWLRQYHUVXVDFWLYHJURZWKLQULFKPHGLD%HWWV
HWDO

.UXK HW DO HPSOR\HG PDVV VSHFWURPHWU\ WR LQYHVWLJDWH WKH H[SUHVVHG
SURWHRPH LQ HDUO\ DQG FKURQLF VWDJHV RI0 WXEHUFXORVLV GLVHDVH LQ D JXLQHD SLJ
PRGHO5DI60WEZDVRQHRI WKHSURWHLQVGHWHFWHG LQGD\ LQIHFWHG OXQJVDQG
ZDVDEVHQWIURPWKRVH LGHQWLILHGIURPGD\ LQIHFWHG OXQJVDQGWKRVH LGHQWLILHG LQ
XQLQIHFWHG OXQJV .UXK HW DO  7KLV ILQGLQJ VXJJHVWHG WKDW WKH DFWLYLW\ RI
5DI60WELV OLNHO\ WREHPRVW UHOHYDQW WRHDUO\ GD\0WXEHUFXORVLV LQIHFWLRQ7KH
ILQGLQJVSUHVHQWHGLQWKLVVHFWLRQVXSSRUWHGRXULQYHVWLJDWLRQRI5DISURWHLQVZKLFK
LVGLVFXVVHGLQWKHQH[WVHFWLRQ
63 
 
 
1.8 Investigating RafS-mediated ribosomal stabilisation in mycobacteria: 
project rationale and aims 
 
The role of RafS has not been investigated prior to the start of this project. 
This project investigates the role of putative RSFs, RafSMsm and RafSMtb using 
physiological and biochemical approaches. Further details of the discovery of the Raf 
proteins and the findings regarding RafHMsm are described in section 1.6.3. The 
mycobacterial ribosome stabilisation hypothesis states that in mycobacteria, the 
association of 50S and 30S ribosomal subunits results in the formation of inactive 
70S stabilised ribosomes. We investigated the hypothesis that RafS is an RSF which 
plays a role in stress tolerance in M. smegmatis and in M. tuberculosis.  
Given the association of RafSMtb expression with nutrient limitation and guinea 
pig lung infection described in section 1.7.2, physiological studies were employed to 
investigate the role of RafSMsm in growth and stasis during nutrient abundance and 
limitation. The role of RafSMsm in mature biofilm and pellicle formation, in competitive 
survival and in resuscitation from prolonged stasis were also investigated. Regarding 
biochemical investigations, I employed ribosomal profiling to investigate whether 
RafSMsm plays a role in stabilisation of a subset of ribosomes during active growth 
and early stationary phase. Also, the effect of purified RafSMsm and RafHMtb on in 
vitro translation was investigated. The role of RafSMtb in growth and competitive 
survival was investigated.  
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In summary, the project’s aims were to investigate: 
 
1. the effect of rafSMsm deletion on active growth, survival, resuscitation and 
competitive fitness in nutrient abundance and starvation, 
2. the effect of rafSMtb deletion on active growth and competitive fitness in prolonged 
stationary phase, 
3. the effect of rafSMsm deletion on pH, heat and antibiotic stress tolerance, 
4. the effect of rafSMsm deletion on mature biofilm and pellicle formation, 
5. bioinformatic features of Raf proteins, 
6. the effect of RafS and RafH on in vitro translation,  
7. the effect of rafSMsm deletion on ribosome subunit association in active growth 
and stationary phase. 
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2. Materials and Methods 
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2.1 Media and Chemicals 
 
M. smegmatis and E. coli strains were routinely cultured at 37°C in LB Tween 
80 and LB media, respectively. Media was prepared and sterilised by autoclaving at 
121oC for 15 mins. 7H9 (BD) medium was used for culturing M. tuberculosis and for 
carrying out the MABA assay. 7H11 agar (BD or Sigma) was used for culturing M. 
tuberculosis. Antibiotics (Sigma) were prepared by dissolving in distilled water and 
filter-sterilising using a 0.2 µm pore syringe filter (Nalgene).  
 
2.1.1 Media formulations  
 
Luria Broth (LB)   
Components per L: 
5 g Yeast extract  (Fisher Sci.), 5 g NaCl  (Sigma), 10 g Tryptone  (Fisher Sci.), 15g 
Agar  (Sigma)  (for LB agar only). 
Trace compounds: 0.01 g EDTA, 0.1 g MgCl2 · 6H2O, 1 mg CaCl2 · 2H2O, 0.2 mg 
NaMoO4 · 2H2O,  0.4 mg  CoCl2 · 6H2O,  1 mg MnCl2 · 2H2O,  2 mg ZnSO4 · 7H2O, 
5 mg FeSO4 · 7H2O, 0.2 mg CuSO4 · 5H2O 
 
LB Tween  (LBT) 0.05% Tween 80  (Sigma)   
LB Kan 40 40 µg/ml kanamycin  (Sigma)   
LB Hyg 50 50 µg/ml hygromycin  (Sigma)   
LB Hyg 100 100 µg/ml hygromycin  (Sigma)   
LB Amp 100 100 µg/ml ampicillin  (Sigma)   
LB Chlor 20 20 µg/ml chloramphenicol (Sigma)   
LB C 20, A 100 20 µg/ml chloramphenicol (Sigma) 
100 µg/ml ampicillin  (Sigma)   
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7H9 medium 
4.7 g Middlebrook 7H9 broth powder (BD), 2 ml glycerol (Sigma), 0.05 % (v/v) 
Tween 80 (Sigma), make to 900 ml with dH2O. 100 ml of sterile Middlebrook OADC 
supplement (BD) added after autoclaving and stored at 4 oC. 
Components per L:   
Ammonium sulphate 0.5 g, L-Glutamic Acid 0.5 g, sodium citrate 0.1 g, pyridoxine 
1.0 mg, biotin 0.5 mg, disodium phosphate 2.5 g, monopotassium phosphate 1.0 g, 
ferric ammonium citrate 0.04 g, magnesium sulphate 0.05 g, Calcium Chloride 0.5 
mg, zinc sulphate 1.0 mg, copper sulphate 1.0 mg 
Middlebrook OADC enrichment approximate formula per liter sodium chloride 8.5 g, 
bovine albumin (Fraction V) 50.0 g dextrose 20.0 g, catalase 0.03 g  
 
7H11 agar 
21 g Middlebrook 7H11 broth powder (BD), 5 ml glycerol (Sigma), is made to 900 ml 
with dH2O. 100 ml of sterile Middlebrook  OADC  supplement   (BD)  is added  after 
autoclaving along with hygromycin antibiotic where needed (50 ug/ml) 
Components per L:  
Enzymatic Digest of Casein 1g,  Disodium Phosphate 1.5 g,  
Monopotassium Phosphate  1.5 g, Ammonium Sulfate 0.5 g, 
Monosodium Glutamate 0.5 g, Sodium Citrate 0.4 g,  
Ferric Ammonium Citrate 0.04 g, Magnesium Sulfate 0.05 g, Copper Sulfate  0.001 
g, Pyridoxine  0.001 g ,Zinc Sulfate 0.001 g Biotin  0.0005 g, Malachite Green 
0.00025 g, Agar 13.5 g, Middlebrook OADC Enrichment Approximate Formula Per 
Liter Sodium Chloride 8.5 g, Bovine Albumin (Fraction V) 50.0 g 
Dextrose 20.0 g, Catalase 0.03 g 
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0 g, Catalase 0.03 g 
 
Hartmans-de Bont (HdB) minimal medium 
 
Components per L 
3.88 g K2HPO4, 2.13 g NaH2PO4. 2H20, 2.0 g (NH4)2S04, 
8 ml 10 % glycerol (Sigma), 0.05 % (v/v) Tween 80 (Sigma), trace compounds (as 
below). 
Trace compounds: 0.1 g MgCl2. 6H20, 10 mg EDTA, 2 mg ZnSO4. 7H20, 1 mg 
CaCl2 2H20, 5 mg FeSO4.7H20, 0.2 mg Na2MoO4. 2H20, 0.2 mg of CuSO4.5H20, 
0.4 mg of CoCl2. 6H20, 1 mg MnCl2.2H20. 
 
M63 minimal medium 
 
10X M63 salt solution was made with 2 g (NH4)2 SO4, 13.6 g KH2PO4 and 0.5 mg 
FeS04.7H20 per L and autoclaved. A 20% glucose solution was made by dissolving 
200 g glucose per L and autoclaving. 1 L M63 media was made by mixing 100 ml 
10X M63 Salt solution and 100 ml 20% glucose to achieve a final percentage of 2%. 
Freshly made filter-sterilised casamino acids (BD) were added to achieve a final 
percentage of 0.5% (made from acid hydrolyzed casein with low sodium chloride and 
iron concentrations). Sterile supplements were added to achieve final concentrations 
of 1 mM MgS04.7H20 and 0.7 mM CaCl2.  
 
2.1.2 Chemical Formulations  
 
Chemical formulations are listed below unless stated elsewhere. 
PBS: Phosphobuffer 
saline (Components 
per L) 
8 g NaCl (Sigma), 0.2 g KCl  (Sigma), 1.44g Na2HPO4  
(Sigma) and 0.24 g KH2PO4  (Sigma), adjusted to pH 7.4 
with conc. HCl and autoclaved.  
For PBS-20% glycerol, glycerol 200 ml glycerol were added  
CTAB: cetyl trimethyl 
ammonium bromide  
(Components per L) 
 
100 ml 1 M Tris HCl pH 8.0, 280 ml 5 M NaCl, 40 ml  of 0.5 
M EDTA, 20 g of CTAB (cetyltrimethyl ammonium bromide) 
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2.2 Bacterial strains, plasmids and primers 
 
 
Bacterial strains, plasmids and primers are shown in Tables 2.1, 2.2  and 2.3, 
respectively. Plasmid constructs are shown in Table 2.4. Overnight cultures were 
grown by inoculating bacteria from an agar plate to 5 ml of LB supplemented with 
appropriate antibiotics in a 50 ml plastic centrifuge tube (BD) and then incubating 
overnight at 37oC shaking at 200 rpm (E. coli) or 150 rpm (M. smegmatis). Strains 
were stored in 50% glycerol stocks at -80oC. 
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Table 2.1: Bacterial strains employed in this study. 
 
Strain 
 
Description/ relevant genotype 
 
 
Source 
 
M. smegmatis mc2155 
 
 
Wild type Mycobacterium smegmatis 
 
Laboratory 
strain 
 
M. tuberculosis H37Rv 
 
Wild type  virulent Mycobacterium 
tuberculosis strain 
 
Laboratory 
strain 
 
E. coli HB101 
Competent Cells  
 
 
F–, thi-1, hsdS20 (rB–, mB–), supE44, 
recA13, ara-14, leuB6, proA2, lacY1, galK2, 
rpsL20 (strr), xyl-5, mtl-1.  
 
High Transformation efficiency 108cfu/µg; 
employed as an intermediate cloning strain 
 
 
PrOmega 
 
E. coli GM2163 cells 
 
 
F– dam-13::Tn9 (Camr) dcm-6 hsdR2 (rk 
–mk+) leuB6 hisG4 thi-1 araC14 lacY1 
galK2 galT22 xylA5 mtl-1 rpsL136 (Strr) 
fhuA31 tsx-78 glnV44 mcrA mcrB1 
 
Dam and Dcm methylase deficient and 
 deficient for plasmid recombination; 
employed as an intermediate cloning strain 
due to lack of methylation of CCWGG 
restriction sites 
 
 
Laboratory 
Strain 
 
E. coli Rosetta™  
 
 
F– ompT hsdSB(rB– mB–) gal dcm pRARE2 
(CamR) pRARE2 supplies tRNAs for the 
codons AUA, AGG, AGA, CUA, CCC, and 
GGA  
BL21 DE3 derivative 
 
increases codon usage of E. coli; employed 
as a recombinant protein expression strain 
 
 
Novagen 
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Table 2.2. Plasmids employed in this study for mutant cloning. 
 
Plasmid 
 
 
Selection in media 
 
Strains 
 
Usage 
 
PCR®-Blunt 4-
TOPO® 
(Invitrogen) 
 
LB Kan 40 
 
 
E. coli HB101 
 
 
Amplification of 
cloning inserts 
 
 
pYUB854 
 (Kessel et al., 
2008)  
 
LB Hyg 100  (E. coli) 
LB Hyg 50 (Msm) 
7H9 Hyg 50 (Mtb) 
 
E. coli HB101, 
M. smegmatis 
mc2155,  
M. tuberculosis 
H37Rv 
 
 
Mycobacterial- E. coli 
shuttle plasmid used 
in the preparation of 
the linear allelic 
substrate 
 
pJV53 
(Kessel et al., 
2008)  
  
 
LB Kan 40 
LBT Kan 40 
 
 
Electrocompetent 
M. smegmatis 
mc2155 and M. 
tuberculosis 
H37Rv 
 
 
Acetamide-induced 
expression of 
Che9c gp60 and gp61 
enzymes which 
enhance homologous 
recombination of 
dsDNA in 
mycobacteria   
 
 
pET15b 
(Novagen) 
 
LB Amp 100 
 
 
Rosetta™ 
E. coli (Novagen) 
 
 
Expression of His-
tagged proteins for 
protein purification 
 
 
pMV361 
 
 
LB Kan 40 
LBT Kan 40 
 
 
 
E. coli HB101,  
M. smegmatis 
mc2155 
 
Mycobacterial- E. coli 
shuttle plasmid, 
Integrating vector for 
overexpression and 
mutant 
complementation in 
M. smegmatis mc2155 
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Table 2.3 Primers used for PCR amplification and screening (obtained from Sigma 
and stored at -20oC) 
 
Number 
 
Primer Name 
 
5’ to 3’ Sequence  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
1878_UR_F 
1878_UR_R 
1878_ DR_F 
1878_ DR_Rnew 
3241dnF  
3241dnR  
3241upF  
3241upR  
D1878_Screen_F 
D1878_Screen_R 
D3241c_Screen_F 
D3241c_Screen_R 
Msm_1878_F_ NF  
Msm_1878_R_CR 
Msm_1878_NR 
Msm_1878_CF 
NewMtb_3241c _F_NF 
NewMtb_3241c _R_CR 
Mtb_3241c _NR 
Mtb_3241c _CF 
Corrected3241c_forpET15b_F 
3241c_forpET15bR 
Corrected 1878_forpET15b_F  
1878_forpET15b_R 
Rv0079_forpET15b_F 
Rv0079_forpET15b_R 
3935_forpET15b_F 
3935_forpET15b_R 
3241c_forpET15b_F 
3241c_forpET15bR 
ggtacctcgctcttggccgctacgccg 
tctagaatggcttgacatacttggcaactcgtttc 
gctagcctggcctgaccggccgac 
actagtggggtcatgccggagaggatg 
tctagaatccgtctggcgtgatcggcg 
ggtaccgtagtccttgtcgcggctgaacag 
actagtgaccgcgacacttggtgtgtgcttg 
aagcttacctgaatccacggctagccttgacatacg 
gcgtggcgtgaagcaactttcgg 
acgatccgcgcgaactcctggt  
gaaagcgtgattacccaattgag 
cgtagagccggaagtagttc 
caattgtaatgtcaagccattcgatggattcaagc  
aagctttcaggccaggcggatcag  
aagcttttagtcgttgtagcgcgcctc 
caattgtaatgggcgtcgccgagcac  
caattgtaatgtcaaggctagccgtg  
aagcttttatctggtgttgaagccgt  
aagcttttatctggtgttgaagccgttctc  
caattgtaatgccagccgaggcacac  
catatgatgtcaaggctagccgtggatt  
ggatcctcacgccagacggatcaacc  
catatgatgtcaagccattcgatggattcaa  
ggatcctcaggccaggcggatcagc  
catatggtggaaccgaaacgcagtcg  
ggatcctcatgccagaccgtcggcaa  
catatgatggacgtcgatgtgtcgacc 
ggatccctagccgtccgcaggggt 
catatgtagtggattcaggtcaggttctg 
ggatcctcacgccagacggatcaacc  
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Table 2.4. List of plasmids constructed in this study 
 
 
Plasmid Name 
 
Insert length (bp) 
1 pYUB854:rafSMsm AES 3431 
2 pYUB854: rafSMtb AES 3890 
3 pET15b: rafHMtb 822 
4 pET15b: rafHMsm 777 
5 pET15b: rafSMtb 660 
6 pET15b: rafSMsm 
pMV361: rafSMsm 
693 
7 693 
8 pMV361: rafSMsm N 498 
9 pMV361: rafSMsm C 201 
10 pMV361: rafSMtb 660 
11 pMV361: rafSMtb N 438 
12 pMV361: rafSMtb C 228 
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2.3 Molecular biology techniques 
 
2.3.1 Preparation of pellets for mycobacterial colony PCR or gDNA extraction 
 
In a class III laboratory, single M. tuberculosis colonies were isolated on 7H11 
agar. 10 ml 7H9 stationary phase cultures (37oC, 125 rpm) were harvested (10 mins, 
2000 g) and boiled for 10 mins to heat kill. All manipulations were then carried out in 
the Class II laboratory. Single M. smegmatis colonies were isolated on LB agar. 50 
ml LBT stationary phase cultures (37oC, 150 rpm) were harvested by centrifugation 
(15 mins, 4000 rpm). 
 
2.3.2 Extraction of genomic DNA from mycobacteria: CTAB method 
 
 Mycobacterial cell pellets prepared as described (section 2.3.1) and were 
resuspended in 5 ml distilled water and 500 μl lysozyme (10 mg/ml) and vortexed 
and incubated at 37 oC for 1 hour. 60 μl proteinase K (10 mg/ml) and 700 μl 10% 
SDS were added and the mixture was vortexed and incubated at 65oC for 10 mins. 7 
ml chloroform/iso-amylalcohol mix (24:1) were added and the mixture vortexed and 
centrifuged for 5 mins at 18 000 g. 5.5 ml of the top phase was recovered and an 
equal volume of isopropanol was added and incubated at -20 oC for 30 mins. The 
DNA was pelleted by centrifugation at 13 000 rpm for 20 mins and the pellet washed 
with 70% ethanol, air dried and resuspended in 500 μl distilled water. 
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 2.3.3 Polymerase Chain Reaction (PCR) and agarose gel electrophoresis 
 
PCR was performed using DNA Engine DYAD (MJ Research) with Pfu DNA 
polymerase (PrOmega) or Taq DNA polymerase (Fermentas) with associated buffers 
and a 2mM dNTP mix from Fermentas. Primers used are shown in Table 2.3. The 
PCR program was carried out as shown (Table 2.5). To improve annealing, 2.5 µl 
DMSO were added per 25 µl reaction. Each 25 µl reaction also contained 5 µl diluted 
primers and 0.5 µl template DNA. Gradient PCR was carried out to determine the 
optimal annealing temperature where required. 
Analysis of PCR products was carried out using gel electrophoresis. Agarose 
gels used were composed of 1% (w/v) agarose and SYBR® Safe DNA gel stain 
(Invitrogen) in a 1:10 000 dilution. Gel images were obtained using the Gel Doc 
feature of the Quantity One program (Bio-Rad). The 1 kb Fermentas bench top 
ladder was used routinely. 
Table 2.5 PCR thermal cycling conditions used during gene cloning. 
PCR Step 
 
Temperature  
(oC) 
Duration Number of cycles 
1. Initial Incubation 95 2 mins 1 
2. Denaturation 95 30 s  
30 3. Annealing varies 30 s 
4. Elongation 72 varies 
5. Final Extension 72 10 mins 1 
6. Soak 4 Indefinite 1 
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2.3.4 Restriction enzyme digestion, ligation and transformation 
 
Fast digest® restriction enzymes and associated green buffers (Fermentas) 
were used according to the manufacturer’s instructions. Digested fragments were 
purified from agarose gels using the QIAGEN® Gel extraction kit according to the 
manufacturer’s instructions. Ligations were carried out using the Fermentas DNA 
Ligation Kit according to the manufacturer’s recommendations, using a 3:1 molar 
ratio of insert to vector.  
1 µg of plasmid DNA, prepared using the Mini Prep kit (QIAGEN®), or ligation 
product was added to 100 µl of chemically competent cells and the mixture was 
incubated on ice for 20 min. The cells were heat shocked at 42˚C for 45 sec, 
returned to ice for a further 2 min and then allowed to recover in 1 ml LB at 37˚C, 
150 rpm, for 1 hour. This suspension was pelleted and resuspended in 100 μl media 
and spread onto LB plates with an appropriate selection marker and incubated at 
37˚C overnight.  
 
2.3.5 Preparation and transformation of electrocompetent M. smegmatis cells 
 
The method used for electroporation was based on that of Bibb et al. (Bibb et 
al., 2002). Electrocompetent cells were prepared by growing an Msm culture to mid-
log phase (OD600 0.5–0.7), harvesting and washing them three times in cold 50 ml 
10% glycerol and resuspending them in the same buffer. The cells were stored in 
400 μl aliquots at -80oC. For transforming these cells by electroporation, 400 µl of 
electrocompetent Msm cells were mixed with 100 ng of DNA and transferred to a 
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chilled 0.2 cm electrocuvette (BioRad). The cells were electroporated using Gene 
Pulser (BioRad) set to 2.5 kV and 25 µF and the pulse controller set to 1000 Ω.  
The cells were allowed to recover in 2 ml of LB medium for 6 hours and then 
pelleted and resuspended in 100 µl of LB which was plated onto LB antibiotic plates. 
Plates were incubated at 37˚C for 2 to 3 days. Individual colonies were streaked onto 
fresh antibiotic containing plates. For preparing recombineering electrocompetent 
cells, the above method was used to insert pJV53 into Msm. Msm:pJV53 was grown 
to mid-log phase with 0.2% acetamide and electrocompetent cells were prepared 
again as described. These cells were electroporated with the linear allelic exchange 
substrate (AES). 
 
2.3.6 Preparation and transformation of electrocompetent M. tuberculosis cells 
 
M. tuberculosis H37Rv:pJV53 was grown on 7H11 OADC agar, at 37 oC, and 
subcultured in 7H9, with 0.05% Tween 80, 20 μg/ml kanamycin and 0.2% succinate, 
to mid log phase (7 to 10 days at 37 oC, 125 rpm). 10 ml cultures were incubated in 
125 ml flasks. The cultures were induced with 0.2% acetamide and incubated for 24 
h at 37 oC. Electrocompetent cells were prepared by harvesting and washing thrice 
in 25 ml 10% glycerol and resuspending in the same buffer.  
For transforming these cells by electroporation, 200 µl of electrocompetent M. 
tuberculosis cells were mixed with 100 ng of linear AES and transferred to a 0.2 cm 
electrocuvette (BioRad). The cells were electroporated at 2.5 kV, 25 µF and 1000 Ω. 
The cells were allowed to recover in 2 ml of 7H9 medium for 24 hours and then 
pelleted and resuspended in 100 µl of 7H9 which was plated onto LB kanamycin 
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plates. Plates were incubated at 37˚C for 21 days. Individual colonies were sub-
cultured onto 7H11 OADC hygromycin 50 μg/ml agar (Bibb et al., 2002). 
 
2.3.7 Mycobacterial recombineering and complementation 
 
Mycobacterial recombineering was carried out using the method of Kessel et 
al. (Kessel et al., 2007). Upstream and downstream regions flanking the gene to be 
deleted were amplified by PCR with appropriate restriction sites. Gel electrophoresis 
was used to confirm successful PCR amplification of the UR and DR regions and 
products were cloned into PCR®-4Blunt-TOPO (Invitrogen) and amplified in 
dam/dcm methylase deficient E. coli or HB101 E. coli. Sequencing (Beckman Coulter 
genomics) was done to confirm that the inserts were of the correct sequence. UR 
and DR inserts were digested from PCR®-4Blunt-TOPO and obtained using gel 
electrophoresis.  
Plasmid pYUB854 was digested with appropriate restriction enzymes and 
incubated with 1 µl thermosensitive alkaline phosphatase (TSAP) (Thermosci) to 
prevent religation. The DR insert was ligated to linear pYUB854 with T4 DNA ligase 
(Thermosci) and the resulting plasmids were isolated and digested with appropriate 
restriction enzymes. After confirming that the DR insert was present, the UR insert 
was then ligated to linear rafSMsm. The resulting plasmids were digested to confirm 
that both UR and DR inserts were present. The pYUB854/rafS UR/DR plasmid was 
digested with appropriate restriction enzymes to obtain the linear AES.  
The pJV53 plasmid encoding recombineering mycobacteriophage Che9c 
enzymes gp60 (exonuclease) and gp61 (recombinase) to enhance recombination of 
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a double stranded linear AES was inserted by electroporation into electrocompetent 
wild type M. smegmatis and gp60 and gp61 expression was induced with 0.2% 
acetamide, after which competent cells were prepared. The linear AES was 
electroporated into these cells and colonies were obtained from hygromycin (50 
µg/ml) selective plates. A pure mutant colony was identified from electroporation 
plates and screened using colony PCR. 
For complementation of ΔrafS mutants by insertion of pMV361/rafS (KanR), 
ΔrafSMsm1:pJV53 was subcultured four times on plain LB agar to allow cells that have 
lost pJV53 to predominate due to the selective advantage of not needing to produce 
proteins involved in kanamycin resistance. Similarly, ΔrafSMtb2:pJV53 and 
ΔrafSMtb3:pJV53 strains were subcultured seven times on plain 7H9 agar.  
Single colonies were streaked onto agar both with and without kanamycin (40 
µg/ml). Colonies absent from the Kan+ plate but present on the Kan- plate were 
considered to lack pJV53. Subsequently, electrocompetent cells were prepared and 
pMV361/rafS was electroporated into these cells. Colony PCR was used to confirm 
that endogenous rafS gene was absent from the complemented mutant. 
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2.4 Physiological assays 
 
2.4.1 Preparation of M. smegmatis stationary phase starter cultures  
 
M. smegmatis was streaked onto plain LB agar and incubated for 2 days at 
37oC. After ensuring there were no contaminants visible, a streak of cells was 
inoculated to a falcon tube with 5 ml media or 50 ml media in a 250 ml conical flask 
incubated at 37oC at 150 rpm for 20 hours. Cultures were verified to be in stationary 
phase by measuring optical density at 600nm. 
 
2.4.2 Optical density measurement 
 
For bacterial cultures, OD600nm was measured in a spectrophotometer (WPA) 
using the appropriate media as a blank. 1 ml samples were read in 1.5 ml plastic 
cuvettes (BRAND). The sample was diluted with the appropriate media if the reading 
measured greater than 1. Similarly, other measurements were taken for other 
samples at the optical density indicated. 
 
2.4.3 M. smegmatis normoxic growth curve assays 
 
Stationary phase starter cultures were prepared as described and inoculated 
into 50 ml media in 250 ml glass conical flasks with sponge bungs (standard 
normoxia with culture: air ratio of 1:5). These were incubated at 37oC at 150 rpm on 
an orbital shaker. Samples were taken at intervals indicated and OD600nm was 
measured as described.  
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2.4.4 M. smegmatis Colony Forming Unit (CFU) assays 
 
M. smegmatis CFU assays were carried out by adding 10 μl per culture to 90 
μl of LBT media in a sterile 96 well plate (BD falcon). In subsequent wells containing 
90 μl of LBT media, 10 μl per well was transferred to the next column of wells with a 
multichannel pipette (Eppendorf) and mixed. In this manner, 7 serial dilutions were 
carried out. 10 μl of each dilution was spotted onto a petri dish with approximately 50 
to 60 ml LB agar. The plates were incubated for 3 to 4 days at 37oC and colonies 
were counted and recorded with the appropriate dilution factor. CFU cell count 
estimates (CFU/ml) were calculated using the equation below: 
𝐶𝐹𝑈 𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 = 𝐶𝑜𝑙𝑜𝑛𝑦 𝑐𝑜𝑢𝑛𝑡 × 100 × 10𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
 
2.4.5 M. smegmatis survival and resuscitation assays 
 
Stationary phase LBT starter cultures were prepared as described. For survival 
assays in normoxia, per strain, 0.1 ml of each stationary phase culture were 
inoculated into 5 ml sterile media in 50 ml falcon tubes (BD) capped with sterile 
sponge bungs and incubated at 37oC at 150 rpm. Sterile water was added uniformly 
at intervals to account for loss of water due to evaporation. For survival assays in 
hypoxic stasis, intact plastic 125 ml conical flasks (Corning) were autoclaved with 
100 ml media with orange caps.  
These caps were then replaced with sterile rubber suba-seal bungs after 
adding 1 ml stationary phase culture inocula. CFU assays were carried out at the 
intervals specified. For survival assays in 0% glycerol HdB and PBS, 100 ml per 
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stationary phase culture were pelleted and resuspended in 100 ml of sterile distilled 
water and by centrifugation at 2000 g to remove nutrients.  
The pellets were then resuspended in plastic 125 ml conical flasks (Corning) 
and sealed as described above. For CFU sampling, each seal was wiped with 70% 
ethanol and CFU assay samples were obtained by extraction with BD Microlance 3 
25G x 5/8” 0.5 mm x 16 mm needles with 2 ml syringes (BD). For resuscitation 
assays, 1 ml of each culture were added to 50 ml LBT in glass conical flasks with 
sponge bungs and OD600nm was monitored at intervals indicated. Growth curve 
sampling was carried out described as for the normoxic growth curve assays. After 
plotting CFU/ml (vertical axis) versus time (d) (horizontal axis), significance testing 
was carried out (section 2.6). 
 
2.4.6 M. smegmatis and M. tuberculosis survival competition assay  
 
Independent wild type and ΔrafS stationary phase starter cultures were set up 
as described. A 3 ml mixed inoculum was made by adjusting individual strain levels 
as calculated based on the final target of OD600nm 0.5 per strain using the following 
equation and adding an appropriate volume of sterile distilled water to make up the 
final 3 ml volume: 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 𝑟𝑒𝑞𝑢𝑖𝑟𝑒𝑑 𝑓𝑜𝑟 𝑖𝑛𝑜𝑐𝑢𝑙𝑎𝑡𝑖𝑜𝑛 =
0.5
𝑂𝑝𝑡𝑖𝑐𝑎𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑟𝑦 
𝑝ℎ𝑎𝑠𝑒 𝑐𝑢𝑙𝑡𝑢𝑟𝑒
× 3 
200 µl of mixed inoculum were added per 5 ml media in 50 ml Falcon tubes 
(BD). CFU sampling was carried out after vortexing tubes at intervals indicated and 
ΔrafSMsm and mixed colony counts were recorded and CFUs calculated. Percentage 
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abundance of the ΔrafS mutant was calculated using the following equation and 
assay replicates with ΔrafS starting percentage abundance greater than or equal to 
50% were carried forward for further CFU sampling: 
 
 𝛥𝑟𝑎𝑓𝑆 percentage abundance =
𝛥𝑟𝑎𝑓𝑆 colony count 
Total colony count 
× 100  
 
2.4.7 M. smegmatis Microtitre plate alamar blue assay (MABA) for investigation 
of chemical stress susceptibility assay 
 
Minimum inhibitory concentrations (MICs) were determined for wild type M. 
smegmatis using the MABA assay (Collins et al., 1997, Lougheed et al., 2011). 
Stationary phase LBT starter cultures were prepared as described. 100 µl per M. 
smegmatis stationary phase LBT starter culture were inoculated to 50 ml LBT and 
incubated (37 oC, 150 rpm) up to mid-log phase (OD600nm approximately 0.5).  
Cells were harvested and washed thrice with sterile PBS and then 
resuspended in sterile PBS + 20 % glycerol and stored in 100 µl aliquots in sterile 1 
ml Eppendorf tubes at -80 oC. 100 µl of cells were plated on plain LB to and 
incubated (37 oC) to check for growth of contaminants. Chemicals (Sigma) were 
dissolved according to the manufacturer’s recommendations, filter sterilised (0.2 μm 
pore size) and stored at -20 oC. Stock concentrations were determined based on 
published MIC data. 
Outer perimeter wells of clear 96 well plates (BD Falcon) were filled with 200 
µl sterile distilled water to protect experimental wells from dehydration. 180 µl media 
were added to the first column and 90 µl sterile media were added to the remaining 
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columns. 1 µl 200X chemical stock solution was added to the first column. Two-fold 
serial dilutions were performed by transferring 90 µl across the columns of the 
microplate with a multichannel pipette for each chemical in triplicate and using new 
sterile tips for each transfer. The 10th column contained media only and cell only 
controls in triplicate. Frozen cells were thawed and diluted (10 µl in 10 ml 7H9) and 
then 10 µl of this cell suspension were added to each well excluding media only 
wells. Plates were incubated at 37 oC for 66 hours.  
20 µl alamar blue (PrOmega) were added to each well and the plates were 
incubated for a further 6 hours, giving a total of 72 hours, after which MICs were 
visually determined. Wells with blue fluid were taken to contain cells which were not 
viable.  Wells with pink fluid were taken to contain cells which were viable.  Wells 
which contained purple fluid were also considered to contain viable cells (although 
less than in pink wells).  
The lowest chemical concentration which inhibited viability (giving a blue 
colour) was taken to be the MIC. Fold differences in mean MICs were calculated as 
shown (equation 1). 95% confidence intervals were calculated using Microsoft Excel. 
Fold differences less than or equal to 2 fold were considered to be insignificant (van 
de Kasteele et al., 2012). A decreased MIC indicates greater antibiotic susceptibility. 
Equation 1: 𝐹𝑜𝑙𝑑 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑖𝑛 𝑀𝐼𝐶 =  Mean MIC of wild type
Mean MIC of ΔrafSMsm
  
 
2.4.8 M. smegmatis mature biofilm formation assay 
 
Stationary phase LBT starter cultures were prepared as described. 1 ml M63 
media were added per well of a 24 well non-tissue culture treated plate (BD). 
Stationary phase cultures were centrifuged for 2 mins at 5 g to remove clumps and 
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10 μl of each culture supernatant were inoculated per well. The plates were 
incubated in normoxia for 4 days at 300C or 5 days at 28.50C. Biofilm formation at 
the interface of the solid surface and liquid medium was checked (biofilm formation 
in a ring shape on walls of the well). Culture was removed from wells by briskly 
shaking to remove. Plates were submerged in a tray of water and then vigorously 
shaken to remove liquid over a waste tray.  
1 ml 0.5% crystal violet (SIGMA) were added per well and stained for 10 min 
and then removed. The plate was washed twice in a fresh distilled water tray, 
shaking out as much liquid as possible after each wash and vigorously tapped onto 
paper towels to remove excess liquid. The plates were allowed to dry in a fume 
cabinet for 20 mins and 1 ml 95% ethanol were added per and incubated covered for 
1 hour. 1 ml of the suspension was transferred to cuvettes and optical density (OD570 
nm) was measured. 
 
2.4.9 M. smegmatis pellicle assay  
 
Pellicle assays were adapted based on a method by B. Khoo (American 
Society for Microbiology Microbe online library; http://www.microbelibrary.org/; web 
page is no longer available). Stationary phase LBT starter cultures were prepared as 
described. 5 ml 7H9 OADC without Tween were aseptically added to sterile glass 
test tubes with steel caps. Stationary phase cultures were centrifuged for 2 mins at 
200 rpm to remove clumps and 10 μl of each culture supernatant were inoculated 
per tube and incubated at 37oC for 48 hours. Photographs of the pellicle formed at 
the air-liquid interface were obtained.  
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2.4.10 M. smegmatis acid pH stress assay  
 
Sterile LBT media at pH 3, 5 and 7 were prepared. Actual pHs were measured 
with a pH meter and recorded. 2 ml of each medium were added to a sterile 24 well 
plate (BD). Stationary phase LBT starter cultures were prepared as described. 18 ml 
of each stationary phase culture was centrifuged at 2 000 g and each pellet was 
resuspended in 90 μl media. 10 μl of the suspension were added to each well and 
mixed. The plates were incubated at 37oC and CFU assays were carried out at 0, 3 
and 6 hours. Significance testing was carried out (section 2.6). 
 
2.4.11 M. smegmatis heat stress survival assay 
 
Stationary phase LBT starter cultures were prepared as described and 
transferred to an incubator at 55oC at 150 rpm, ensuring even distance from the fan. 
CFU assays were carried out at intervals indicated. Significance testing was carried 
out (section 2.6). 
 
2.4.12 Preparation of M. tuberculosis stationary phase starter cultures 
 
M. tuberculosis was streaked onto plain 7H11 agar with a 10 µl sterile plastic 
loop and incubated for 7 days at 37oC. After ensuring there were no contaminants 
visible, a streak of cells was inoculated to a new plastic 125 ml conical flask with 
plastic caps (Corning) with 50 ml 7H9 media and incubated at 37oC at 125 rpm for 
10 days. Cultures were verified to be in stationary phase by measuring optical 
density at 600nm. 
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2.4.13 M. tuberculosis growth curve assay 
 
M. tuberculosis stationary phase starter cultures were prepared as described. 
1 ml per starter culture was subcultured into 50 ml of 7H9 media in new sterile 125 
ml plastic conical flasks (Corning) and incubated at 37oC at 125 rpm. OD600nm 
measurement in a spectrophotometer was carried out at intervals indicated. 
 
2.4.14 M. tuberculosis CFU assays 
 
 CFU assays were carried out by sampling 10 μl of culture and adding to 90 μl 
of 7H9 media in a 96 well plate. In subsequent wells containing 90 μl of media, 10 μl 
of each sample were transferred with a multichannel pipette to the next column of 
wells and mixed. In this manner, 7 serial dilutions were carried out. 10 μl of each 
dilution was spotted onto a petri dish with approximately 50 to 60 ml 7H11 agar. The 
plates were sealed with parafilm and incubated for 14 days at 37oC and then 
colonies were counted and recorded with the corresponding dilution factor. CFU 
estimates (CFU/ml) were calculated using the equation below: 
𝐶𝐹𝑈 𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 = 𝐶𝑜𝑙𝑜𝑛𝑦 𝑐𝑜𝑢𝑛𝑡 × 100 × 10𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
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2.5 Biochemical methods 
 
2.5.1 Recombinant protein induction and analysis 
 
Strains were grown on LB AC plates overnight and used to inoculate 50 ml 
starter cultures, and grown at 150 rpm at 37oC. Per strain, 1 ml overnight culture was 
used to inoculate 50 ml LB AC media and strains were grown until OD600nm 0.5 to 0.8 
at 150 rpm at 37oC. The cultures were kept at 4oC for 30 mins and then were 
adjusted to the final concentration of IPTG needed. The cultures were allowed to 
grow for another 3 h (or other time indicated) at 150 rpm at 37oC and 1 ml culture 
was pelleted at 18 000 g and stored at -20oC. 
For recombinant protein expression analysis of small pellets, each pellet was 
resuspended in 1x primary amine free Bugbuster (Novagen) with 200 μl benzonase 
(Novagen) and 0.833 μl 1X rLysozyme (Merck). The mixture was incubated at room 
temperature for 20 mins, shaking at 20 rpm and then pelleted at 18 000 g for 20 mins 
at 4oC. The supernatant (soluble fraction) was transferred to a fresh tube and 
insoluble fraction was labeled and both stored at -20oC.  
To confirm protein expression, insoluble pellets were resuspended in 50 μl 
distilled water. 10 μl Laemmli buffer loading dye (SIGMA) were added per 10 μl 
soluble and insoluble fractions, and incubated at 95oC for 10 minutes to allow protein 
denaturation. SDS-PAGE gels were prepared and run as described in the next 
section with 4 μl of each insoluble fraction and 16 μl of each soluble fraction loaded 
per well.  
 
 
89 
 
2.5.2 SDS-PAGE 
 
The composition of protein gels is given in Table 2.6. Protein samples were 
thawed at room temperature and insoluble fractions were resuspended in 50 µl 
deionised water. 10 μl of each sample was mixed with 10 µl 2X Laemmli buffer 
(Sigma) by vortexing and heated at 98oC for 10 mins on the heat block. Samples 
were cooled and loaded to protein gels. 4 μl of each insoluble sample and 20 µl of 
each soluble fraction were loaded.  
The ladder used was EZ RUN Rec Protein Ladder (10 to 200 kDa) (Fischer 
Scientific) or PageRuler Plus prestained protein ladder (10 to 250 kDa) (Thermosci). 
The gel was run at 135 V for 45 minutes and staining was carried out with Imperial™ 
Protein stain (Thermo Scientific) as recommended.  Staining and destaining were 
carried out for 1 hour each at 20 rpm or destaining was carried out overnight. 
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Table 2.6. Composition of protein gels for SDS-PAGE. TEMED indicates 
Tetramethylethylenediamine. Acrylamide and APS were obtained from SIGMA. 
12% Separating Gel  
Reagents 
Amount 
per gel 
4.5% Stacking Gel 
Reagents 
Amount per 
gel 
40% acrylamide  2.4 ml 40% acrylamide  0.3 ml 
GLB (Gel Lower Buffer) 2 ml GUB (Gel Upper Buffer) 0.66 ml 
dH20 3.6 ml Distilled H20 1.68 ml 
TEMED  8 μl TEMED  10 μl 
APS 10%  40 μl  APS 10% 20 μl 
Final Volume 8 ml Final Volume 2.64 ml 
 
Gel Lower Buffer components per 500 ml 
90.85g Tris, 20ml 10% SDS, adjusted to pH 8.8 with 10ml conc HCL 
 
Gel Upper Buffer components per 500 ml 
30.3g Tris, 20ml 10% SDS, adjusted to pH to 6.8 with approx. 20ml conc 
HCL 
 
 
 
2.5.3 Scaled up recombinant protein induction and lysis for FPLC 
 
 Overnight cultures were set up in 250 ml glass flasks and in 50 ml LB AC and 
incubated as described in section 2.5.1. 25 ml of each starter culture was inoculated 
to 1 L LB AC and incubated as before, carrying out IPTG induction as required. The 
cultures were pelleted (8000 g, 10 mins, JA26 XP centrifuge (Beckman), JA14 rotor). 
Pellets were resuspended in 10 ml binding FPLC buffer B and sonicated for 2x 10 
mins (40% power, 2 sec pulse) with a 5 minute interval between. Fractions were 
separated (16000 g, 45 min, 4°C, Avanti J 26 XP, J25.5 rotor). The supernatant was 
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transferred to a fresh tube and 40 μl elution buffer were added per ml sample and 
filtered with a 0.2 μM pore syringe filter (PALL). 
 
2.5.4 FPLC protein purification 
 
 FPLC buffers were prepared using the His buffer kit (GE) as per the 
manufacturer’s instructions. Binding buffer (A) (20 mM imidazole, 20 mM sodium 
phosphate, 500 mM NaCl, pH 7.4) and elution buffer (B) (500 mM imidazole, 20 mM 
sodium phosphate, 500 mM NaCl, pH 7.4) were prepared in deionised water and 
filtered using a vacuum pump and Millipore filter papers. With the AKTA-FPLC 
system (GE), a pump wash was carried out with buffers A and B for 5 mins.  
A 1 ml His-trap column (GE) was attached to the platform, and buffer A was 
allowed through (5 mins, flow rate 0.5 or 1ml/min; maximum pressure alarm 0.6 
MPa). The superloop sample end (GE) was manually washed with 5 ml buffer A and 
filled with filtered (PALL 0.2 μM pore syringe filter) protein sample, which was then 
injected to the column. The column was washed with buffer A until UV level dropped 
to 0 and then with a buffer A/B mix as required. Fractions were collected (serpentine, 
12 mm tubes, 1 ml) and analysed by SDS-PAGE. Pure protein fractions were pooled 
and stored at 4oC and concentrated the following day or immediately using Amicon 
(Millipore) or centrisart concentrators (Sartorius) as per the manufacturer’s 
instructions with appropriate buffers (Tables 2.7, 2.8). 
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Table 2.7: Glycerol storage buffer compositions for Raf protein storage. Final 
concentrations of items are indicated. 
Buffer  
component 
RafSMsm  
storage buffer 
RafHMtb  
storage buffer 
Tris-HCl 10 mM 20 mM 
NaCl 50 mM 200 mM 
Glycerol 10% 10% 
DTT - 2 mM 
Final pH 7.4 8 
 
Table 2.8: TAKM7 buffer compositions for Raf protein storage for translation assays. 
Final concentrations of items are indicated. 
Buffer  
component 
RafSMsm  
TAKM7 buffer 
RafHMtb  
TAKM7 buffer 
Tris-HCl pH 7.6 20 mM 20 mM 
NH4Cl 70 mM 70 mM 
Glycerol 10% 10% 
KCl 30 mM 30 mM 
MgCl2 7 mM 7 mM 
Final pH 7.4 8 
 
2.5.5 Ribosomal Profiling 
 
Buffers compositions are; ribosomal buffer (10 mM Tris-HCl (pH 7.4), 70 
mM KCl, 1 or 10 mM MgCl2), 15% sucrose (15% sucrose w/v, 50 mM Tris-HCl [pH 
7.4], 25 mM KCl, 10 mM MgCl2), 40% sucrose (40% sucrose w/v, 50 mM Tris-HCl 
[pH 7.4], 25 mM KCl, 10 mM MgCl2), sucrose cushion (1.1 M sucrose w/v, 50 mM 
Tris-HCl [pH 7.4], 25 mM KCl, 10 mM MgCl2). Buffers containing sucrose were 
autoclaved and pipetted aseptically.  
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Cultures were grown in LBT media in 2 L flasks at 37oC at 150 rpm. For mid 
log profiling, stationary phase cultures were inoculated to 1L media and grown to an 
OD600nm of 0.5 to 0.8. 2 L of culture were pelleted per strain. For stationary phase 
profiling, stationary phase cultures were inoculated to 2 x 400 ml media and a total of 
800 ml culture was pelleted per strain (10 min per 250 ml culture, JA14 rotor, Avanti 
J-26XP centrifuge, 8000 g) and frozen at -20˚C. 
The previous method (Trauner et al., 2010) was modified to incorporate new 
equipment and improve accuracy of profiles. 13.2 ml thinwall polyallomer Beckman 
centrifuge tubes (Ref no. 331372) were used for centrifugation. For preparing 
sucrose gradients, a horizontal line was drawn 1.5 cm from the base of each 
gradient to indicate the end of fractionation. 5.5 ml sterile 40% sucrose were added 
to the tubes, covered and placed vertically in a -80oC freezer. When frozen, 5.5 ml 
sterile 15% sucrose were added and the tubes were returned to the freezer. When 
needed, the frozen sucrose layers were thawed and equilibrated overnight at 4oC on 
a flat surface. 
For cell lysis, the French press was replaced with a cell disruptor. Cell pellets 
were thawed and resuspended in 10 ml ribosomal buffer and a manual cell 
homogeniser was used to disrupt clumps. Cell suspensions were lysed with a cell 
disruptor (30 kpsi twice per sample, 4oC, Constant Systems). 50 ml distilled water 
and 50 ml ribosomal buffer were added to the cell disruptor prior to lysis. Between 
different strains, the cell disruptor was cleaned by adding 50 ml distilled water, 50 ml 
70% ethanol, 50 ml distilled water and 50 ml ribosomal buffer in this order. At the 
end of lysis, 50 ml distilled water, 50 ml 70% ethanol and 50 ml distilled water were 
added for cleaning.  
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Cell lysates were centrifuged (Optima L100 XP, Sw41Ti rotor, 30,000 g, 30 
min, 4°C) using ribosomal buffer for balancing. Clarified cell extracts were loaded 
onto 4 ml sucrose cushions and centrifuged (Optima L100 XP, Sw41Ti rotor, 31,000 
g, 2 hours 30 min, 4°C) for ribosome pelleting. The supernatant was removed by 
decanting. The top half of the tube was removed with a pair of scissors to facilitate 
resuspension of the pellet. The ribosomal pellet was resuspended in cold 200 μl 
ribosomal buffer and incubated on ice for 20 mins before storing in eppendorf tubes 
at -80oC. 
Thawed ribosome pellets were loaded onto gradients, ensuring that the final 
levels were even, and centrifuged (Optima XP L100, 5 h, 35,000 rpm, 4 °C,SW 41-Ti 
rotor). 200 μl from the gradient meniscus was pipetted into the final well to obtain the 
reading for the last fraction. A 40 × 1.1 mm needle (BD) was used to pierce the tube 
base and fractions were collected in a 96-well plate (approximately 3 drops per well) 
upto the line drawn. 2 μl per fraction was read on the NanoDrop machine 
(Thermosci, nucleic acids module, absorbance wavelength 254 nm, 40% sucrose as 
blank).  
Normalised fraction ratios were calculated per fraction number as shown 
(Equation 1A and 1B) (the last fraction was attributed fraction ratio 1 and the 
penultimate fraction was attributed fraction ratio 0.8). Normalised absorbance ratios 
were calculated per fraction as shown (Equation 2) (attributing the highest 
absorbance value as absorbance ratio 1). Ribosomal profiles were plotted with 
fraction ratio on the horizontal axis and absorbance ratio (254 nm) on the vertical 
axis. Ribosomal sub-species appear as a series of three peaks corresponding to the 
70S, 50S and 30S species. 
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Equation 1A: 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑅𝑎𝑡𝑖𝑜 𝐷𝑖𝑣𝑖𝑠𝑜𝑟 = 𝑃𝑒𝑛𝑢𝑙𝑡𝑖𝑚𝑎𝑡𝑒 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑛𝑢𝑚𝑏𝑒𝑟
0.8
 
Equation 1B: 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑖𝑜 = 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑛𝑢𝑚𝑏𝑒𝑟
𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑅𝑎𝑡𝑖𝑜 𝐷𝑖𝑣𝑖𝑠𝑜𝑟
 
 
Equation 2: 𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑟𝑎𝑡𝑖𝑜 = 𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒
𝐻𝑖𝑔ℎ𝑒𝑠𝑡 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑣𝑎𝑙𝑢𝑒
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2.5.6 Preparation of M. smegmatis S100 extract and ribosomes for translation 
assays 
 
Buffers were prepared according to the following compositions: 
Homogenisation buffer (HB): pH 7.6, stored at 4oC 50 mM Tris, 100 mM NH4Cl, 7 
mM MgCl2, 0.5 mM EDTA, 0.001%Tween 20, 5 mM β-Mercaptoethanol (added on 
the day of experiment). Sucrose cushion (SC): pH 7.6, stored at 4oC, 50 mM Tris, 
350 mM NH4Cl, 7 mM MgCl2, 0.5 mM EDTA, 1.1 M sucrose, 0.001% 10% Tween 20, 
3 mM β-Mercaptoethanol (added on the day of experiment). 
Bacterial pellets were resuspended in 1.5 ml HB per gram wet pellet and 
vortexed. Pellets were lysed twice in a French press at 1020 psi using a 35 ml 
French Pressure Cell. 2 μl/g wet cell pellet RQ DNase was added after the first 
passage. The lysates were pooled after the second passage and stirred using a 
magnetic stirrer (max. 240 rpm). 1.5 g cold alumina per gram wet cell pellet were 
added to the lysate and stirred for 30 min. 
The suspension was transferred to a Sorvall GSA tube (SLA1500, 250 ml) 
and spun at 3600 rpm (2000g) for 10 min to pellet the alumina. The speed was 
increased to 8000 rpm (10000g) and spun for 30 more min to pellet cell debris. The 
supernatant was filtered through an autoclaved tea filter and transferred into Sorvall 
SS34 tubes and spun at 16000 rpm (30000g) for 30 min. The supernatant (S30 
extract) was transferred into a 200 ml measuring cylinder on ice avoiding the pellet 
and white layer at the surface.  
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13 ml of S30 extract was layered slowly onto Beckman Ti 50.2 tubes with 9 ml 
sucrose cushion and spun at 33000 rpm (~100000g) for 16 hrs overnight. This 
resulted in the S100 extract (supernatant) and ribosomal pellet. Three quarter of 
S100 extract (supernatant) was transferred into a measuring cylinder, also taking the 
upper yellow part of the sucrose cushion. S100 was dialysed with dialysis tubing 
(MWCO 6000-8000) in TAKM7 buffer.  
S100 extract was added to 20 ml Vivaspin™ concentrators (MWCO 6000-
8000) equilibrated with TAKM7 and spun at 4600 g in a Heraeus centrifuge at 4°C 
(ca. 3300 rpm). The flow through was discarded regularly (after 30 min) and filled up 
with S100. S100 was concentrated to approx. 16 ml and 0.125 ml glycerol were 
added per ml S100 and mix gently with a pipette. Supernatant was transferred to a 
fresh tube and 500 µl aliquots were pipetted and frozen in liquid nitrogen and store at 
-80°C.  
The remaining supernatant covering the ribosome pellet was discarded and 
the tubes were inverted. The ribosome pellet was washed twice with TAKM7, and 
pellets resuspended in approx. 2 ml TAKM7. 50 μl aliquots of the ribosome solution 
were frozen with liquid nitrogen and stored at -80 °C and these were known as non-
dissociated ribosomes. Dissociated ribosomes were prepared by resuspending 
in 50mM Tris (pH7.6), 500 mM KCl, 0.05 mM MgCl2 and 5 mM β-mercaptoethanol. 
Ribosome concentrations were determined by absorption measurements on the 
basis of 23 pmol ribosomes per A260 unit (Akbergenov et al., 2011). 
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2.5.7 Preparation of mRNA for translation assays 
 
Plasmids pZ296 (pT7-hRluc) and pZ547(pT7-Omega hFluc) were employed 
to prepare R-luc and Omega F-luc mRNA, respectively. Plasmid DNA was prepared 
by Midiprep (Qiagen) according to the manufacturer’s instructions. The plasmid was 
resuspended in 450 μl water. 450 µl of plasmid was mixed with 45 µl NaAc [3M] and 
1350 µl 100% ethanol, vortexed and then stored at -80 °C for > 40 mins. The mixture 
was centrifuged at, 4 °C, 18 000 rpm for 15 min and the supernatant was discarded. 
The pellet was washed with 500 µl 80% ethanol (pre-cooled to -20°C) and 
centrifuged for 10 mins, 4 °C, 18 000 g and the supernatant was discarded. The 
pellet was dried in a speed vacuum device for 10 minutes without heating, dissolved 
in 100 µl dH20 and the DNA concentration was measured. 
The plasmid was linearized with HindIII (digested overnight in HindIII 10X 
buffer) and plasmid linearisation was confirmed by agarose gel electrophoresis.  400 
µl of Phenol: Chloroform: Isoamylalcohol mixture [25:24:1] was added to the 
restriction digest to purify the DNA. The mixture was vortexed 3 x 20 sec until the 
organic and inorganic phases homogenised. The mixture was centrifuged at 4 °C, 18 
000 rpm for 15 min and the supernatant was transferred to a new tube. 400 µl 
chloroform were added and the mixture was vortexed 3 x 20 sec. The mixture was 
centrifuged at, 4 °C, 18 000 g for 15 min and the supernatant was transferred to a 
new tube. 
DNA was precipitated by adding 40 µl sodium acetate [3M] (24.6 g in 100mL 
H2O; adjusted to pH 5.2 with acetic acid) and 1200 µl 100% ethanol to the DNA and 
mixed by vortexing and then stored at -80 °C for 40 mins. The mixture was 
centrifuged at 4 °C, 18 000 g for 15 min and the supernatant was discarded. The 
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pellet was washed with 500 µl 80% ethanol (pre-cooled to -20 °C). The mixture was 
centrifuged at 4 °C, 18 000 g for 15 min and the supernatant was discarded. The 
pellet was dried in a speed vacuum device for 5 minutes without heating and 
dissolved in 200 μl distilled H20. 
For in vitro transcription, the reaction mixture was prepared as shown in table 
2.9 in 1 x 2 ml tubes and incubated for 4 hours in a thermomixer (500 rpm). The 
reaction should appear turbid and it is then frozen overnight at -20oC.  
 
Table 2.9 In vitro transcription reaction mixture for mRNA preparation for translation 
assays 
Component Volume [µl] 
Hepes [1M, pH 7.5] 160 
MgCl2 [1M] 50 
DTT [1M] in dH20 80 
ATP [100mM] 80 
CTP [100mM] 80 
GTP [100mM] 80 
UTP [100mM] 80 
RNase Inhibitor 20 
DNA 200 
Spermidine [1M] in dH20 4 
dH2O 1126 
T7 RNA Polymerase 40 (+40 after 2 hours) 
Total 2000 
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For RNA precipitation, the transcription reaction was thawed and centrifuged 
for 5 mins at 4 °C, 18 000 g. The supernatant was aspirated (approximately 2000 µl) 
into two 2 mL tubes and mixed in new tube with 450 µl LiCl [10M] per 1000 µl 
reaction. The pellet was resuspended in 1 ml dH2O and mixed with a thermomixer, 
for 4 mins at 40 °C at 106 g. This mixture was centrifuged for 5 mins at 4 °C, at 18 
000 g. 1 ml of supernatant was aspirated, mixed in a new tube with 450 µl LiCl [10M] 
and stored on ice. The steps in the last three sentences were repeated 5 to 7 times. 
The RNA precipitation reaction was incubated on ice for at least 30 min. The 
mixture was centrifuged for 5 mins at 4 °C, at 18 000 g and the supernatant was 
discarded. Pellets were washed with ice-cold ethanol [80%]. The mixture was 
centrifuged for 5 mins at 4 °C, at 13000 rpm and the ethanol supernatant was 
discarded. Pellets were dried in a speed vacuum device for 1-2 min at 30°C. Pellets 
were pooled in a total of 400 µl dH2O and stored at 4°C overnight to allow pellets to 
dissolve.  
To each 400 µl RNA solution, 40 µl NaAc [3M] and 1200 µl 100% EtOH were 
added, shaken and stored at -80 °C for > 40 mins. The mixture was centrifuged for 5 
mins at 4 °C, at 18 000 g and the supernatant was discarded. The pellet was washed 
with 500 µl 80% ethanol (pre-cooled to -20 °C). The mixture was centrifuged for 5 
mins at 4 °C, at 18 000 g and the supernatant was discarded. The pellet was dried  
in a speed vacuum device without heat, dissolved in 150 µl dH2O and the RNA 
concentration was measured. mRNA was adjusted to a final concentration of 2 
µg/µl.; an aliquot of mRNA was diluted by mixing 1.5 µl mRNA with 148.5 µl 10 mM 
Tris HCl, pH 8.0 and measuring A260 and then diluting with water. 
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2.5.8 Preparation of translation pre-mix 
 
The pre-mix used in translation assays was prepared with the components 
shown in Table 2.10. 
Table 2.10 Components of the translation assay pre-mix (30 µl). 
Component Volume [µl] Stock Final Concentration 
S30 Premix (PrOmega) 12 NA 40% (vol/vol) 
M. smegmatis S100 extract 6 NA 20%(vol/vol) 
tRNAs (Sigma) 1.2 10 µg/µl 0.4 µg/µl 
Amino acids (Sigma) 1.2 5 mM 200 µM 
RNasin (Thermoscientific) 0.6 40 U/µl 0.8 U/µl 
Protease Inhibitor (Roche) 0.6 50x 1x 
mRNA 2 2 µg/µl 13.3 ng/µl 
dH2O 2.4 NA NA 
Total Premix Volume 26 NA NA 
 
 
2.5.9 Luciferase mRNA translation assay 
 
M. smegmatis ribosomes and M. smegmatis S100 extract were prepared as 
described in section 2.5.6. Omega F-luc mRNA or Renilla R-luc mRNA was prepared 
as described in section 2.5.7. 7.5 pmol M. smegmatis ribosomes were incubated with 
30 µl of a translation mixture pre-mix (Table 2.10, section 2.5.8) and Raf proteins 
stored in TAKM7 buffer (section 2.5.4) at 37oC for the time indicated and stopped on 
ice. PrOmega reagents were obtained from the Dual Luciferase Assay Kit 
(PrOmega). 
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Where pre-incubation of Raf proteins without mRNA is indicated, mRNA was 
added after incubating ribosomes with all other components as specified. 
Paromomycine, served as a positive control in the concentrations indicated and Raf 
proteins were omitted in these controls. Non-dissociated or dissociated wild type 
ribosomes were used as specified. The dual luciferase assay was performed as 
specified by the manufacturer (PrOmega). Bioluminescence was measured in a 
luminometer (FLx800; Bio-Tek Instruments). 
 
2.5.10 PolyU mRNA translation assay 
 
M. smegmatis ribosomes and S100 extract were prepared as described in 
section 2.5.6 and polyU mRNA was obtained from Sigma. 7 Non-dissociated or 
dissociated wild type ribosomes were employed as specified. 5 pmol M. smegmatis 
ribosomes were incubated with Raf proteins and 30 µl of a translation mixture pre-
mix (composition indicated in Table 2.10, section 2.5.8) in TAKM7 buffer (section 
2.5.4). 14CPhe amino acids were the only amino acids supplied.  
Where pre-incubation of Raf proteins without mRNA is indicated, mRNA was 
added after incubating the ribosomes with all other components as specified. The 
mixture was incubated at 37oC for the time indicated and the reaction was then 
stopped on ice. For detection of 14CPhe, RNA was hydrolysed with 5 ml of 5M KOH 
and protein was precipitated with 5% TCA. Each reaction mixture was filtered 
through a 0.45 mm nitrocellulose membrane and exposed to a phosphoimager 
screen for detection of 14CPhe incorporation. 
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2.6 Statistical testing 
 
Significance testing was carried out between data groups with one-way ANOVA 
with Holm-Šídák multiple comparison test and p-values were obtained using 
GraphPad Prism 6 software (GraphPad Prism version 6.00 for Windows, GraphPad 
Software, San Diego California USA, www.graphpad.com). P-value significance was 
described as listed by GraphPad Prism 6 with p-values greater than or equal to 0.05 
being not significant, p-values between 0.01 and 0.05 being significant, p-values 
between 0.001 and 0.01 being very significant and p-values between 0.0001 and 
0.001 being extremely significant. 
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3. Role of RafS in mycobacterial 
physiology 
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3.1 Role of RafS in mycobacterial physiology: aims 
 
 We investigated the hypothesis that the putative ribosome stabilisation factor 
RafS, plays a role in mycobacterial physiology in growth, survival and stress 
tolerance phenotypes. We aimed to construct and complement deletion mutants 
ΔrafSMsm and ΔrafSMtb and investigate their physiological characteristics. M. 
smegmatis mutants expressing full length and truncated RafS genes were also 
constructed and investigated. Several assays were carried out in the model 
organism, M. smegmatis and key assays were carried out in M. tuberculosis. 
 
3.2 Construction of M. smegmatis mutants   
 
3.2.1 Construction of ΔrafSMsm and ΔrafSMsmc M. smegmatis mutants. 
 
I aimed to construct ΔrafSMsm and ΔrafSMsmc mutants. I employed 
mycobacterial recombineering for ΔrafSMsm construction (Kessel et al., 2007). This 
involves cross over between a double stranded linear AES and the M. smegmatis 
wild type genome, resulting in the replacement of the endogenous rafSMsm gene from 
the wild type genome with a hygromycin resistance gene casette present within the 
AES. ΔrafSMsmc refers to ΔrafSMsm complemented with a copy of rafSMsm whose 
expression is controlled by an hsp60 promoter mediating constitutive expression 
included on an integrating plasmid (Materials and Methods section 2.3.7). Bacterial 
strain, plasmid and primer details are given in Materials and Methods tables 2.1., 2.2 
and 2.3, respectively. 
For construction of the linear AES, Upstream (UR) and downstream (DR) 
regions (821 bp and 721 bp, respectively) flanking the rafSMsm (MSMEG_1878) gene 
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were amplified by PCR of wild type M. smegmatis genomic DNA (Fig. 3.1A) (Table 
2.3). The PCR products were cloned into PCR®-4Blunt-TOPO (Invitrogen) and 
amplified in E. coli GM2163 cells. The DR was inserted between NheI and SpeI 
restriction sites and the UR between KpnI and XbaI restriction sites of PCR®-4Blunt-
TOPO. The UR and DR inserts were digested from TOPO/rafSMsmUR and 
TOPO/rafSMsmDR and sizes were confirmed by gel electrophoresis (Fig. 3.1B).  
The pYUB854 plasmid containing the hygromycin resistance casette 
(Appendix Figure 1) was digested with NheI and SpeI and the DR insert was ligated 
to linear pYUB854 digested with NheI and SpeI. The pYUB854/rafSMsmDR plasmids 
were isolated and digested with KpnI and XbaI so that the UR could be inserted. The 
UR was ligated to linear pYUB854/rafSMsmDR. The resulting 
pYUB854/rafSMsmUR/DR plasmid was digested with KpnI and SpeI to obtain the 
rafSMsm linear AES (3936 bp) and presence of UR and DR inserts was confirmed by 
restriction digest of the AES with KpnI and XbaI (UR) NheI and SpeI (DR) (Fig. 3.1 
C). A summary of the mycobacterial recombineering strategy for construction of 
ΔrafSMsm is shown in Figure 3.1D. 
The recombineering helper plasmid pJV53 was electroporated into wild type 
M. smegmatis. 0.2% w/v acetamide was used to induce expression of gp60 and 
gp61, which assist in the recombination of the AES with the bacterial genome. The 
linear AES was electroporated into these cells and HygR colonies were obtained on 
hygromycin selective plates. Colony PCR was used to screen electroporation 
colonies by amplifying a region surrounding the rafSMsm upstream and downstream 
sequences in order to confirm successful insertion of the hygromycin resistance 
casette between rafSMsm flanking regions (Fig. 3.2 A). Three ΔrafSMsm mutants were 
obtained from three separate electroporations of the linear AES to recombineering 
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cells prepared from three separate M. smegmatis colonies and were named 
ΔrafSMsm1, ΔrafSMsm2 and ΔrafSMsm3. These were called independent ΔrafSMsm 
mutants. (Fig. 3.2 B). 
The ΔrafSMsm1 strain was complemented with the plasmid pMV361/rafSMsm 
(KanR) (Materials and Methods section 2.3.6). For this purpose, serial subculturing of 
ΔrafSMsm1: pJV53 on plain LB agar was carried out to select for the loss of pJV53. 
Then, ΔrafSMsm1 colonies were streaked onto LB agar with and without kanamycin. 
KanS ΔrafSMsm1 colonies were isolated and electroporated with pMV361/rafSMsm and 
KanR colonies were selected. The resulting ΔrafSMsm1: pMV361/rafSMsm strain was 
named ΔrafSMsmc. ΔrafSMsmc was confirmed to be hygromycin and kanamycin 
resistant and colony PCR was used to confirm that the endemic rafSMsm gene was 
absent (Fig. 3.2 C).  
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Figure 3.1 Construction of the ΔrafSMsm mutant by mycobacterial recombineering. 
Upstream (821 bp) and downstream (721 bp) regions flanking the rafSMsm gene were 
amplified from M. smegmatis wild type genomic DNA and a double stranded linear 
allelic exchange substrate (AES) carrying a hygromycin resistance cassette was 
constructed and exchanged with the endemic rafSMsm gene. (A) PCR amplification of 
rafSMsm upstream (lane 2) and rafSMsm downstream (lane 4) flanking sequences. (B) 
Restriction digest of upstream (B1 lane 2) and downstream (B2 lane 2) flanking 
sequences from TOPO/rafSMsmUR and TOPO/rafSMsmDR plasmids, respectively. (C) 
Restriction digest confirmation of presence of upstream (lane 2) and downstream 
(lane 3) sequences in the rafSMsm linear allelic exchange substrate. The 
pYUB854/rafSMsmUR/DR plasmid was digested with KpnI and SpeI to obtain the 
rafSMsm linear AES (3936 bp) and presence of UR and DR inserts confirmed by 
restriction digest of the AES with KpnI and XbaI (UR) NheI and SpeI (DR).  (D) 
Mycobacterial recombineering strategy for constructing ΔrafSMsm. AES indicates 
allelic exchange substrate. Primers for amplification of upstream and downstream 
regions are indicated adjacent to arrows. DNA ladder and band sizes in bp are 
indicated in lane 1 of each panel. 
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3.2.2 Construction of M. smegmatis strains expressing RafS full length and 
truncated proteins  
 
M. smegmatis strains expressing RafS full length and truncated proteins were 
constructed in order to investigate whether constitutive expression of Raf proteins 
affects physiological characteristics of M. smegmatis. We intended to investigate 
these strains under conditions for which ΔrafSMsm showed a significantly different 
phenotype to wild type M. smegmatis. Truncated RafS proteins were expressed to 
investigate the roles of individual domains.  
Details of Raf protein structures based on bioinformatic predictions are given 
in section 4.2. Integrating vectors were constructed for constitutive expression of full 
length and truncated RafS proteins (in M. smegmatis) via the hsp60 promoter of 
plasmid pMV361. Bacterial strain, plasmid and primer details are given in Materials 
and Methods tables 2.1., 2.2 and 2.3, respectively. 
Candidate truncation regions were selected based on alignment with the short 
HPF protein PY which also contains an N terminal S30AE domain (See Figure 4.3 
for predicted secondary structures of Raf proteins). For each protein, within the 
region after the S30AE domain, a specific truncation residue was chosen such that 
the residue has low helix, strand and buried index propensities based on Jpred 
secondary structure predictions (Cole et al., 2008). The chosen truncation residues 
were 166 for RafSMsm and 141 for RafSMtb. 
Full length rafSMsm and rafSMtb and sequences of N and C terminal domains 
were amplified from M. smegmatis genomic DNA using primers 13 to 20 (Table 2.3). 
The 6 PCR products indicated (Fig. 3.3 A) were cloned into PCR®-4Blunt-TOPO 
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(Invitrogen) between MfeI and HindIII restriction sites and transformed into HB101 E. 
coli. Inserts were digested from ‘TOPO/rafS expression sequence’ plasmids with 
MfeI and HindIII and ligated to the linear pMV361 vector digested with MfeI and 
HindIII. The ‘pMV361/rafS expression sequence’ vectors were electroporated into 
wild type M. smegmatis. The electroporation colonies were screened by colony PCR 
to identify colonies with rafS expression sequences using primers 13 to 20 (Table 
2.3). (Fig. 3.3 B, C).  
A study containing evidence for changes in the annotation of the M. 
tuberculosis H37Rv genome suggested that rafSMtb (Rv3241c) should be re-
annotated such that its original length of 645 bp increases to 660 bp (Kelkar et al., 
2011). The Rv3241c gene would start at a site 15 bp upstream of the previously 
annotated site, causing substitution of the first methionine amino acid with the 
sequence “MSRLAV”. Prior to knowing about the reannotation, I had completed 
construction of the vectors described. Subsequently, I re-constructed the 
pMV361/rafSMtb and pMV361/rafSMtbN vectors with the new gene lengths as 
described. 
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bp) and rafSMtbN (C2, 438 bp) and rafSMtbC (C3, 219 bp). DNA ladder and band 
sizes in bp are indicated in lane 1 of each panel.  
 
3.3 Role of RafSMsm in normoxic growth 
 
3.3.1 Role of RafSMsm in normoxic growth in liquid media 
 
 
The normoxic growth characteristics of wild type M. smegmatis, ΔrafSMsm, and 
ΔrafSMsmc strains in LBT and minimal HdB media were investigated. The Luria 
Bertani or LBT rich medium contained the complex carbon sources yeast extract and 
tryptone (peptides formed by casein digestion by trypsin). Hartman’s de Bont 
minimal medium contained 0.04% glycerol as the sole carbon source (Materials and 
Methods sections 2.4.3, Appendix Table 1). No significant differences in strain 
growth characteristics in LBT or Hdb were observed (Fig. 3.4).  
We next investigated the role of RafSMsm in growth during the transition from 
LBT stasis to active growth in HdB and also from HdB stasis to active growth in LBT. 
Transition from LBT to HdB (nutrient downshift) involves adjustment to utilisation of 
glycerol, the sole and limited carbon source. Transition from HdB to LBT (nutrient 
upshift) involves adjustment to utilisation of complex carbon sources present in 
tryptone and yeast extract. LBT stationary phase cultures subcultured to HdB 
showed no apparent differences in growth characteristics (Fig. 3.5 A). HdB stationary 
phase cultures subcultured to LBT media also showed no apparent differences in 
growth characteristics (Fig. 3.5 B) Taken together, the results indicated that RafSMsm 
is dispensable for normoxic growth in LBT and HdB media and for growth during 
nutrient downshift and upshift. 
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We next investigated the growth characteristics of strains constitutively 
expressing full length and truncated rafS proteins via an hsp60 promoter of the 
pMV361 integrating plasmid. Wild type M. smegmatis/pMV361, M. 
smegmatis/pMV361: rafSMsm, M. smegmatis/pMV361: rafSMsmN and M. 
smegmatis/pMV361: rafSMsmC strains were cultured to late log phase in LBT media 
and no apparent differences in growth characteristics were observed (Fig. 3.6 A).  
Growth characteristics of M. smegmatis/pMV361, M. smegmatis/pMV361: 
rafSMtb, M. smegmatis/pMV361: rafSMtbN strains in LBT media did not appear to be 
different (Fig. 3.6 B).  Given the lack of difference in strain growth, I did not pursue 
characterisation of M. smegmatis/pMV361: rafSMtbC. The data indicated that 
constitutive expression of RafSMsm and RafSMtb and truncated constructs in wild type 
M. smegmatis does not affect growth in LBT media.  
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3.3.2 Role of RafSMsm in mature biofilm and pellicle formation 
 
I next investigated whether RafSMsm plays a role in normoxic mature biofilm 
and pellicle formation (Materials and Methods sections 2.4.8, 2.4.9). Mature biofilms 
cultured in M63 minimal media for 4 days at 30oC indicated no significant difference 
in biofilm formation (Fig 3.7 A). Mature biofilms cultured in M63 minimal media for 5 
days at 28.5oC also indicated no significant difference in biofilm formation (Fig 3.7 
B). Pellicles cultured in 7H9 media in triplicate for 2 days at 37oC indicated no 
apparent difference in pellicle formation in all strains investigated (Fig 3.7 C). Taken 
together, the data indicated that RafSMsm is dispensable for biofilm and pellicle 
formation.  
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3.4 Role of RafSMsm in tolerance of acid, heat and antibiotic stress 
  
We investigated the role of RafSMsm in tolerance of acid stress, a condition 
present in granulomas and thus known to be physiologically relevant to M. 
tuberculosis pathology (Shleeva et al., 2011). Short term survival assays were 
employed to investigate survival of stationary phase cells in LBT media at pH 2.73, 
4.7 and 6.74 (normoxia) in a 24-well format (Materials and Methods section 2.4.10). 
The results indicated no significant differences between wild type and ΔrafSMsm1 
viabilities (Fig. 3.8).  
Since ∆rafHMsm viability is impaired in heat stress at 55oC (Trauner et al., 
2010), we investigated the role of RafSMsm in tolerance of heat stress 55oC. 
Differences in survival of wild type and ΔrafSMsm1 stationary phase cells at 55oC 
were investigated during a period of 6.5 h (Materials and Methods section 2.4.11). 
The data indicated no significant difference between wild type and ΔrafSMsm1 
viabilities (Fig. 3.9).   
We also investigated the role of RafSMsm in antibiotic stress tolerance. Due to 
RafSMsm being a ribosome-binding protein (Trauner, 2010), we investigated antibiotic 
susceptibility to ribosome-targetting antibiotics. Antibiotics with non-ribosomal targets 
were also included for comparison.. The microplate alamar blue assay (MABA) was 
employed for MIC determination in 7H9 (Fig. 3.10 A) and HdB media (Fig. 3.10 B) 
(Collins et al., 1997) (Materials and Methods section 2.4.7).  
Growth of wild type and ΔrafSMsm1 strains was investigated in antibiotics at a 
10-fold serial dilution concentration series starting from 200X reported MIC values 
over a period of 48 hours. Mean fold differences in between wild type and ΔrafSMsm 
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MICs were less than 4-fold indicating no significant differences (van de Kassteele et 
al., 2012). Taken together, the data indicated that RafSMsm was dispensable for short 
term viability in acid pH and heat stress and also for antibiotic tolerance in LBT and 
HdB minimal media in normoxia. 
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Figure 3.9. RafSMsm is dispensable for short term survival in heat stress (55oC , 
normoxia). Wild type M. smegmatis, ΔrafSMsm1, ΔrafSMsmC strains (3 biological 
replicates each) were cultured to stationary phase in LBT media (3h duration) and 
transferred to an incubator at 55oC, 150 rpm to monitor viability over a 6.5 h period. 
6.5 h means were compared using a one-way ANOVA with Holm-Šídák multiple 
comparison test; ns indicates a non-significant p-value > 0.05. 
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3.5 Role of RafSMsm in stasis survival and resuscitation 
 
As shown previously, ΔrafHMsm viability was compromised in 41 day hypoxic 
stasis (Trauner et al., 2012). Thus, survival assays were carried out in order to 
investigate whether rafSMsm plays a role in maintaining viability during normoxic and 
hypoxic stasis in rich and carbon-limited media. These assays were intended to 
investigate long term trends indicating differences in strain survival.  
Normoxic survival assays were carried out in LBT and HdB (0.04% and 0% 
glycerol) stasis (Materials and Methods section 2.4.5). (See Appendix Table 2 for a 
summary of conditions investigated). The survival assay in normoxic LBT stasis 
indicated significantly lower ΔrafSMsm survival on the 44th day of LBT stasis (p= 
0.0377). Also, this defect appeared to be complemented by the ΔrafSMsmc mutant 
(Fig 3.10). This assay was not continued further due to the formation of large clumps 
in cultures of all strains that could not be disrupted by vortexing.  
The survival assay in HdB (0.04% glycerol) also indicated no significant 
differences in strain survival in 72 days stasis (Fig 3.12 A). When a carbon source 
was not provided in the 0% glycerol HdB assay, 0.02% tyloxapol was employed as 
dispersal agent that is non-hydrolysable by mycobacteria and does not act as a 
carbon source in order to achieve stringent carbon starvation. No significant 
differences in strain survival were observed in 73 days HdB (0% glycerol) stasis (Fig 
3.12 B).   
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Figure 3.11. Role of RafSMsm in survival in normoxic LBT stasis. Wild type M. 
smegmatis, ΔrafSMsm1 and ΔrafSMsmC strains (three biological replicates per strain) 
were cultured to normoxic stasis in LBT media (3h duration) and subcultured to LBT. 
Strains were allowed to grow to stationary phase at 150 rpm, 37oC (1 day duration of 
growth to stasis) and CFU cell counts were obtained at days indicated. Day 0 
indicates the CFU reading taken after subculturing strains from LBT stasis to LBT 
prior to long-term incubation. n = 3 except for day 45 ΔrafSMsm1 and ΔrafSMsmc time 
points, where n = 2. Average CFU/ml were plotted. Error bars indicate standard 
deviation. Means were compared using a one-way ANOVA with Holm-Šídák multiple 
comparison test; ns indicates a non-significant p-value > 0.05; * : significant p = 0.01 
to 0.05.   
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Hypoxic survival assays were carried out in LBT and HdB (0.04% glycerol) 
stasis (Materials and Methods section 2.4.5). The hypoxic stasis survival assay (255 
days) in LBT indicated no significant differences in strain survival (Fig. 3.13 A). The 
hypoxic stasis survival assay in HdB (0.04% glycerol) (364 days) indicated an overall 
trend of no significant difference in strain viability between wild type and ΔrafSMsm,  
However, a significantly lower ΔrafSMsm viability than wild type (p= 0.0019) 
was observed at day 55, and this defect was not recovered in the complemented 
strain which also showed a viability defect at day 55 (wild type versus ΔrafSMsmc p= 
0.0019). Also, another significant ΔrafSMsmc viability defect was observed at day 364 
(wild type versus ΔrafSMsmc p= 0.0116) (Fig. 3.13 B). It would be worthwhile to further 
investigate ΔrafSMsm viability defects around day 55 (HdB 0.04% glycerol, hypoxia) 
with more frequent viability testing before and after day 55. Also, employing an 
alternative complementation strain, such as one where rafSMsm is expressed under 
the control of its native promoter would be useful as a control.  
We next investigated the role of RafSMsm in survival in oxygen-limited general 
nutrient starvation PBS stasis. The results indicated no significant differences in 
viabilities between strains in 345 days of stasis (Fig 3.14). Taken together, the data 
indicated that RafSMsm is dispensable for prolonged survival in normoxic LBT and 
HdB stasis and in hypoxic LBT and HdB stasis. 
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Figure 3.14. Role of RafSMsm in survival in PBS stasis (general nutrient starvation). 
Wild type M. smegmatis, ΔrafSMsm1 and ΔrafSMsmc strains were cultured to normoxic 
stasis in LBT (3h duration) and cultures were pelleted. The pellets were resuspended 
in modified PBS and transferred to suba-sealed flasks (cultures not exposed to air). 
CFU cell counts were obtained at days indicated. Day 0 indicates the CFU reading 
taken after resuspending strains from LBT stasis to modified PBS, prior to long-term 
incubation. 3 biological replicates per strain are included except for ΔrafSMsmc where 
2 replicates are included. Average CFU/ml are plotted. n = 3 for all points except wild 
type day 48 where n=2. Error bars indicate standard deviation. Means were 
compared using one-way ANOVA with Holm-Šídák multiple comparison test; ns: 
non-significant p-value > 0.05. 
 
Resuscitation of aged stasis cultures was carried out to investigate whether 
rafSMsm deletion affects resuscitation of aged cultures in fresh LBT media (Materials 
and Methods section 2.4.5) (Fig. 3.15). An assumption was made that the viabilities 
of the inoculum cultures were not significantly different. This assumption was based 
on the lack of significant differences observed between strain viabilities in adjacent 
time points of the survival assays from which the inocula were derived. 
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Resuscitation of normoxic HdB (0.04% glycerol) stasis cultures indicated no 
significant differences in strain resuscitation characteristics, indicating dispensability 
of RafSMsm (Fig 3.14). Resuscitation of normoxic HdB (0 % glycerol), hypoxic LBT 
and hypoxic HdB (0.04% glycerol) stasis cultures also showed no apparent 
differences in resuscitation of all strains (Appendix Fig. 2). In the latter three 
experiments, two replicates per strain were obtained and further investigation of 
these conditions was not pursued since the data indicated that resuscitation was 
successful for all strains.  
 
 
 
Figure 3.15. RafSMsm is dispensable during resuscitation of aged normoxic HdB 
stasis cultures in rich media (normoxia). Wild type M. smegmatis (blue), 
ΔrafSMsm1(red) and ΔrafSMsmc (green) day 65 0% glycerol, 0.02% Tyloxapol HdB 
normoxic aged cultures (3 biological replicates per strain) were resuscitated by sub-
culturing 1 ml of each culture to fresh LBT medium and monitoring growth in 
normoxic conditions. Means were compared using one-way ANOVA with Holm-
Šídák multiple comparison test; ns: non-significant p-value > 0.05. 
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3.6 Investigating the role of RafSMsm in competitive survival 
 
We next investigated whether rafSMsm deletion affects strain fitness and 
survival when ΔrafSMsm is cultured in competition with wild type M. smegmatis 
(Materials and Methods section 2.4.6). The ΔrafSMsm strain (HygR) was distinguished 
from the wild type in a mixed population by CFU enumeration using selective agar 
containing hygromycin. The LBT competition assay indicated no significant 
differences in strain survival (Fig. 3.16).  
The HdB assay also indicated a trend of no significant difference in strain 
survival, other than at day 6 when ΔrafSMsm mutant survival was significantly lower 
than wild type (assay with two independent ΔrafSMsm mutants p = 0.002) (Fig. 3.17 
A). Furthermore, I confirmed that this trend was similar upto 33 days with 
independent ΔrafSMsm mutant 3 (plotted separately, but derived from same 
experiment as Fig 3.18 A; day 6 p = 0.0065)) (Fig. 3.17 B). Taken together, the data 
from the LBT and HdB competition assays indicated that RafSMsm is dispensable for 
competitive survival in 27 days of rich stasis and in 32 days of carbon-limited 
normoxic stasis.  
 
  
133 
 
 
 
Figure 3.16. RafSMsm is dispensable during 28 day competitive LBT growth and stasis 
(normoxia). M. smegmatis wild type (3 biological replicates) and two independently 
constructed ΔrafSMsm mutants (3 biological replicates each of ΔrafSMsm mutants 2 
and 3) were cultured to stasis in LBT media (3h duration), mixed in equal amounts 
and the mixture was subcultured to LBT media and incubated at 37oC. CFU readings 
were obtained on LB agar (total count) or LB agar with 50 µg/ml hygromycin 
(ΔrafSMsm count). Day 0 indicates the CFU reading taken after subculturing strains 
from LBT stasis to LBT media, prior to long-term incubation. Average CFU values 
are indicated. Error bars indicate standard deviation. Means were compared using 
one-way ANOVA with Holm-Šídák multiple comparison test; ns: non-significant p-
value > 0.05. 
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3.7 Role of RafSMtb in M. tuberculosis physiology 
 
3.7.1 Construction of ΔrafSMtb mutants 
 
ΔrafSMtb deletion mutants were constructed in order to investigate key 
conditions informed by M. smegmatis investigations. The mycobacterial 
recombineering strategy for construction of ΔrafSMtb is summarised in Fig 3.18 G. 
Upstream and downstream regions (1014 bp rafSMtb UR and 987 bp rafSMtb DR, 
respectively) flanking the ΔrafSMtb (Rv3241c) gene were amplified by PCR of wild 
type M. tuberculosis genomic DNA using primers 3241upF, 3241upR, 3241dnF, 
3241dnR (Table 2.3), (Fig. 3.18 A, B). Bacterial strain, plasmid and primer details are 
given in Materials and Methods tables 2.1., 2.2 and 2.3, respectively. 
The PCR products were cloned into PCR®-4Blunt-TOPO (Invitrogen) and 
amplified in E. coli GM2163 cells. The rafSMtb DR was cloned between XbaI and 
KpnI restriction sites and the rafSMtb UR between SpeI and HindIII restriction sites 
(Materials and Methods sections 2.3.3, 2.3.4). For construction of the linear AES, the 
UR and DR inserts were digested from TOPO/ rafSMtb UR and TOPO/ rafSMtb DR, 
respectively (Materials and Methods section 2.3.7) (Fig 3.18 C, D).  
The rafSMtb UR was ligated to linear pYUB854 digested with SpeI and HindIII. 
The resulting pYUB854/ rafSMtb UR plasmids were isolated and digested with SpeI 
and HindIII to confirm the presence of the UR (Fig 3.18 E). The DR insert was ligated 
to linear pYUB854/rafSMtb UR. pYUB854/rafSMtb UR/DR plasmids were digested to 
confirm UR and DR presence (Fig. 3.18 F). The pYUB854/rafSMtb UR/DR plasmid 
was digested with KpnI and SpeI to obtain the rafSMtb linear AES (4135 bp).  
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The recombineering helper plasmid pJV53 was electroporated into wild type 
M. tuberculosis. 0.2% w/v acetamide was used to induce expression of gp60 and 
gp61, which assist in recombination of the AES with the bacterial genome.  The 
rafSMtb AES was electroporated into acetamide-induced electrocompetent 
H37Rv:pJV53 cells. HygR colonies were obtained on hygromycin plates (Materials 
and Methods section 2.3.6). 
Several attempts were made to screen electroporation colonies with a single 
PCR covering the entire HygR cassette, rafSMtb upstream and downstream regions 
and peripheral regions to show successful replacement of the rafSMtb gene with the 
HygR cassette. Since these attempts were unsuccessful, I employed two colony 
PCRs which amplified the region surrounding the rafSMtb DR region (Fig 3.18 A2, 
B3). Genomic DNA from 8 HygR colonies from the electroporation plates was 
extracted as described (Materials and Methods section 2.3.1, 2.3.2). Regions 
surrounding the rafSMtb downstream region (4135 bp; ΔrafSMtb and 2888 bp; wild 
type) were amplified by PCR with the primers indicated (Fig 3.19).  
PCR products from 5 colonies indicated rafSMtb AES insertion (Fig. 3.19 A1). 
In these colonies, the wild type rafSMtb gene was absent (Fig. 3.19 B1), whereas the 
positive control with wild type genomic DNA confirmed that the latter PCR was 
successful (Fig. 3.19 B2). Taken together, the analyses confirmed construction of 5 
independent ΔrafSMtb mutants, which were named ΔrafSMtb 2, 3, 4, 5 and 6. I 
attempted to complement ΔrafSMtb mutants 2 and 3 by inserting plasmid pMV361/ 
ΔrafSMtb, but was unable to unmark the ΔrafSMtb mutants for this purpose, since the 
recombineering helper plasmid, pJV53 (KanR) was not lost despite 7 passages on 
plain 7H11 agar without kanamycin.  
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3.7.2 Role of RafSMtb in active growth and in competitive survival  
 
M. tuberculosis is known for its slow growth. In optimal laboratory growth 
conditions, a doubling time of 16 hours can be achieved, whereas in the human host, 
growth rates are dependent on the site and stage of infection. Active replication is 
characteristic of the acute phase of infection which precedes the persistent state. 
(Beste et al., 2009). I investigated the role of RafSMtb in active growth of M. 
tuberculosis in 7H9 rich media (normoxia) (Materials and Methods section 2.4.13).  
The 7H9 media contained glycerol, glutamic acid, oleic acid, bovine serum 
albumin and glucose which are potential carbon sources. It also contains the co-
factor biotic and sodium citrate which facilitates citrate-mediated iron transport. The 
data indicated an overall trend of no apparent differences in strain growth 
characteristics other than between days 1 and 3 when a higher growth rate was 
observed for the wild type compared to ΔrafSMtb mutant (Fig. 3.20).  
Since this trend did not continue, we concluded that there was no significant 
growth defect of the ΔrafSMtb mutants.  It was observed that gas bubbles were 
exclusively present in all ΔrafSMtb mutant cultures and absent from the wild type 
cultures, indicating that the effect rafSMtb deletion on ΔrafSMtb mutant metabolism 
warrants further investigation.  
We next investigated the effect of rafSMtb deletion on competitive survival in 
7H9 rich normoxic stasis (Materials and Methods sections. 2.4.6, 2.4.14) (Fig 3.21). 
Given that the strains did not grow sufficiently in HdB media, we limited the 
investigation to 7H9 rich media. There were several difficulties in obtaining CFU data 
and this was due to agar dehydration during incubation which affected cell growth. 
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Towards the end of the assay, this problem was resolved by using thicker agar 
plates. Complete time points obtained were plotted and the experiment was 
discontinued beyond the time frame indicated due time limitations.  
For the final time points obtained, we observed significantly higher wild type 
viabilities compared to ΔrafSMtb (Assay 1, day 164 p = 0.0025, Assay 2 day 238 p = 
0.0003) (Fig 3.21 A and B). The data thus far indicated that RafSMtb is dispensable 
for normoxic active growth and plays a role in survival in 228 day normoxic 
competitive stasis in M. tuberculosis in rich medium. Further time points are needed 
to characterise the ΔrafSMtb competitive survival defect. 
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Figure 3.20. RafSMtb is dispensable for growth of M. tuberculosis in rich 7H9 medium 
(normoxia). M. tuberculosis wild type H37Rv and two independently constructed 
ΔrafSMtb mutants were cultured in 7H9 medium at 37oC, 125 rpm for 10 days. The 
strains were subcultured to 7H9 medium and growth of wild type H37Rv (3 biological 
replicates) and two independently constructed ΔrafSMtb mutants (3 biological 
replicates each of ΔrafSMtb mutants 2 and 3) and incubated at 37oC, 125 rpm for 10 
days. Growth was monitored at intervals indicated. Average optical density 
(OD600nm) is plotted. Error bars indicate standard deviation.  
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3.8 RafS physiological findings: discussion 
 
The findings presented thus far indicate that RafSMsm is dispensable in several 
conditions, including active normoxic growth, survival in normoxic and hypoxic 
stationary phase and stress tolerance. It would be useful to investigate RafSMsm 
expression levels and ΔrafSMsm phenotypes in other nutrient starvation conditions, 
such as nitrogen and phosphate starvation which may then be used to inform further 
ΔrafSMtb characterization. Also, construction and characterization of a ΔrafSMsm 
ΔrafHMsm mutant (double knockout) would be useful for investigating whether the 
deletion of both Raf proteins affects growth, survival and stress tolerance 
phenotypes. 
RafSMtb was found to play a role in long term survival in competitive normoxic 
stasis. Regarding the latter finding, a more detailed study is required to investigate 
the ΔrafSMtb competitive survival defect, particularly beyond day 142. Furthermore, 
these findings suggest that carrying out longer term competition assays may be 
worthwhile for RafSMsm characterization. For both genes, proteomic data will be 
useful to determine under which conditions Raf proteins are expressed.  
Also, it remains to be investigated as to whether RafSMtb plays a role in 
metabolism during active growth, given that bubbles were observed in ΔrafSMtb rich 
medium cultures. Further investigations will be needed to determine whether 
RafSMsm and RafSMtb have different roles in M. smegmatis and M. tuberculosis 
respectively or whether some phenotypes overlap and are common to both genes. 
The findings in this chapter are discussed further in Chapter 5. 
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Chapter 4: RafS protein 
characteristics and effects on 
ribosome translation and subunit 
association 
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4.1 RafS protein characteristics and effects on ribosome translation and 
subunit association: aims 
 
 RafSMsm and RafHMsm had been found to bind M. smegmatis ribosomes during 
stasis (Trauner, 2010). Also, given the presence of the S30AE ribosome-binding 
domain in Raf proteins and the function of PY (an S30AE protein and RSF in E. coli), 
we aimed to investigate the hypothesis that RafS is a ribosome stabilisation factor in 
mycobacteria. For this purpose, the following were carried out: 
1. Analysis of RafSMsm and RafSMtb protein bioinformatic features and comparison 
to those of RafHMsm and RafHMtb. 
2. Expression and purification of Raf proteins for biochemical assays. 
3. Investigation of the effect of RafSMsm and RafHMtb proteins on in vitro translation 
of M. smegmatis ribosomes. 
4. Investigation of the role of RafSMsm in M. smegmatis ribosome subunit 
association. 
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4.2 Bioinformatic analysis of RafS proteins 
 
4.2.1 Bioinformatic analysis of RafS proteins: aims 
 
 
The following bioinformatic features of RafSMsm and RafSMtb proteins were 
investigated: 
1. taxonomical prevalence of RafSMtb-related proteins 
2. conserved domain identification of RafS proteins 
3. protein sequence alignment comparison of RafS and RafH proteins 
4. predicted protein structures : structural comparison of RafS, RafH and E. coli 
PY and/or HPF 
5. disordered and protein-binding regions of RafS proteins 
6. putative N and C terminal domain regions and inter-domain linker regions of 
RafS proteins 
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4.2.2 RafS protein taxonomical coverage, conserved domain identification and 
sequence alignment analyses 
 
Raf proteins are classified as “long HPFs” (hibernation promoting factors) due 
to their long C terminal extensions which differs from “short HPFs”, such as PY of E. 
coli, which contain shorter C terminal extensions (Trauner, 2010). The predicted 
molecular weights of RafSMsm and RafSMtb proteins are 26.40 kDa and 24.53 kDa, 
respectively (ProtParam, Expasy). Further characteristics of Raf proteins, such as 
predicted stability and theoretical isoelectric point are listed in Appendix Table 3. We 
investigated the bioinformatic features of RafSMsm and RafSMtb proteins including 
taxonomical coverage, conserved domain identification and sequence alignment.  
Analysis of taxonomical coverage of RafS-related proteins was carried out 
based on the protein sequence of RafSMtb (Rv3241c). This indicated predominant 
prevalence of RafS-related proteins in bacterial genera. There were 3792 RafS-
related proteins in bacteria, 73 in cyanobacteria and 48 in eukaryotes (TB database) 
(Fig. 4.1 A). Phylogenetic analysis of Raf proteins indicated close phylogenetic 
similarity of RafSMtb and the RafS homologue of M. bovis, which is an 
uncharacterized protein to date (MUSCLE-EBI) (Fig. 4.1 B). Notably, a RafS 
homologue is present in M. leprae, a mycobacterial species known for its 
conservative genome, whereas RafH is absent in M. leprae. 
For RafSMsm and RafSMtb, conserved domains were found within both N 
terminal regions of RafSMsm (residues 30 to 145) and RafSMtb (residues 15 to 110). 
The RafS conserved domains were the RaiA (ribosome associated inhibitor A) 
domain, yfiA (ribosome subunit interface protein), ribosome associated protein Y 
(Psrp-1) and the S30AE ribosome binding domain/sigma 54 modulation protein 
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(DELTA-BLAST) (Figure 4.2 A, B). Psrp-1 is a protein of unknown function found in 
the cyanobacterium Synechococcus PCC 7002 that is encoded by a light-repressed 
transcript whose expression was suppressed in the presence of light (Tan et al., 
1994). NCBI DELTA-BLAST also indicated that 22 putative 30S ribosome subunit-
binding sites were present within the putative S30AE domains of each RafS protein.  
RafS and RafH protein sequence alignment (4 in total) indicated 69% protein 
sequence similarity between RafS and RafH proteins (EBI Clustal Omega alignment, 
percentage similarity obtained from T-Coffee 11) (Fig. 4.3 A). RafH protein 
sequences showed longer C-terminal extensions than RafS proteins. RafSMsm and 
RafSMtb protein sequence alignment indicated 98% protein sequence similarity (EBI 
Clustal Omega alignment, percentage similarity obtained from T-coffee 11) (Fig. 4.3 
B). Two regions of protein sequence dissimilarity between the RafS protein 
sequences were observed (Regions 1 and 2, Fig. 4.3 B). It remains to be understood 
as to whether these regions play a role in determining functional differences between 
RafSMsm and RafSMtb proteins. 
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4.2.3 RafS and RafH: features of predicted protein structures 
 
We investigated RafS and RafH predicted protein structures and compared 
them to that of PY (E. coli). Secondary structure-coloured, N to C terminus 
progression-coloured and confidence-coloured protein predicted structures of Raf 
proteins are shown in Figure 4.4. Raf protein predicted structures consisted of N 
terminal globular domains that adopt a βαβββα topology. For each RafS protein, this 
domain was found in the region previously defined as the S30AE conserved domain 
(RafSMsm 30 - 145 and RafSMtb 15 - 110 of Figure 4.2) (Fig. 4.4 A).  
Raf protein N-terminal domains are putative ribosome-binding domains that 
were predicted with high confidence and appeared structurally similar to that of PY 
(E. coli short HPF homologue) (Fig. 4.4 C). N-terminal Phyre2 and PSPIRED 
predicted secondary structures for RafSMsm and RafSMtb agreed with each other 
(Buchan et al., 2013) (Appendix Figures 3 and 4). Raf protein C-terminal domains 
were predominantly predicted with lower confidence, indicating that similar structures 
are lacking among existing protein structures. The structural characteristics and roles 
of the C-terminal domains are yet unknown. A linker joining the N and C terminal 
domains is apparent in all Raf protein structures (Fig. 4.4 B). 
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RafSMsm and RafSMtb predicted protein structures were further investigated in 
order to identify putative domain boundaries and disordered and protein binding 
regions (Fig. 4.5 A).  For both RafS proteins, protein-binding disordered regions were 
predicted at the N terminal starting sequence as follows; RafSMsm 0 – 25 (N1) and 
RafSMtb 0 – 10 (N2) (Confidence score > 0.5) (Buchan et al., 2013).  
Also, disordered regions were predicted which overlap with predicted inter-
domain boundary regions  as follows; RafSMsm residues 125 – 175 (L1) and RafSMtb 
residues 110 – 150 (L2) predicted disordered regions overlap with RafSMsm residues 
125 – 150 (I1) and RafSMtb residues 105 – 135 (I1) predicted domain boundary 
regions (Fig. 4.5 A, B).  For both RafS proteins, ‘N’ regions overlapped with ‘Region 
1’ of low protein sequence similarity. Also, predicted disordered and inter-domain 
boundary regions ‘L’ and ‘I’ overlapped with second region of low protein sequence 
similarity, ‘Region 2’, (refer to Fig. 4.2B for RafS protein sequence alignment). 
Putative inter-domain linker regions identified by alignment termini profiling 
(region ‘I’ determined in Fig 4.6 B) were used to identify putative domains of RafS 
predicted protein structures. Based on this prediction, RafS protein domains were 
annotated as shown in Fig. 4.7. Binding of RafSMsm and RafHMsm to 30S subunits of 
stationary phase ribosomes has previously been shown by mass spectroscopy 
(Trauner, 2010). However, the binding site(s) of Raf proteins on the ribosome and 
location of Raf protein domains during docking to the ribosome is yet unknown. 
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4.2.5 Bioinformatic analysis of RafS proteins: summary  
 
In summary, bioinformatic predictions suggest that RafSMsm and RafSMtb each 
contain: 
1. a putative ribosome-binding N terminal globular domain of βαβββα topology, 
identified as the S30AE domain by conserved domain analysis and 
homologous to the N-terminal domains of RafHMsm, RafHMtb and PY. 
2. a putative N-terminal protein-binding disordered region (corresponding RafSMsm 
and RafSMtb sequences differ). 
3. a putative disordered inter-domain linker region (corresponding RafSMsm and 
RafSMtb sequences differ).  
4. a putative C-terminal domain of unknown function. 
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4.3 Raf protein expression and purification 
 
4.3.1 Raf protein expression and purification: aims and mutant construction 
 
We aimed to purify recombinant His-tagged RafS and RafH proteins for 
investigating biochemical characteristics of Raf proteins. To achieve this, the initial 
objective was to construct E. coli strains expressing N-terminal His-tagged Raf 
proteins (with 6 histidine residues), determine optimal conditions for soluble protein 
expression and carry out protein purification by immobilized metal (Ni2+) ion affinity 
chromatography (IMAC) to obtain soluble Raf proteins.  
The pET15b vector was chosen for induction of Raf protein expression with 
IPTG and N terminal 6-His tagging of expressed Raf proteins. Also, E. coli 
Rosetta™:pRARE cells (Novagen) were employed as expression strains for the 
recombinant Raf proteins. The pRARE plasmid carried by the expression strain 
supplies tRNAs for the codons AUA, AGG, AGA, CUA, CCC and GGA, providing for 
“universal” translation, to avoid limiting translation codon usage to those supplied by 
E. coli. Bacterial strain, plasmid and primer details are given in Materials and 
Methods tables 2.1., 2.2 and 2.3, respectively.  
Full length gene sequences of Rv0079 (RafHMtb), MSMEG_3935 (RafHMsm), 
Rv3241c (RafSMtb) and MSMEG_1878 (RafSMsm) were amplified by PCR from 
genomic DNA using primers 21 to 30 (Table 2.3). PCR products were sub-cloned 
into PCR®-4Blunt-TOPO in E. coli HB101, between NdeI and BamHI restriction 
sites. Inserts were confirmed to be of correct size and sequence by colony PCR and 
sequencing (Beckman Coulter genomics), respectively.  
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4.3.2  RafS and RafH protein expression trials  
 
Expression of Raf protein sequences present on pet15b vectors was induced 
with IPTG. Recombinant protein induction and SDS-PAGE analysis were carried out 
as described in Materials and Methods sections 2.5.1, 2.5.2. Soluble Raf proteins 
were expressed successfully for all strains constructed. Both soluble and insoluble 
proteins were seen for all strains at 0.1 mM and 1 mM IPTG at 37oC. Raf protein 
bands were identified by comparing with a control strain carrying the pET15b vector 
(Fig. 4.11 A). Raf proteins were present in soluble fractions and absent in empty 
vector control lanes.  
The predicted molecular weights of Raf proteins were RafSMsm: 26.4 kDa, 
RafSMtb:29.47 kDa, RafHMsm 24.53 kDa and RafHMtb: 29.02 kDa. Actual Raf protein 
gel bands appeared to concur approximately with the predicted sizes (taking into 
account the additional 1 kDa weight of the His tag), excepting the band for RafHMsm. 
The protein gel band for RafHMsm was approximately 60 kDa which was twice that as 
expected (Fig. 4.11 A, B lane 3). It is unclear as to whether the latter finding is an 
artifact of protein expression or is physiologically relevant. We did not pursue 
investigating this further due to time limitations. Raf protein predicted 
physicochemical parameters are listed in Appendix Table 3.  
I also attempted Raf protein expression at 18oC overnight to determine 
whether a lower temperature could enhance the amount of soluble Raf protein 
expressed by slowing protein folding and thus potentially making the folding more 
accurate. I was unable to further increase soluble protein expressed using this 
condition (data not shown). Expression time courses of Raf protein-expressing 
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strains were carried out as shown in sections 4.3.3 and 4.3.4. In these experiments, 
relative proportions of soluble to insoluble Raf proteins were compared. 
 
 
 
Figure 4.11. SDS-PAGE of soluble protein expression profiles of His-tagged Raf 
proteins in E. coli. His-tagged Raf protein expression was induced with 0.1 mM (A) 
and 1 mM IPTG (B) for 3 h at 37oC, 220 rpm. Lanes contain soluble protein fractions 
of strains expressing RafHMtb (lane 2), RafHMsm (lane 3), RafSMtb (lane 4), and 
RafSMsm (lane 5) and empty pET15b vector control (lane 6). Ladder protein weights 
are indicated in kDa (A and B lane 1). Raf protein migration indicated the following 
approximate molecular weights; RafHMtb (40 kDa), RafHMsm (60 kDa), RafSMtb (32 
kDa), and RafSMsm (35 kDa). 
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4.3.3 RafSMsm purification  
 
I next aimed to determine the optimal time for RafSMsm protein expression. A 
RafSMsm expression 6 hour (1 mM IPTG) time course assay indicated that the optimal 
IPTG induction time was 4 - 6 hours (Fig. 4.12). The 4 h time was selected to 
facilitate carrying out induction and FPLC within 1 working day. The empty vector 
control indicated that the protein background of the soluble fraction lanes were 
sufficiently empty in the 30 kDa range where RafSMsm expression was expected (Fig. 
4.12).  
I employed gradient FPLC to test the elution profile of RafSMsm from 20 mM to 
500 mM imidazole. This indicated that the optimal imidazole concentration for 
removing impurities was 205 mM imidazole (41% buffer B mix). Scaled-up 
recombinant protein induction (1L cell pellet) and FPLC protein purification were 
carried out (Materials and Methods sections 2.5.3, 2.5.4). RafSMsm was eluted at 500 
mM imidazole i.e. a 24 ml stepwise elution at 100% buffer B (Fig. 4.8 C). The FPLC 
chromatogram summarizing RafSMsm elution is shown in Fig. 4.13. The SDS-PAGE 
elution profile of RafSMsm is shown in Fig. 4.14 A. Fractions 3 to 16 were 
subsequently pooled and concentrated. 
 Several concentrators showed significant losses when attempting to 
concentrate RafSMsm (Appendix Table 4). Improved protein concentration was 
achieved using centrisart concentrators (10 kDa MWCO) (Sartorius) as per the 
manufacturer’s instructions. Centrisart concentrators utilise centrifugation to pull an 
inner chamber with a polysulfone membrane downwards and buffer to be discarded 
enters the chamber and can be removed, while the desired protein remains in the 
tube base. Protein concentrations were determined using a Bradford assay. The final 
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RafSMsm concentration achieved was 0.6 mg/ml (72% recovery). The aliquots 
obtained were considered to be of sufficient purity due to the absence of bands in 
the background of the lanes above and below the RafSMsm bands (Fig. 4.14 B). 
 
 
 
Figure 4.12. RafSMsm protein expression analysis. His-tagged Raf protein expression 
was induced with 0.1 mM (empty vector control) and 1 mM IPTG (RafSMsm) for 6 h at 
37oC, 220 rpm. Cells were harvested and lysed and cell extracts were analysed by 
SDS-PAGE. (A) SDS-PAGE time course assay of protein expression of the pET15b 
empty vector control at 0.1 mM IPTG. Soluble and insoluble fractions are indicated 
as “S” and “I” respectively. (B) Time course expression of RafSMsm, 1 mM IPTG. 
Soluble and insoluble fractions are indicated as “S” and “I” respectively. Ladder 
protein weights are indicated in kDa (A, B Lane 1). RafSMsm protein migration 
indicated an approximate molecular weight of 28 to 30 kDa. 
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Figure 4.13. FPLC chromatogram indicating purification procedure for RafSMsm. His-
tagged RafSMsm protein expression was induced with 1 mM IPTG for 4 h at 37oC, 
220 rpm. Cells were harvested, lysed and the cell extract was loaded onto a 1 ml His 
column (GE) using a superloop (GE). Unbound protein was removed with 20 mM 
and 205 mM imidazole. Subsequently, a 24 ml stepwise elution was carried out at 
500 mM imidazole (1 ml fractions were eluted). (A) FPLC chromatogram indicating 
his column purification procedure for RafSMsm (B) RafSMsm elution profile. Elution of 
the first 15 fractions is shown. In total, 24 fractions were eluted and are the SDS 
PAGE elution profile is shown in Fig. 4.14.  
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4.3.4  RafSMtb, RafHMsm and RafHMsm expression time courses and purification 
attempts 
 
I next aimed to determine the optimal induction time for expression of RafSMtb, 
RafHMsm and RafHMsm. Time course assays indicated an optimal induction time of 4 
hours for expression of soluble RafSMtb, RafHMtb and RafHMsm at 0.1 mM IPTG (Lanes 
A7, B5 and C5, respectively, Fig. 4.9). For RafSMtb, 4 hours was considered to be the 
preferred induction time to 6 hours to facilitate protein induction and FPLC 
purification in 1 working day. 
 
 
Figure 4.15. SDS-PAGE analysis of time course expression of Raf proteins at 0.1 
mM IPTG. His-tagged Raf protein expression was induced with 0.1 mM IPTG for 4 to 
6 h at 37oC, 220 rpm. Cells were harvested and lysed and cell extracts were 
analysed by SDS-PAGE. (A) RafSMtb 6 hour expression time course. (B) RafHMsm 4 
hour expression time course. (C) RafHMtb 4 hour expression time course. Soluble 
and insoluble fractions are indicated as “S” and “I” respectively. Protein weights are 
indicated in kDa for the ladder in lanes A1, B1 and C1. Raf protein migration 
indicated the following approximate molecular weights; RafSMtb (28 - 30 kDa), 
RafHMsm (60 kDa) and RafHMtb (35 - 38 kDa). 
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4.3.5  RafSMtb purification attempts 
 
A considerable amount of soluble RafSMtb protein was present at 4 hours (Fig 
4.16 A) and I attempted to purify soluble RafSMtb protein from a 1 L culture pellet. I 
did not obtain RafSMtb in SDS-PAGE gels via FPLC after several attempts using 
FPLC buffers as described for RafSMsm. Protein appeared not to be eluted since 
bands corresponding to the size of RafSMtb were absent from SDS-PAGE elution 
profiles (data not shown). Due to time limitations, I did not pursue testing other 
conditions, such as FPLC with buffers adjusted to other pHs, other induction 
conditions or with a reducing agent additive. 
 
4.3.6  RafHMsm purification attempts 
 
Although RafHMsm is predicted to be 24.53 kDa, a protein gel band (around 60 
kDa) (Fig. 4.16) indicates that the soluble version of the protein may form dimers. 
Whether this is of physiological relevance or is an artifact caused by protein 
overexpression and aggregation is unknown. The predicted isoelectric point (PI) for 
RafHMsm was 7.86, suggesting that the protein is likely to be basic and positively 
charged at pH 7.  
Dr. Kathryn Lougheed kindly assisted in this project by attempting to purify 
RafHMsm by FPLC. She could not purify soluble RafHMsm under the buffer conditions 
described for RafSMsm with pH adjusted to 8 due to significant aggregation of protein 
in FPLC fractions (data not shown) (Materials and Methods sections 2.5.3, 2.5.4).  
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4.3.7 RafHMtb purification  
 
Dr. Kathryn Lougheed kindly assisted in this project and purified RafHMtb 
which was used in translation assays with non-dissociated ribosomes and the polyU 
mRNA translation assay with dissociated ribosomes (Materials and Methods 
sections 2.5.3, 2.5.4). RafHMtb expression was induced in a 2 L culture using 0.1 mM 
IPTG for 4 h at 37oC. FPLC was carried out with buffers adjusted to pH 8 with 
stepwise elutions and RafHMtb was eluted at 200 mM and 300 mM imidazole (data 
not shown). The predicted isoelectric point (PI) for RafHMtb was significantly high at 
10.21, thus explaining the need for FPLC buffers at pH 8.  
Pooled FPLC protein fractions were dialysed using a Slide-a-Lyzer® dialysis 
cassette 3.5 kDa MWCO (Thermo Scientific) according to the manufacturer’s 
instructions. 1L buffer containing 20 mM Tris, 200 mM NaCl and 10% glycerol, pH 8 
was used for dialysis at 10oC overnight. During dialysis, a significant amount of 
protein aggregated and was spun down so that the supernatant containing soluble 
protein could be further concentrated. Amicon concentration (Millipore) was carried 
out as described by the manufacturer. The final concentration of RafHMtb obtained 
was 1.5 μg/ml in a 2 ml volume (Fig. 4.18 A).  
I subsequently carried out RafHMtb purification and altered the induction 
conditions to employ 0.5 mM IPTG for induction of 2 L bacterial culture for 4 h at 
37oC, 220 rpm. Given the increased culture volume, I employed two 1 ml His trap 
columns for FPLC purification. I loaded 24 ml cell lysate to 2 x 1 ml His-trap columns. 
FPLC buffers (pH8) were modified to include 100 mM sodium phosphate. I carried 
out stepwise elutions at 300 mM and 500 mM imidazole (60% and 100% buffer B 
mix, respectively).  
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Fig. 4.17 indicates the SDS-PAGE analysis of 20 fractions eluted at 500 mM 
imidazole. Fractions were concentrated with modified TAKM7 buffer (pH 8, 10% 
glycerol, 2 mM DTT) in Amicon 3 MWCO concentrators (Millipore) (Fig. 4.18 B). 
RafHMtb eluted at 300 mM imidazole was of sufficient concentration (1.6 mg/ml, Fig. 
4.18 B) and purity and was subsequently utilised in translation assays. Given the 
ability to concentrate protein with amicon rather than overnight dialysis, I considered 
the method optimized by myself to be the more convenient of the two methods. 
 
 
 
Figure 4.16. SDS-PAGE analysis of RafHMtb FPLC fractions eluted at 500 mM 
imidazole. His-tagged RafHMtb protein expression was induced with 0.5 mM IPTG for 
4 h at 37oC, 220 rpm. Cells were harvested, lysed and the cell extract was loaded 
onto a 1 ml His column (GE) using a superloop (GE). Unbound protein was removed 
with 20 mM imidazole. Subsequently, a 20 ml stepwise elution was carried out at 500 
mM imidazole (1 ml fractions were eluted). A 20 μl sample of each fraction was 
denatured and loaded to a 12% SDS-PAGE gel. Fraction numbers are indicated. 
RafHMtb protein migration indicated an approximate molecular weight of 35 kDa (12% 
gel). L indicates the Page-Ruler prestained plus protein ladder (Thermosci). 
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Figure 4.17. SDS-PAGE analysis of purified RafHMtb. His-tagged RafHMtb protein 
expression was induced with 0.1 mM IPTG for 4 h at 37oC, 220 rpm. Cell were 
harvested lysed and the cell extract was loaded onto a 1 ml His column (GE) using a 
superloop (GE). FPLC was performed with buffers adjusted to pH8. Unbound protein 
was removed with 20 mM imidazole. Subsequently, 10 ml stepwise elutions were 
carried out at (A) 200 mM and 300 mM imidazole (1 ml fractions were eluted) and (B) 
300 mM and 500 mM stepwise elutions. Fractions identified as containing pure 
RafHMtb were subsequently pooled and concentrated with amicon concentrators and 
the final sample was analyzed by SDS-PAGE. (A) RafHMtb purified by Dr. Kathryn 
Lougheed (8% gel) (lane 3). S1 indicates sample 1. 1 indicates the Page-Ruler 
prestained plus protein ladder (Thermosci). (B) RafHMtb protein purified by Nandita 
Keshavan eluting at 300 mM imidazole (lane 2) and at 500 mM imidazole (lane 3) 
(12% gel). S2 and S3 indicate samples 2 and 3 respectively. 1 indicates the EZ run 
protein ladder (FischerSci). Protein weights in kDa are indicated. RafHMtb protein 
migration indicated an approximate molecular weight of 30 kDa (8% gel) and 35 kDa 
(12% gel). 
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4.3.8 Raf protein expression and purification: summary  
 
Expression conditions that allow soluble Raf protein expression were 
determined for all N-terminal His-tagged Raf proteins. Raf proteins RafSMsm and 
RafHMtb were successfully purified by FPLC (Table 4.1). Raf protein instability indices 
indicated that RafSMsm is a stable protein with the lowest instability index whereas the 
other three Raf proteins were classified as unstable. The proteins purified to date 
were RafSMsm and RafHMtb for which the instability indices were lowest (Appendix 
Table 3). 
RafH proteins had higher aliphatic indices and a higher proportion of buried 
residues than RafS proteins (Appendix Table 3). Buried residues are likely to be less 
accessible to Ni2+ ions of the His trap columns and RafH protein binding is likely to 
be weaker than for RafS proteins. Raf proteins showed a range of isoelectric points 
(pH at which the protein is of neutral charge). RafHMtb elution occurred at a lower 
imidazole concentration than for RafSMsm. The larger predicted number of negative 
than positive residues and negative charge at physiological pH may have contributed 
RafSMsm affinity to Ni2+ upto 500 mM imidazole.  
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Table 4.1: Summary of outcomes for Raf protein expression and purification  
 
Raf 
Protein 
 
Soluble protein expression  
conditions 
 
FPLC Purification 
outcome 
 
RafSMsm 
 
4 h, 1 mM IPTG, 37oC,  
1L cell pellet 
 
 
Purified to 0.6 mg/ml 
Yield = 3 mg/L culture 
 
RafHMtb 4 h, 0.5 mM IPTG, 37oC, 
2L cell pellet 
Purified to 1.6 mg/ml 
Yield = 1.6 mg/L culture 
 
RafHMsm 4 h, 0.1 mM IPTG, 37oC, 
1L cell pellet 
 
Purification unsuccessful to date 
RafSMtb 4 h, 0.1 mM IPTG, 37oC, 
1L cell pellet 
 
Purification unsuccessful to date 
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 4.4 Effect of Raf proteins on in vitro mycobacterial translation 
 
4.4.1 Effect of Raf proteins on in vitro mycobacterial translation: aims  
 
 Having purified RafSMsm and RafHMtb proteins, we next investigated the effect 
of these proteins on in vitro translation by M. smegmatis ribosomes. We aimed to 
investigate translation of 3 types of mRNA with or without a Shine Dalgarno (SD) 
sequence and translation by 2 types of ribosomes as listed below: 
The 3 mRNA translation systems investigated were: 
1. Omega luciferase mRNA translation (mRNA with SD sequence and 
translational enhancer sequence from Tobacco Mosaic Virus). 
2. Renilla luciferase mRNA translation (mRNA with SD sequence). 
3. PolyU mRNA translation (mRNA without SD sequence). 
The 2 types of M. smegmatis ribosomes investigated were: 
1. Non-dissociated ribosomes.  
2. Dissociated ribosomes (ribosomes are resuspended in low Mg2+ buffer, which 
encourages ribosome dissociation). 
The translation systems are further described in section 4.4.2.  
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4.4.2 In vitro mycobacterial translation systems: overview  
 
The in vitro translation assays were carried out using RafSMsm and RafHMtb 
proteins which were purified by myself (RafSMsm and RafHMtb) and Dr. Kathryn 
Lougheed (RafHMtb). Dr. Rashid Akbergenov from the laboratory of Prof. Erik C. 
Böttger, University of Zurich carried out the translation assays and supplied us with 
raw data and methods. I was involved in the protein purification, experimental 
design, data plotting and discussion stages. 
Translation by non-dissociated and dissociated M. smegmatis ribosomes was 
investigated. Translation assays were attempted by (i) direct incubation of Raf 
proteins with mRNA and the translation reaction mixture or (ii) pre-incubation of Raf 
proteins with the translation mixture without mRNA, followed by mRNA addition and 
incubation. A typical translation reaction mixture consisted of 7.5 pmol M. smegmatis 
ribosomes and 30 µl of a translation mixture containing 0 to 4 μg mRNA, 100 μM 
amino acid mixture, 40% (vol/vol) of M. smegmatis S100 extract, 0.4 μg/μl of total M. 
smegmatis tRNA, 12 μl of commercial S30 Premix without amino acids 
We investigated translation of mRNAs which were with and without the SD 
sequence. The Omega and Renilla luciferase mRNAs each contained an SD 
sequence and AUG start codon that is recognized by ribosomes prior to translation. 
Luciferase originated from Photinus pyralis (Omega luciferase) or from Renilla 
reniformis (Renilla luciferase) and oxidizes luciferin and causes bioluminescence, 
which was used as an indicator of luciferase mRNA translation. Omega luciferase 
mRNA is a modified firefly luciferase mRNA that contains a translational enhancer 
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from the Tobacco Mosaic Virus which is present at the 5’UTR of the mRNA and is 
associated with increased protein synthesis (Zeyenko et al., 1994).  
PolyU mRNA was also employed, which is a synthetic mRNA, consisting of 
uracil ribonucleotides only and lacks an SD sequence. Translation of polyU mRNA 
results in synthesis of a polypeptide made of phenylalanine (Phe) amino acids only. 
PolyU mRNA translation does not involve initiation and termination, allowing the 
effect of Raf proteins on translation elongation to be investigated. When luciferase 
mRNA was employed, bioluminescence (luciferase activity) was measured as an 
indicator of translation activity. When polyU mRNA was employed, 14CPhe 
incorporation was measured as an indicator of translation activity (Materials and 
Methods section 2.5.6).  
 
4.4.3 Effect of Raf proteins on translation by non-dissociated M. smegmatis 
ribosomes 
 
We first investigated whether Raf proteins inhibit translation by non-
dissociated M. smegmatis ribosomes (see method described in sections 2.5.6 to 
2.5.10). RafSMsm and RafHMtb showed no apparent effect on translation of Omega 
luciferase mRNA by non-dissociated ribosomes (Fig 4.18). Direct incubation of Raf 
proteins with luciferase mRNA and the translation reaction mixture or pre-incubation 
of Raf proteins with the translation mixture without mRNA, followed by incubation 
with mRNA did not show any significant change in translation activity.  
Next, we investigated whether Raf proteins inhibit translation by non-
dissociated ribosomes when pre-incubated with ribosomes for 1 hour, prior to 
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Given that we did not observe any apparent inhibitory activity for the Raf: 
ribosome ratios investigated thus far, we next investigated the effect of higher 
amounts of Raf proteins on the translation of Omega luciferase mRNA by non-
dissociated ribosomes (Materials and Methods section 2.5.6). RafSMsm partially 
increased in vitro Omega luciferase mRNA translation by non-dissociated ribosomes 
by 42% (13 RafSMsm: 1 ribosome) (Fig. 4.20 A) and RafHMtb partially inhibited in vitro 
Omega luciferase mRNA translation by non-dissociated ribosomes by 30% (Fig. 4.20 
B) (34 RafHMtb: 1 ribosome).  
Given the partial translation increase that was observed when Omega 
luciferase mRNA and an excess of RafSMsm were employed, we next investigated the 
effect of Raf proteins on translation of Renilla luciferase mRNA, which does not 
include a translational enhancer, by non-dissociated ribosomes. The data suggested 
that both Raf proteins inhibited translation of Renilla luciferase mRNA, following a 
temporary increase in translation.  
At RafSMsm:ribosome 5:1, translation had increased, and by RafSMsm:ribosome 
8:1, translation had decreased by 75%. At RafHMtb:ribosome 7:1, translation had 
increased, and by RafHMtb:ribosome 21:1, translation had decreased by 73%. The 
data suggests that compared to Omega luciferase mRNA, Renilla luciferase mRNA, 
which lacks a translational enhancer, is more useful for investigating the effect of Raf 
proteins on translation by non-dissociated ribosomes due to higher levels of 
inhibition achieved.  
 

 


)LJXUH(IIHFWRI5DISURWHLQVRQLQYLWUR2PHJDOXFLIHUDVHP51$WUDQVODWLRQE\
QRQGLVVRFLDWHG0 VPHJPDWLV ULERVRPHV $ 5DI60VP SDUWLDOO\ LQFUHDVHV LQ YLWUR
2PHJD OXFLIHUDVHP51$ WUDQVODWLRQ E\ QRQGLVVRFLDWHG0 VPHJPDWLV ULERVRPHV
$QDYHUDJHRI WHFKQLFDO UHSOLFDWHV LVSORWWHG %5DI+0WESDUWLDOO\ LQKLELWV LQYLWUR
2PHJDOXFLIHUDVHP51$WUDQVODWLRQE\QRQGLVVRFLDWHG0VPHJPDWLVULERVRPHV
WHFKQLFDO UHSOLFDWHV DUH SORWWHG $ % 1RQGLVVRFLDWHG ULERVRPHV ZHUH SUH
LQFXEDWHGZLWKLQFUHDVLQJDPRXQWVRI5DISURWHLQZLWKRXWP51$IRUPLQDWR&
7KHUHDFWLRQVZHUHLQFXEDWHGIRUPLQDWR&ZLWKWKHUHPDLQLQJFRPSRQHQWVRI
WKH WUDQVODWLRQPL[WXUH LQFOXGLQJ2PHJD OXFLIHUDVHP51$2PHJD ILUHIO\ OXFLIHUDVH
)OXFDFWLYLW\ZDVPHDVXUHG



 


)LJXUH5DI60VPDQG5DI+0WELQKLELWLQYLWUR5HQLOODOXFLIHUDVHP51$WUDQVODWLRQ
E\QRQGLVVRFLDWHG0VPHJPDWLV ULERVRPHV1RQGLVVRFLDWHGULERVRPHVZHUHSUH
LQFXEDWHGZLWK LQFUHDVLQJ DPRXQWV RI 5DI60VPZLWKRXWP51$ IRU PLQ DW R&
7KHUHDFWLRQVZHUHLQFXEDWHGIRUPLQDWR&ZLWKWKHUHPDLQLQJFRPSRQHQWVRI
WKHWUDQVODWLRQPL[WXUHLQFOXGLQJ5HQLOODOXFLIHUDVHP51$5HQLOODILUHIO\OXFLIHUDVH)
OXFDFWLYLW\ZDVPHDVXUHGWHFKQLFDOUHSOLFDWHVSHU5DISURWHLQDUHSORWWHG

*LYHQ WKDW WKH ULERVRPH VWDELOLVDWLRQ IDFWRU 3< ZDV VKRZQ WR LQKLELW
WUDQVODWLRQRI6'P51$DQGDOVRRISRO\8P51$ZHQH[WLQYHVWLJDWHGWKHHIIHFWRI
5DISURWHLQVRQSRO\8P51$WUDQVODWLRQE\QRQGLVVRFLDWHGULERVRPHVVHHPHWKRG
GHVFULEHGLQVHFWLRQVWR3RO\8P51$VDUHIXUWKHUGHVFULEHGLQVHFWLRQ
5DI60VPDQG5DI+0WESDUWLDOO\LQKLELWHG LQYLWURWUDQVODWLRQRISRO\8P51$E\
QRQGLVVRFLDWHG ULERVRPHV E\  5DI60VPULERVRPH  DQG 
5DI+0WEULERVRPHUHVSHFWLYHO\)LJLQGLFDWLQJWKDWWKH5DISURWHLQVSOD\
DUROHLQSDUWLDOLQKLELWLRQRISRO\8P51$WUDQVODWLRQE\QRQGLVVRFLDWHGULERVRPHV

 


)LJXUH  (IIHFW RI5DI SURWHLQV RQ SRO\8P51$ WUDQVODWLRQ E\ QRQGLVVRFLDWHG
ULERVRPHV $5DI60VPSDUWLDOO\ LQKLELWV LQ YLWUR OXFLIHUDVHSRO\8P51$ WUDQVODWLRQ
E\ QRQGLVVRFLDWHG0 VPHJPDWLV ULERVRPHV % 5DI+0WE SDUWLDOO\ LQKLELWV LQ YLWUR
OXFLIHUDVHSRO\8P51$WUDQVODWLRQE\QRQGLVVRFLDWHG0VPHJPDWLVULERVRPHV0
VPHJPDWLVQRQGLVVRFLDWHG ULERVRPHVZHUHSUHLQFXEDWHGZLWK LQFUHDVLQJDPRXQWV
RI5DISURWHLQVIRUPLQFLUFOHVDQGPLQVTXDUHVWULDQJOHVDWR&DQGWKHQ
WKH PL[WXUH ZDV LQFXEDWHG IRU  KRXU DW R& ZLWK SRO\8 P51$ DQG RWKHU
FRPSRQHQWVRIWKHWUDQVODWLRQUHDFWLRQPL[WXUHIRUWHVWLQJRIWUDQVODWLRQDODFWLYLW\)RU
WUDQVODWLRQDFWLYLW\GHWHFWLRQ51$ZDVK\GURO\VHGZLWKPORI0.2+DQGSURWHLQ
ZDVSUHFLSLWDWHGZLWK7&$7KHUHDFWLRQPL[WXUHZDVILOWHUHGWKURXJKDPP
QLWURFHOOXORVHPHPEUDQHDQGH[SRVHGWRDSKRVSKRLPDJHUVFUHHQWRREWDLQWKHOHYHO
RI&3KHLQFRUSRUDWLRQZKLFKLQGLFDWHVWUDQVODWLRQDODFWLYLW\

 
185 
 
4.4.4 RafSMsm and RafHMtb inhibit in vitro luciferase mRNA translation by 
dissociated M. smegmatis ribosomes 
 
Given that the M. smegmatis Raf proteins were found to bind 30S subunits of 
stationary phase ribosomes (Trauner, 2010), we next investigated whether Raf 
proteins may show more potent inhibitory effects on translation when incubated 
dissociated ribosomes. In order to dissociate ribosomes, non-dissociated ribosomes 
were resuspended in buffer containing 0.05 mM MgCl2 and 500 mM KCl (see 
method described in sections 2.5.6 to 2.5.10). 
We first investigated the effect of Raf proteins on Omega luciferase mRNA 
translation by dissociated ribosomes (Fig. 4.23). Average translation inhibition 
percentages were as follows; RafSMsm and RafHMtb inhibition of Omega luciferase 
mRNA translation were 53% (RafSMsm: ribosome 13:1) and 84% (RafHMtb:ribosome 
32:1), respectively. Although there was higher variation between replicates in the 
RafSMsm assay, these assays suggested that RafSMsm inhibited translation of Omega 
luciferase mRNA by dissociated ribosomes. 
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Figure 4.23. RafSMsm and RafHMtb inhibit in vitro Omega luciferase mRNA translation 
by dissociated ribosomes. (A) RafSMsm inhibits in vitro Omega luciferase mRNA 
translation by dissociated M. smegmatis ribosomes. (B) RafHMtb inhibits in vitro 
Omega luciferase mRNA translation by dissociated M. smegmatis ribosomes. In 
order to dissociate ribosomes, non-dissociated ribosomes were resuspended in a 
buffer containing 0.05 mM MgCl2 and 500mM KCl. Dissociated ribosomes were pre-
incubated with increasing amounts of Raf proteins without mRNA for 10 min at 37oC 
(circles and squares) or 30 min at 25oC (triangles). Next, the reactions were 
incubated for 35 min at 37oC with the remaining components of the translation 
mixture including Omega luciferase mRNA. Omega firefly luciferase (F-luc) activity 
was measured.   
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Given the Raf protein-associated inhibition of translation of Renilla luciferase 
mRNA by non-dissociated ribosomes observed (Fig. 4.24), we next investigated 
whether Raf proteins affected Renilla luciferase mRNA translation by dissociated 
ribosomes. RafSMsm and RafHMtb were found to inhibit translation of Renilla luciferase 
mRNA by 93% (RafSMsm:ribosome 10:1) and 96% (RafHMtb:ribosome 26:1), 
respectively. The data indicates that Raf proteins are more potent inhibitors of 
translation of Renilla luciferase mRNA than Omega luciferase mRNA.  
Given that RafSMsm and RafHMtb partially inhibited in vitro polyU mRNA 
translation by non-dissociated M. smegmatis ribosomes (Fig. 4.25), we also 
investigated whether RafSMsm and RafHMtb inhibited polyU mRNA translation by 
dissociated ribosomes. RafSMsm and RafHMtb inhibited translation of polyU mRNA 
translation (Fig. 4.24). Average percentage inhibition of translation for RafSMsm and 
RafHMtb were 67% (RafSMsm:ribosome 11:1) and 80% (RafHMtb:ribosome 23:1), 
respectively.  
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4.4.5 Effect of RafSMsm and RafHMtb on translation by M. smegmatis ribosomes: 
summary. 
 
In summary, RafSMsm and RafHMtb inhibit in vitro translation of dissociated M. 
smegmatis ribosomes. Percentage effects of RafSMsm and RafHMtb on translation are 
summarised in Figs. 4.26 and 4.27. The results in this section indicated that RafSMsm 
and RafHMtb are inhibitors of translation of Renilla luciferase, Omega luciferase and 
polyU mRNA by dissociated ribosomes. Also, RafSMsm and RafHMtb inhibit translation 
of Renilla luciferase mRNA and polyU mRNA (partial inhibition) by non-dissociated 
ribosomes. RafSMsm partially stimulated translation of Omega luciferase mRNA 
whereas RafHMtb partially inhibited translation of Omega luciferase mRNA by non-
dissociated ribosomes, respectively.  
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4.5 Role of RafSMsm in mycobacterial ribosomal subunit association 
 
4.5.1 Role of RafSMsm in mycobacterial ribosomal subunit association: aims 
 
In addition to translation inhibition (section 4.4), ribosomal subunit association 
is a putative mechanism of ribosome stabilisation. Given the inhibitory effect of Raf 
proteins on ribosome translation, we next investigated the effect of Raf proteins on 
ribosomal subunit association.  
The aims were:  
1. To modify the previous protocol (Trauner et al., 2010) in several ways to 
incorporate new equipment and improve ease of profiling (Materials and 
Methods section 2.5.5)  
2. To confirm the appropriate magnesium concentration for ribosomal profiling of 
M. smegmatis cell extracts.  
3. To investigate the effect of rafSMsm deletion on M. smegmatis ribosome subunit 
association in actively growing and early stationary phase cultures by ribosomal 
profiling.  
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4.5.2 Optimization of ribosomal profiling: effect of magnesium concentration 
on M. smegmatis normoxic log phase 70S ribosome subunit dissociation 
 
10 mM Mg2+ has been employed in ribosomal profiling buffers to provide an 
environment conducive to ribosomal subunit association, whereas 1 mM Mg2+ has 
been employed to provide an environment conducive to ribosomal subunit 
dissociation (Trauner et al., 2010). Since log phase cells were less abundant than 
stationary phase cells, log phase profiling on 1L bacterial culture per replicate was 
carried out in order to harvest a sufficient amount of cells for ribosomal profiling 
(Appendix Figure 7).  
A typical experiment resulted in 30 to 35 sucrose gradient fractions. The 
experiments in this section were carried out with cell breakage at room temperature. 
However, for experiments in section 4.5.3, cell breakage was carried out at 4oC, 
since this appeared to be beneficial for improving cell disruptor function and 
ribosomal yield. Further details are given in Materials and Methods section 2.5.5. 
Associative and dissociative effects were confirmed by carrying out profiling of 
ribosomes from wild type and ΔrafSMsmc M. smegmatis strains (Fig.4.28). Wild type 
and ΔrafSMsmc mid log ribosomes were predominantly in the 70S form in 10 mM Mg2+ 
and in the 50S form in 1 mM Mg2+ conditions. I next investigated whether 10 mM 
Mg2+ (associative condition) was required in ribosomal profiling gradients. I carried 
out associative lysis and pelleting (10 mM Mg2+) of mid log ribosomes followed by 
non-associative gradient centrifugation (1 mM Mg2+) for wild type and ΔrafSMsmc (Fig. 
4.28). In this experiment, the use of lower concentrations of ribosomes may have 
accounted for the presence of the 30S peak in the ribosomal profile. 
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Fig. 4.29 indicated lower proportions of 70S ribosomes in wild type and 
ΔrafSMsmc mutant strains in ribosomal profiles where 1 mM Mg2+ was present in 
sucrose gradients, suggesting that 10 mM Mg2+ was required to maintain ribosomal 
association during sucrose gradient centrifugation. Taken together, the results 
confirmed that all steps of ribosomal profiling (of M. smegmatis cell extracts) should 
be carried out under associative conditions (with10 mM Mg2+).  
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4.5.3 Role of RafSMsm in normoxic log phase 70S ribosome subunit association 
 
Having determined the appropriate conditions for ribosomal profiling, we next 
investigated whether loss of rafSMsm affects the ribosomal subunit composition of 
actively growing M. smegmatis cells. Log phase in standard normoxia was defined 
as an OD600nm of 0.5 to 1 in a 1:2 culture: air ratio based on a growth curve 
experiment shown in Appendix Figure 5 (Materials and Methods section 2.5.5). A 
growth curve of strains investigated in these conditions is shown in Appendix Figure 
5. Ribosomal profiles of three independently constructed ΔrafSMsm M. smegmatis 
mutants were investigated.  
In comparison to wild type ribosomal profiles, ΔrafSMsm profiles indicated 
apparently similar proportions of 70S and 50S ribosomal species (Fig. 4.30). Given 
these results, ribosomal profiling of the ΔrafSMsmc mutant (complemented mutant 
constitutively expressing rafSMsm via an hsp60 promoter) under these conditions was 
not pursued further. Thus, it was concluded that there was no ribosomal stability 
defect for the ΔrafSMsm mutant during active growth.  
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Figure 4.30. RafSMsm is dispensable for ribosome stabilisation in normoxic LBT log 
phase in associative conditions (10 mM Mg2+). Ribosomal profiling was carried out 
for independent stationary phase cultures of wild type (A), ΔrafSMsm (B) M. 
smegmatis strains. Three biological replicates per strain are shown. 70S and 50S 
ribosomal forms are indicated. M. smegmatis strains were cultured in the required 
media and cells were pelleted. Cell pellets were lysed by cell disruption into 
associative or non-associative ribosomal buffer using a cell disruptor and clarified by 
ultracentrifugation to remove cellular debris. Ribosomes were pelleted by 
ultracentrifugation on a sucrose cushion. Ribosome sub-species were separated by 
centrifugation on associative or non-associative sucrose gradients. Fractions were 
collected manually and absorbance of fractions was measured at 254 nm. Direction 
of sedimentation for is from right to left. 
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4.5.4  Role of RafSMsm in normoxic stationary phase 70S ribosome subunit 
association 
 
We next investigated whether RafSMsm plays a role in ribosome stabilisation 
during stationary phase. It was determined that homogeneous cultures in early 
stationary phase in LBT in standard normoxia (1:5 culture: air ratio) resulted in 
reproducible and readable ribosomal profiles (Materials and Methods section 2.5.5). 
Ribosomal profiles of wild type, ΔrafSMsm and ΔrafSMsmc cultures indicated that 70S 
and 50S ribosomal species were equally predominant or 50S ribosomal subunits 
were slightly more predominant for all strains (Fig 4.31). Enlarged plots of Fig. 4.31 
are shown in Appendix Figures 8, 9 and 10. I concluded that rafSMsm was 
dispensable for early normoxic stationary phase ribosome stabilisation in associative 
conditions. 
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Figure 4.31. RafSMsm is dispensable for ribosome stabilisation in normoxic LBT early 
stationary phase in associative conditions (10 mM Mg2+). Ribosomal profiling was 
carried out for independent stationary phase cultures of wild type (A), ΔrafSMsm (B) 
and ΔrafSMsmc M. smegmatis strains (C). 3 biological replicates per strain are shown 
with 3 independent mutant replicates for the ΔrafSMsm strain. 70S and 50S ribosomal 
species are indicated with black arrows. Strains were cultured in LBT and cells were 
pelleted. Cell pellets were lysed by cell disruption into associative ribosomal buffer 
using a cell disruptor and clarified by ultracentrifugation to remove cellular debris. 
Ribosomes were pelleted by ultracentrifugation on a sucrose cushion. Ribosome 
sub-species were separated by centrifugation on associative sucrose gradients. 
Fractions were collected manually and absorbance of fractions was measured at 254 
nm. Direction of sedimentation is from right to left. 
 
 
 
 
 
 
 
A 
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4.5.5 Role of RafSMsm in mycobacterial ribosomal subunit association: 
summary 
 
Taken together, the ribosomal profiling data indicated that RafSMsm is 
dispensable for ribosome stabilisation in active growth and in early normoxic 
stationary phase in rich media. In comparing the ribosomal profiles obtained in 
associative conditions in Fig. 4.28 and Fig. 4.30, it was observed that the 50S 
ribosomal species were largely absent in Fig. 4.28 and present in Fig 4.30.  
This difference was suggested to be due to cell disruption being carried out at 
4oC in Fig 4.30 and at room temperature in Fig. 4.28. The 30S peak was not always 
visible in traces and this agreed with what we have seen in previous data from our 
laboratory (Trauner, 2010). This did not affect the interpretation of results since the 
50S peak was taken to be a better indicator of dissociated ribosomes. 
In this study, I observed that both 70S and 50S ribosomal species were 
present in wild type M. smegmatis stationary phase cells. However, Andrej Trauner’s 
wild type M. smegmatis stationary phase profiling resulted in a single predominant 
peak which was annotated as 70S ribosomes. Profiling of the M. bovis wild type, 
however, did yield 50S and 70S ribosomal species (Trauner et al., 2010).  
The reason for the difference in findings for M. smegmatis ribosomes is 
unclear, although differences in methodology may have contributed to this. Based on 
these observations, it is suggested that cell disruption at 4oC may be important for 
ribosomal profiling. As shown, deletion of rafSMsm did not affect ribosomal stability in 
rich normoxic exponential or stationary phase. 
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4.6 Raf protein biochemical findings: discussion 
 
The most significant finding presented in this chapter is the role of RafSMsm 
and RafHMtb in inhibition of in vitro translation of Renilla luciferase, Omega luciferase 
and polyU mRNAs by M. smegmatis dissociated ribosomes, suggesting that these 
proteins are versatile translation inhibitors, since inhibition occurred despite 
significant differences in mRNA type. Also, RafSMsm and RafHMtb both showed 
significant inhibition of translation of Renilla-luc mRNA by M. smegmatis non-
dissociated ribosomes (see section 4.4.3).  
Inhibition of translation was higher when dissociated ribosomes were 
employed. This finding agrees with what is known about Raf proteins binding to 
ribosomes. The M. smegmatis Raf proteins were found to bind to 30S ribosomal 
subunits (Trauner et al., 2010) and thus Raf protein binding to the ribosome is likely 
to occur more frequently when ribosomal subunits are dissociated (known to occur in 
low Mg buffer).  
The Renilla luciferase translation system is considered to be the closest to 
physiological of the translation systems investigated here, since it contains a Shine-
Dalgarno (SD) sequence and lacks a translational enhancer sequence. Given the 
data presented indicating Raf-mediated inhibition, it is recommended that Renilla 
luciferase mRNA translation by dissociated and non-dissociated M. smegmatis 
ribosomes be further investigated for RafSMtb and RafHMsm, should they be 
successfully purified.  
However, the increase in translation that preceded inhibition of Renilla 
luciferase mRNA translation by dissociated ribosomes has not been observed 
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previously in the literature on S30AE ribosome stabilisation factors (Fig 4.23). 
Whether this biphasic effect is physiologically important is unknown. It may be 
worthwhile to investigate whether there is a threshold concentration of Raf proteins 
beyond which they act as inhibitors of translation and below which they do not 
compete effectively with mRNAs due to being displaced by initiation factors. It 
remains a possibility that low concentrations of Raf proteins assist in preventing 30S 
subunit degradation and whether this plays a role in stimulating translation when Raf 
protein abundance is low.  
In comparing the Raf-mediated Renilla luciferase mRNA translation inhibition 
with that of Omega luciferase mRNA, the data suggests that the presence of a viral 
translational enhancer (Omega enhancer from tobacco mosaic virus) reduces the 
translation inhibitory effects of Raf proteins. Nevertheless, the levels of inhibition of 
translation by dissociated ribosomes were 53% and 84% for RafSMsm and RafHMtb, 
respectively. It would be interesting to investigate whether Raf proteins are capable 
of inhibiting translation of viral mRNAs which contain translational enhancers, since 
such data would suggest that Raf proteins may be capable of anti-viral defense in 
mycobacteria. 
Inhibition of polyU mRNA translation by dissociated ribosomes was significant 
for both Raf proteins investigated (67% and 80% for RafSMsm and RafHMtb, 
respectively). This suggests that RafSMsm and RafHMtb are capable of inhibiting 
translation of mRNA that lack SD and AUG start sequences. In this assay, inhibition 
of translation elongation is physiologically relevant since SD sequence recognition by 
the ribosome does not occur. These findings agreed with that shown for PY (60% to 
70% PY: ribosome 1:1) Agafonov also illustrated a role for PY in reducing miscoding 
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during translation of polyU mRNA, a function which may be worthwhile to investigate 
with respect to the Raf proteins (Agafonov et al., 2004).  
Notably, the inhibitory effects of RafSMsm and RafHMtb on in vitro translation 
have not been demonstrated previously in the existing literature on Raf proteins. In 
2012, Kumar et al. presented a paper in which RafHMtb was assigned the name 
“Dormancy Associated Translation Inhibitor (DATIN)”. However, it is unknown as to 
whether the translation assay presented employ mycobacterial ribosomes and the 
association of RafHMtb with mycobacterial dormancy was not experimentally proven. 
Furthermore, Figure 2 of the paper indicated inhibition of translation by RafHMtb, but 
ribosome buffer employed was not stated and the extent of inhibition was not 
quantified (Kumar et al., 2012). 
Also, the mycobacterial translation data presented in this work is more reliable 
than that presented by Kumar et al. It is not clear from Kumar’s study as to how the 
ribosomes were prepared and how many replicates of the assay were carried out. 
Also, they employed an E. coli S30 extract. In our study, we have specifically 
employed M. smegmatis ribosomes and indicated the buffer used in all of our 
translation assays. M. smegmatis ribosomes are structurally different to E. coli 
ribosomes and an extra 497 amino acids are present in M. smegmatis ribosomes 
(Shasmal et al., 2012).   
 Furthermore, the S30 extract is from M. smegmatis and the Raf: ribosome 
ratios and percentage inhibition of translation data are indicated in this study, 
whereas these have not been stated in Kumar et al’s work, and cannot be inferred 
from the amount of Raf protein quoted, since the amount of ribosomes employed 
was omitted. 
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Also, the predicted protein structure of RafHMtb presented in Figure 1 of 
Kumar’s paper (Kumar et al., 2012) is inaccurate and lacks the S30AE domain which 
has been predicted with high confidence in this work (Figure 4.4). In a further paper, 
they published a predicted structure of RafHMtb structure that appeared to be 
structurally different to the one previously published (Kumar et al., 2013). In our 
predicted structures, one can observe the characteristic βαβββα topology of Raf 
protein N-terminal domains and its similarity to the S30AE domain of PY and other 
known S30AE homologues.  
Regarding the effect of Raf proteins on ribosome subunit association, it is 
possible that the presence of RafHMsm compensated for the loss of RafSMsm. This can 
be further investigated by investigating the ribosome subunit composition of a 
ΔrafSMsm ΔrafHMsm strain. We do not rule out the possibility that ribosomal subunit 
association may be a possible mechanism for Raf protein-mediated inhibition and 
stabilisation of ribosomes. It is also worthwhile to attempt to purify higher 
concentrations of Raf proteins and test their effect on association of dissociated 
ribosomes in vitro. 
It remains a possibility that the conditions under which Raf proteins are 
significantly expressed are yet unknown. Thus, it is recommended that further 
ribosomal profiling assays are carried out in conditions of nutrient starvation, such as 
carbon starvation and nitrogen starvation. It is also recommended that the in vitro 
effect of Raf proteins on subunit association be characterised. 
To inform this investigation, it is suggested that mass spectrometry be used to 
determine the Raf protein levels under different starvation conditions in order to 
further investigate the ribosome subunit profile of ΔrafSMsm conditions under which 
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Raf proteins are highly expressed. Ribosomal profiling is a key approach which 
would assist in understanding whether the mechanism of Raf protein-mediated 
inhibition of translation is related to ribosome subunit association, the physiological 
stimuli for inhibition of translation, and whether translation inhibition is a key stress 
tolerance mechanism under a specific physiological condition. 
The spinach plastid protein Psrp-1 is a long HPF and S30AE protein and was 
found to bind at a similar location to that of PY on the 30S subunit. Psrp-1 was 
associated with an increase in the proportion of E. coli 70S ribosomes when 
incubated in vitro with dissociated ribosomes (Sharma et al., 2010). Also, Sharma et 
al. suggested a function for RRF (ribosome recycling factor) and EF-G (elongation 
factor G) in returning Psrp-1-inactivated ribosomes to the actively translating pool 
(Sharma et al., 2010). Given that there are effects of Raf proteins on subunit 
association in vitro, testing the effect of adding factors such as IF3, RRF and EF-G 
would also help to investigate whether Raf-mediated subunit association can be 
reversed by adding translation factors. 
Ribosome subunit association is not the only mechanism associated with 
ribosome inactivation. Notably ribosome subunit dissociation can also achieve 
ribosome inhibition. An example of a factor which achieves this is RsfA or ribosome 
silencing factor A from E. coli. Häuser et al. discovered a role for RsfA in 
independent and competitive growth during the transition from rich to poor media 
and also in interfering with ribosome subunit association and translation (Häuser et 
al. 2012). 
Häuser et al. confirmed binding of RsfA to the ribosomal subunit interface and 
then investigated RsfA binding to previously reported potential interaction partners in 
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the large ribosome subunit using a yeast two-hybrid assay (Häuser et al. 2012). This 
study highlighted ribosome dissociation as another mechanism of ribosome silencing 
other than ribosome stabilisation and it also highlighted a role for ribosome silencing 
in stress tolerance.  
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Chapter 5: General Discussion 
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5.1 Scope of the general discussion 
 
The aim of this work was to investigate whether RafS is a ribosome 
stabilisation factor in mycobacteria and investigate whether it plays a role in stress 
tolerance. It has been determined that deletion of rafSMsm did not have a significant 
effect on growth and survival in rich media and in carbon–limited media in hypoxic 
and normoxic conditions. Also, deletion of rafSMsm did not affect biofilm and pellicle 
formation and survival in short term acid stress and heat stress. Deletion of rafSMtb 
did not affect growth in rich media but was associated with a competitive survival 
defect in prolonged stationary phase. 
Deletion of rafSMsm did not affect ribosome subunit association in active 
growth. However, RafSMsm and RafHMtb were found to inhibit in vitro translation of 
Renilla luciferase mRNA, polyU mRNA and Omega-luciferase mRNA when 
incubated with ribosomes dissociated in a low magnesium buffer. Thus, it has been 
shown that Raf proteins are ribosome inactivating factors, but it remains to 
determined as to whether they can act as ribosome stabilisation factors in vivo under 
physiological conditions. The significant findings of this work and recommendations 
for future study are discussed in the subsequent sections. 
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5.2 Raf proteins are inhibitors of in vitro mycobacterial translation  
 
In this work, ribosome stabilisation is defined as a combination of inhibition of 
ribosome translation and also ribosome subunit association or ribosome multimer 
formation. This definition differentiates ribosome stabilisation from ribosome 
inactivation or ribosome silencing where ribosome subunit association or ribosome 
multimer formation does not occur. This study has shown that Raf proteins RafSMsm 
and RafHMtb satisfy a key requirement that is important for ribosome stabilisation i.e. 
inhibition of translation.  
These findings suggest that it is worthwhile to further investigate the 
conditions under which RafSMsm and RafHMtb are expressed and whether they may 
play a role in conservation of energy and resources. All significant inhibitory effects 
were observed when Raf proteins were present in a molar excess of ribosomes and 
it remains to be determined as to whether these ratios are physiologically related and 
if so, under which conditions.  
It is yet unknown as to whether Raf protein-mediated inhibition of translation 
observed in vitro is associated with a change in ribosome subunit composition. In the 
absence of finding a role for Raf proteins in ribosome subunit association in rich 
media cultures, it remains to be proven as to whether Raf proteins are ribosome 
stabilisation factors, although it has been shown in this study that RafSMsm and 
RafHMtb are ribosome inactivating factors. Also, it has not yet been demonstrated as 
to whether RafH is necessary and sufficient for ribosome stabilisation, although RafH 
is regulated by DosR, which is essential for ribosome stabilisation (Trauner et al., 
2012). 
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Raf-mediated translation inhibition shown in this study agrees with what has 
been shown for E. coli PY. PY inhibits both firefly luciferase mRNA translation by 
approximately 67% (PY: ribosome 1:1) and polyU mRNA translation by 
approximately 88% (PY: ribosome 4:1) (percentage inhibition estimated based on 
bar charts of raw numbers) (Agafonov et al., 2001). However, Raf-mediated 
translation inhibition is less similar to E. coli HPF-mediated translation inhibition 
since HPF inhibited polyU mRNA translation significantly (81%, HPF: ribosome 20:1) 
but only inhibited SD mRNA translation partially (20%, HPF: ribosome 20:1) (Ueta et 
al., 2008).  
The translation assays suggest that Raf proteins are more potent inhibitors of 
ribosomes dissociated by resuspending in a low magnesium buffer. This finding is 
consistent with the finding that Raf proteins bind the 30S ribosomal subunit, which 
has been shown by mass spectrometry (Trauner et al., 2010). It would be interesting 
to further determine whether removing the C-terminal domain affects Raf protein-
mediated inhibition of translation, since this would allow investigating whether the N-
terminal domain is sufficient for inhibiting translation.  
I speculate that there are several possible advantages of ribosome translation 
inhibition, which include (i) conservation of resources (ii) protection of ribosomes 
from damage (iii) preservation of ribosomes for restarting growth after prolonged 
stasis and (iv) translational regulation associated with specific responses, such as 
persistence-related mechanisms. Further investigations regarding these proposed 
advantages are discussed in subsequent sections.  
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5.3 Role of Raf proteins in stress tolerance - RafSMtb plays a role in maintaining 
viability in competitive survival in stasis 
 
The correlations between ribosome stabilisation and stress tolerance have 
been adequately investigated for some ribosome stabilisation factors and have not 
been proven conclusively for others. For example, deletion of E. coli RMF has been 
associated with decreased survival in acid stress and heat stress (section 1.5.3.2), 
whereas PY has been associated with cold acclimation but only a partial role has 
been demonstrated and studies of other stress conditions are lacking (section 
1.5.3.5). In this study, a range of physiological stress investigations were conducted 
to investigate ΔrafSMsm phenotypes. 
As summarised in section 3.8, rafSMsm was dispensable for growth and 
survival in several conditions. In this study, the predominant focus of nutrient 
starvation assays was on carbon limitation. However, it remains to be investigated as 
to whether RafS plays a role in nitrogen or phosphate starvation, given that RafSMtb 
was significantly upregulated after 4 hours and also after 24 hours of stationary 
phase in general nutrient starvation (section 1.7.2).  
A major significant finding of the physiological studies was that RafSMtb plays 
a role in maintaining viability during competitive survival in prolonged rich stasis. The 
stasis competition assay is intended to impose starvation stress on wild type and 
deletion mutant strains as a direct result of inter-strain competition. Survival of 
ΔrafSMtb was severely compromised at days 164 and 238 (154 – 228 days in 
normoxic rich stasis) (section 3.7.2). Notably, the phenotype was observed after a 
long period of time in stasis and it remains to be investigated as to whether more 
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stringent nutrient starvation would be associated with sooner onset of the ΔrafSMtb 
survival defect.  
These data indicated that, along with maintaining survival of M. tuberculosis in 
prolonged stasis, it is also worth investigating whether rafSMtb plays a role in inter-
species competition. The ability to maintain viability under nutrient starvation is a key 
advantage for survival of M. tuberculosis in granulomas. Furthermore, maintaining 
higher viability would enhance spreading of M. tuberculosis to uninfected 
granulomas (section 1.2.2). 
Based on the hypothesis that RafS binds and stabilises 30S subunits and 
prevents them from being degraded, there is scope for investigation as to whether 
this process may be a resource conservation mechanism that correlates with the 
competitive advantage of wild type M. tuberculosis in competition with ΔrafSMtb. It 
may also be investigated as to whether RafSMtb plays a role in preventing other non-
mycobacterial species from scavenging 30S subunits which are nutrient-rich and 
may be released upon cell death during stasis.  
It would be necessary to further investigate Raf protein in vivo expression 
levels (in comparison to ribosome levels) in order to investigate these hypotheses 
and determine whether the Raf: ribosome ratios associated with in vitro inhibition of 
translation are similar.  Furthermore, research on this hypothesis would be useful in 
demonstrating an in vivo condition which confers physiological importance to Raf-
mediated inhibition of in vitro translation. 
To our knowledge, the role of an S30AE protein in maintaining viability in 
competitive stasis has not been shown previously. Furthermore, genes associated 
with competitive defects in prolonged stasis in mycobacteria are lacking. Hauser et 
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al. demonstrated a competitive defect in log phase growth of the ΔrsfA mutant and 
illustrated that the ribosome silencing factor RsfA plays a role in competitive fitness 
in 35 generations of active growth (Hauser et al., 2012). Taken together with our 
data, this suggests that investigation of the effect of deletion of Raf proteins on 
growth and stasis competitive defects in other stress conditions is worthwhile. 
Also, it would be interesting to determine whether the loss in viability of the 
ΔrafSMtb mutant is accelerated in independent nutrient-starved stasis. This would 
assist in understanding whether the competitive defect observed is exclusively a 
competitive defect or is a result of a survival defect in independent culture. 
Furthermore, this finding suggests that a competitive assay investigating potential 
expression regulators of Raf gene expression and survival of Raf gene deletion 
mutants in macrophage and mouse models is worthwhile. This would assist in 
understanding whether RafSMtb can act as a virulence factor that enhances survival 
in nutrient starvation. 
216 
 
5.4 Recommendations for further work on Raf-mediated inhibition of 
translation  
 
5.4.1 Structural investigations of Raf proteins 
 
Based on the mechanisms of translation inhibition suggested for E. coli RSFs 
(see section 1.5), it can be investigated as to whether Raf proteins inhibit translation 
by one or more of the following mechanisms (i) preventing recognition of SD 
sequences or mRNA by blocking the region of 16S rRNA that contains the anti-SD 
sequence (ii) binding to the 30S subunit mRNA channel and thus preventing mRNA 
binding and contact to A and P translation site tRNAs.  
Regarding the docking site of Raf proteins on the ribosome, it is 
recommended that high-resolution crystal structures of Raf proteins in complex with 
the ribosome are obtained. It is worthy to note that the 70S ribosome-PY structure of 
Polikanov et al. suggested that PY binds to the 30S subunit at its mRNA channel. 
Furthermore, PY docking to the ribosome is suggested to result in N and C-terminal 
domains of PY obstructing access of A and P site tRNAs (Polikanov et al., 2012). It 
would be useful to investigate the docking sites of Raf proteins on the ribosome, 
since this would help to determine whether their mode of inhibition of translation 
occurs in a similar manner to that of PY. 
Ye et al. employed NMR spectroscopy to determine the solution structure of 
PY and determined several conserved residues of basic charge localised to the α 
helices of the S30AE domain. These helix-localised basic residues were suggested 
to play a role in binding rRNA, in contrast to the solvent-exposed side of the β 
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sheets, which consists predominantly of polar and hydrophobic residues (Ye et al., 
2002) (Appendix Figure 5).  
These findings support the hypothesis that the PY S30AE domain binds the 
ribosome in vivo, since they suggest that there are residues of appropriate charge 
that can mediate protein-rRNA connections at physiological pH. Similarly, it would be 
useful to gain similar information for Raf proteins and to investigate ribosome-binding 
affinities of Raf proteins. Obtaining the structures of RafS proteins in complex with 
ribosomes would allow determination of which residues of the ribosome are 
contacted by the RafS proteins. 
Ye et al. noted a similarity in structure and in amino acid residues (50% 
conservation of residues) between PY and double-stranded ribosome binding 
domains of Drosphila Staufen and human interferon-induced protein kinase PKR. In 
addition to the questions raised in this section, this suggests that structural studies of 
Raf proteins and PY would also contribute to an understanding of the biochemistry of 
double-stranded ribosome binding domains.  
Also, further investigation of the structures of Raf protein C-terminal 
extensions and orientation of Raf protein linker and C-terminal domains when 
docking at the ribosome is warranted. Should the C-terminal domain be shown to 
localise to a binding site on the ribosome that is not involved in translation, it would 
be interesting to know whether it plays any role in stabilising the conformation of the 
30S subunit so as to prevent conformational changes that could induce dimerisation. 
Alternatively, it may play a role in recognising binding partners or environmental 
stimuli. 
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5.4.2 Investigating Raf-mediated inhibition of translation in competition with 
mRNA and fMet-tRNA and investigating Raf-mediated 30S ribosome subunit 
protection 
 
As discussed in section 5.2, Raf proteins inhibit in vitro translation by M.F 
smegmatis ribosomes. Further evidence is needed to relate in vitro Raf-mediated 
inhibition to in vivo mechanisms. For example, it would be worthwhile to investigate 
whether Raf proteins compete effectively with mRNA and fMet-tRNA for binding to 
the ribosome. To investigate this, it would be important to attempt translation assays 
with dissociated ribosomes without pre-incubation of Raf proteins with ribosomes 
prior to adding the other components of the translation mixture.  
Similar questions regarding PY-mediated inhibition of translation are also 
outstanding. Although it was shown that PY inhibits aminoacyl tRNA binding to the 
ribosome, this was demonstrated with PY pre-incubation with ribosomes without 
other components of the translation reaction mixture (Agafonov et al., 2001). If Raf 
proteins are less effective as translational inhibitors when mRNA and tRNA are 
abundant, this would lead to the question as to whether their inhibitory effects are 
therefore less potent during nutrient abundance and more potent during nutrient 
limitation.  
I suggest that direct incubation of proteins with the translation mixture is more 
close to the physiological conditions of nutrient abundance, whereas pre-incubation 
of ribosomes and Raf proteins without the other components of the translation 
mixture is more relevant to conditions of nutrient starvation. These studies would 
also assist in understanding whether there is a nutrient-dependent mechanism for 
releasing Raf proteins from ribosomes and restoring ribosomes to active translation. 
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In addition to these studies, it is worthwhile investigating whether Raf proteins 
may have a role in protecting 30S subunits from being degraded and if so, whether 
this plays a role in conservation of cellular resources. Investigating this would involve 
investigating whether Raf-30S subunit complexes are less prone to degradation by 
endoribonucleases. Could Raf protein-mediated inhibition of translation be a means 
of protecting 30S subunits from being degraded post-lysis, so that 30S subunits can 
be protected as a nutrient source exclusively to mycobacteria?  
 
5.4.3 Investigating Raf-mediated inhibition of response-specific mRNAs  
 
It is still not known as to whether Raf proteins play a role in global shut down 
of protein synthesis or whether they more specifically inhibit translation of specific 
transcripts under specific stress conditions. As Di Pietro suggests, it is important not 
to conclude that ribosome associated inhibitors are causative agents of global 
translation shut down when ribosome-associated inhibitors’ expression or ribosome 
binding correlates with translation shut down (Di Pietro et al., 2013).  
Given the mRNA-dependent inhibition of PY outlined in section 1.5.3.5 (Di 
Pietro et al., 2013), it would be useful to investigate whether Raf proteins may be 
involved in selectively inhibiting translation i.e. inhibiting translation of mRNA 
encoding certain types of genes as part of a physiological response. To inform 
selection of mRNAs for investigating mRNA-dependent translation inhibition, it would 
be worthwhile to first investigate Raf protein expression levels in different conditions 
by mass spectrometry. This would assist in determining whether there are specific 
pathways or stress tolerance conditions under which Raf protein expression is 
upregulated or downregulated.  
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For example, to further investigate whether Raf proteins play a role in 
tolerance of energy-limiting conditions, it would be useful to know whether Raf 
proteins permit the translation of specific mRNA transcripts that are important for 
energy-limitation stress tolerance. Given the findings discussed in sections 1.6.4 and 
1.7.2, it is worthwhile to investigate Raf-mediated inhibition of translation of a 
selection of mRNAs that encode proteins that play a role in tolerance of nutrient 
starvation (RafS) and hypoxia (RafH) in comparison to mRNAs that are not involved 
in stress tolerance. 
 
5.4.4 Investigating Raf-mediated inhibition of leaderless mRNA translation 
 
Cortes et al. determined that there is an extensive leaderless mRNA 
transcriptome in M. tuberculosis which lack a 5’ UTR (untranslated region). 5’ UTRs 
contain an SD sequence that is typically recognised by the ribosome during initiation.  
Given the Raf-mediated inhibition of polyU mRNA observed, it would be interesting 
to further investigate whether Raf proteins are also capable of inhibiting translation of 
mycobacterial leaderless mRNA. polyU and leaderless mRNA both lack the Shine 
Dalgarno sequence that is required for typical mRNA recognition by ribosomes.  
Although its role in mycobacterial physiology is not known, genes with active 
growth functions were notably absent from the M. tuberculosis leaderless mRNA 
transcriptome, suggesting that leaderless mRNA may play a role in stationary phase 
or persistent mycobacterial physiology (Cortes et al., 2013). Although Raf proteins 
are inhibitors of polyU mRNA translation, it remains a possibility that there are 
conditions or mRNAs for which translation inhibition is partial or low, since Raf-
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protein mediated inhibition of polyU mRNA translation by non-dissociated ribosomes 
was partial (see section 4.4.2). 
The first evidence for the formation of a subpopulation of functionally distinct 
ribosomes under adverse conditions that are capable of leaderless translation was 
obtained by Kaberdina et al. They demonstrated that treatment of E. coli with the 
antibiotic kasugamycin results in the formation of 61S ribosomes depleted for several 
essential proteins of the small subunit, including the functionally important proteins 
S1 and S12 and that these ribosomes were capable of leaderless mRNA translation. 
The genes that were translated encoded chaperones, stress proteins, ribosomal 
proteins and ribosome modifying enzymes (Kaberdina et al., 2009). 
Kaberdina et al. also showed that these respective mRNAs became 
leaderless in the presence of the antibiotic. The 61S stress ribosomes were found to 
be protein-depleted ribosomes which allowed translation of selected genes 
(Kaberdina et al., 2009). It remains to be shown as to whether there are similar 
ribosome protein depletion mechanisms in mycobacteria and whether these 
mechanisms occur in response to specific antibiotics or other stresses. Given these 
findings, it would be worth isolating leaderless mycobacterial mRNAs and 
investigating whether or not Raf proteins inhibit or permit their translation. 
 In a more recent study, Vesper et al. showed that in E. coli, the toxin anti—
toxin module mazEF (downstream of rela) regulates the formation of leaderless 
mRNA and specialised ribosomes that carry out their translation. MazE acts as an 
anti-toxin and is bound to toxin MazF after these proteins are synthesised. ClpAP 
protease degrades MazE and this releases MazF, an endoribonuclease toxin that 
cleaves single stranded mRNAs at ACA sequences. MazF cleaves closely upstream 
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of the AUG start codon of specific mRNAs and converts them to leaderless mRNAs. 
MazF also removes 43 nucleotides from the 3’ terminus of 16S rRNA at the decoding 
centre of 30S ribosomal subunits. The ribosomes then become capable of translation 
of leaderless mRNA and are known as 70SΔ43 ribosomes (Vesper et al., 2011).  
Given that PY binds at this proposed site of the 30S subunit, according to 
Polikanov et al., it is worthwhile to investigate whether PY-bound ribosomes are 
protected from modification by MazF or whether MazF is capable of displacing PY in 
order to mediate leaderless mRNA translation. This leads to the question as to 
whether a similar system exists in mycobacteria, for which Raf proteins play a role. I 
suggest that if Raf proteins are displaced by other (hypothetical) mycobacterial 
proteins involved in leaderless mRNA translation, then it should subsequently be 
investigated as to whether Raf proteins protect mycobacterial ribosomes from 
cleavage by non-mycobacterial ribosome-targeting toxins, such as MazF. 
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5.4.5 Investigating RafS protein cleavage and post-cleavage activity: RafSMtb 
and RafSMsm are predicted substrates of Clp protease, a key post-
transcriptional regulator in M. tuberculosis 
 
Post-transcriptional regulation via Clp protease has been shown to play a role 
in regulation of M. tuberculosis physiology. Inhibition of Clp protease leads to 
mycobacterial death in vitro and in mouse infection models, suggesting that it plays 
an important role in ensuring cell viability during in vivo infection (Raju et al., 2012). 
In a recent paper, Raju et al. showed that several proteins accumulate after Clp 
protease deletion and that these are putative Clp protease substrates (Raju et al., 
2014). 
In this study, RafS was highlighted as a putative Clp protease substrate. 
Deletion of Clp protease resulted in a 2.46 fold increase (p<0.01) in both RafSMtb and 
RafSMsm accumulation in 48 hours of growth in rich 7H9 media, respectively. RafH 
was notably absent from this list (Raju et al., 2014). In this work, we have shown for 
the first time that RafSMsm is an inhibitor of in vitro translation. Based on the predicted 
features of Raf proteins described in section 4.1, it would be interesting to know 
whether Clp protease degrades Raf proteins or whether Clp-mediated cleavage 
transforms Raf proteins into structures that are still active but perform a different 
function.  It would be worthwhile to: 
1. Investigate whether RafS is cleaved by Clp protease and the effect of this 
cleavage on protein structure and translation inhibition.  
2. Determine whether RafS accumulation is toxic to cells by over-expressing 
RafS proteins in a strain where the gene encoding Clp protease is deleted. 
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3. Determine whether Clp protease is capable of cleaving ribosome-bound 
RafS. 
4. Determine whether blocking Clp-dependent degradation of RafS is toxic to 
mycobacteria. 
 
5.4.6 RafS protein-mediated inhibition of translation as a platform for 
developing peptide-based anti-mycobacterial therapeutics: is RafS 
accumulation toxic to mycobacteria?  
 
The primary aim of this work was to characterise the function of RafS in 
mycobacteria. However, given the potent translation inhibition mediated by Raf 
proteins, it is apt to ask whether Raf protein accumulation is toxic to mycobacteria. 
Notably, RafSMtb was detected in 30-day infected guinea pig lungs but was absent in 
chronic infection at 90 days (section 1.7.2) (Kruh et al., 2010). Furthermore, using 
microarray analysis, Garton et al. found that rafSMtb was one of 334 genes that were 
significantly repressed in sputum of infected patients compared to aerobic cultures of 
M. tuberculosis (p = 5.9 x 10-3) (Garton et al., 2008).  
Added to the finding that RafS is predicted to be cleaved by Clp protease (see 
section 5.4.5), these studies indicate that it is worth further investigation as to 
whether RafS accumulation is toxic to mycobacteria. Also, it is worthwhile to pursue 
structural characterisation of Raf-mediated inhibition of translation since a more 
detailed understanding of Raf protein structure and function may be useful for 
developing small-molecule therapeutic peptides that inhibit ribosome translation.  
In order to determine whether this is a viable prospect, it will be important to 
ensure that Raf proteins are not inhibitors of eukaryotic translation and translation by 
225 
 
ribosomes of species that are important for the natural flora of the lung environment. 
It will also be important to develop peptides that are not cleaved by mycobacterial 
Clp protease, since this would allow sustained concentrations of the peptide and to 
investigate bioavailability and peptide uptake into granulomas. 
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5.4.7 Recommendations for further investigations of RafHMtb as a ribosome 
inactivating stress tolerance factor  
 
In this work, it has been shown for the first time that RafHMtb inhibits 
mycobacterial translation. Notably RafHMsm has been shown to contribute to DosR 
phenotypes, which plays a role in association of 50S and 30S subunits (promoting 
70S monomer formation) in hypoxic stasis (Trauner et al., 2012). It remains to be 
shown as to whether RafHMsm is necessary and sufficient for ribosome subunit 
association. Provided that RafHMsm can be purified in sufficient amounts, it is 
recommended that the effect of RafHMsm on ribosome subunit association be 
investigated in vitro.    
Based on analyses of gene expression in a fatty acid rich culture stasis model, 
Rodriguez et al. suggested that lipid storage is used by M. tuberculosis to ameliorate 
reductive stress damage and has shown that devR (of the DosR 2 component 
system) and rafHMtb show significantly increased expression in exponential and 
stationary phase. Analysis of the 500 bp upstream region of the initiation codon of 
the rafHMtb gene indicated the presence of a lipid signature sequence (Rodriguez et 
al., 2014).  
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Rodriguez et al. suggested that M. tuberculosis requires mechanisms to 
counteract reductive stress during metabolic changes to adapt to fatty acid 
metabolism since NADPH is likely to accumulate as a result of these changes 
(Rodriguez et al., 2014).  Given these findings, it would be worthwhile to investigate 
whether rafHMtb plays a physiological role in protecting ribosomes from reductive 
stress when M. tuberculosis switches to metabolism of fatty acids as the main 
carbon source.  
RafHMtb was identified to be localised to the cell wall of M. tuberculosis by 2D 
LC-MS (1 of 306 proteins) (Mawuenyega et al., 2005). Furthermore, Commandeur et 
al. found also that RafHMtb is cell wall-associated and is also a moderate inducer of 
IFN-γ production in splenocytes of mice infected with M. tuberculosis (Commandeur 
et al., 2013). Since Ortiz et al. have also shown that 100S dimers in E. coli cluster at 
the cell wall in nutrient-starved stationary phase, this leads to the question as to 
whether RafHMtb plays a role in sequestering 70S ribosomes and/or 30S subunits at 
the cell wall.  
In addition to the recommendations presented thus far, it is worth investigating 
whether induction of RafHMtb expression may affect mycobacterial physiology in 
exponential phase.  Pang et al. suggests that RafHMtb expression in exponential 
phase may be repressed by the mprAB two-component system. M. tuberculosis 
mprAB was associated with repressing stress-related genes in exponential phase. 
Deletion of mprAB was associated with significant upregulation of RafHMtb in 
exponential phase (4.16 fold) (Pang et al., 2006). 
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Deletion of mprAB was also associated with increased resistance to SDS and 
enhanced growth in peripheral blood monocytes (Pang et al., 2006). Since it has 
been shown that RafHMtb inhibits mycobacterial translation (this work) and is 
regulated by DosR which promotes 70S monomer formation (Trauner et al., 2012), it 
would be useful to further investigate whether RafHMtb expression is repressed by 
mprAB in exponential phase and whether induction of RafHMtb expression in 
exponential phase confers stress tolerance benefits, such as those indicated by 
Pang et al. 
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5.5 Concluding remarks 
 
The data and recommendations for further study presented thus far suggest 
that RafS and RafH are both inhibitors of mycobacterial ribosome translation and 
that there are several outstanding research questions which are worth investigation. 
Further investigation would assist in relating the in vitro inhibitory effect of Raf 
proteins on translation to an in vivo mycobacterial role such as stress tolerance or 
nutrient conservation. 
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Appendix 
 
 
 
 
Appendix Figure 2. Map of the plasmid pYUB854 which was employed in 
mycobacterial recombineering. hyg indicates the hygromycin resistance gene and 
restriction sites are shown in blue. 
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Appendix Table 1. Parameters obtained during M. smegmatis growth assays 
. 
Appendix Table 2. Conditions for investigating ΔrafSMsm1 survival and resuscitation 
phenotypes. Energy limitation conditions are listed in column 1 in short form. Energy 
sources or components supplied (+) or lacking (-) are indicated. Complex energy 
sources refers to Tryptone and Yeast extract. 
 
Energy Limitation 
Condition 
(short form) 
 
Normoxia 
 
Complex 
energy 
sources  
 
 
Carbon 
source 
(Glycerol) 
 
 
 
Tween 80 
(dispersal 
agent, 
Carbon 
source) 
 
Nitrogen 
source 
PBS (sealed) - - - + - 
HdBN (0%G) + - - - + 
HdBN (0.04%G) + - + + + 
HdBH (0.04%G) - - + + + 
LBTH  - + - + + 
LBTN + + - + + 
 
Growth assay 
(normoxia) 
 
Wild type M. smegmatis parameters 
 
Mid log active 
growth  
optical density 
range 
 
Duration of one 
doubling during 
active growth 
Final stationary 
phase optical 
density range 
LBT 
 
0.5 to 1 3 hours 2.5 to 3 
HdB 
 
0.25 to 0.5 4 hours 0.5 
Nutrient upshift 
(HdB to LBT) 
0.25 to 0.5 4 hours 0.5 
Nutrient downshift 
(LBT to HdB) 
0.2 to 0.4 4 hours 0.4 

 
 
$SSHQGL[)LJXUH5ROHRI5DI60VP LQ UHVXVFLWDWLRQRIDJHGVWDVLV FXOWXUHV LQ ULFK
PHGLD:LOG W\SH0VPHJPDWLV EOXHǻUDI60VPUHGDQGǻUDI60VPF JUHHQDJHG
FXOWXUHVSHUVWUDLQZHUHUHVXVFLWDWHGE\VXEFXOWXULQJPORIHDFKFXOWXUHWRIUHVK
/%7PHGLXPDQGPRQLWRULQJJURZWKLQQRUPR[LFFRQGLWLRQV$5HVXVFLWDWLRQRIGD\
+G%JO\FHUROQRUPR[LFFXOWXUHVZLWKELRORJLFDOUHSOLFDWHVSHUVWUDLQ%
5HVXVFLWDWLRQRIGD\K\SR[LF/%7VWDVLVFXOWXUHVZLWKELRORJLFDOUHSOLFDWHVSHU
VWUDLQ & 5HVXVFLWDWLRQ RI GD\  K\SR[LF +G% VWDVLV FXOWXUHV ZLWK  ELRORJLFDO
UHSOLFDWHVSHUVWUDLQ$YHUDJHRSWLFDOGHQVLW\QP LVVKRZQ(UURUEDUV LQGLFDWH
VWDQGDUG GHYLDWLRQ 0HDQV ZHUH FRPSDUHG XVLQJ D RQHZD\ $129$ ZLWK +ROP
âtGiNPXOWLSOHFRPSDULVRQWHVWS WRQVS! 
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Appendix Table 3: Raf protein predicted physicochemical parameters obtained from 
ProtParam (Expasy). (A) Raf proteins are listed in order of decreasing stability and 
other parameters are included. (B) Several parameters affecting thermostability and 
protein charge are shown. The His tag was not included in these analyses. 
 
(A) 
Raf 
protein 
Theoretical 
PI 
Expected 
Charge at 
pH7.4 
Instability 
index Classification 
Predicted 
molecular 
weight (kDa) 
RafSMsm 6.27 Negative 37.89 stable 26.4 
 
RafHMtb 10.21 Positive 42.05 unstable 29.47 
 
RafSMtb 8.82 Positive 43.33 unstable 24.53 
RafHMsm 7.86 Positive 48.87 unstable 29.02 
 
 
(B) 
Raf 
protein 
 
Aliphatic 
index 
Grand 
Average of 
Hydropathicity 
Number of 
amino 
acids 
Negatively 
charged 
residues  
(Asp + Glu) 
 
Positively 
charged 
residues  
(Arg + Lys) 
 
RafSMsm 68.22 -0.790 230 42 38 
RafHMtb 86.92 -0.231 273 27 36 
RafSMtb 77.43 -0.651 214 34 37 
RafHMsm 83.22 -0.47 258 38 39 
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Appendix Table 4. Concentrators that have shown low protein recovery during 
concentration of RafSMsm at 25 oC, 5 000 g for 20 min intervals. MWCO indicates 
Molecular Weight Cut Off. 
Concentrator 
 
Details 
Amicon Ultra-15 10 kDa MWCO 
(Millipore) 
Cellulose acetate membrane 
 
Vivaspin 10 kDa MWCO and Vivaspin 
turbo 5 and 10 kDa MWCO 
concentrators (GE) 
Polyethersulfone (PES) membranes 
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Appendix Figure 3. Secondary structure analysis of RafSMsm. (PSPIRED server, 
Buchan et al, 2013) 
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Appendix Figure 4. Secondary structure analysis of RafSMtb (PSPIRED server, 
Buchan et al, 2013). 
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Appendix Figure 7. Growth curves of M. smegmatis wild type, ΔrafSMsm 1 and 
ΔrafSMsmc (1 biological replicate each). Strains were cultured in LBT to stationary 
phase (9 h duration) and subcultured to 1L LBT in 2L flasks (1:2 culture: air ratio).  
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Appendix Figure 8. Enlarged plot shown in Fig. 4.31 A. Ribosomal profiling was 
carried out for 3 independent stationary phase cultures of wild type M. smegmatis. 
70S and 50S ribosomal species are indicated with black arrows. Strains were 
cultured in LBT and cells were pelleted. Cell pellets were lysed by cell disruption into 
associative ribosomal buffer using a cell disruptor and clarified by ultracentrifugation 
to remove cellular debris. Ribosomes were pelleted by ultracentrifugation on a 
sucrose cushion. Ribosome sub-species were separated by centrifugation on 
associative sucrose gradients. Fractions were collected manually and absorbance of 
fractions was measured at 254 nm. Direction of sedimentation is from right to left. 
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Appendix Figure 9. Enlarged plot shown in Fig. 4.31 B. Ribosomal profiling was 
carried out for 3 independent stationary phase cultures of M. smegmatis 3 
independent ΔrafSMsm mutants. 70S and 50S ribosomal species are indicated with 
black arrows. Strains were cultured in LBT and cells were pelleted. Cell pellets were 
lysed by cell disruption into associative ribosomal buffer using a cell disruptor and 
clarified by ultracentrifugation to remove cellular debris. Ribosomes were pelleted by 
ultracentrifugation on a sucrose cushion. Ribosome sub-species were separated by 
centrifugation on associative sucrose gradients. Fractions were collected manually 
and absorbance of fractions was measured at 254 nm. Direction of sedimentation is 
from right to left. 
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Appendix Figure 10. Enlarged plot shown in Fig. 4.31 C. Ribosomal profiling was 
carried out for independent stationary phase cultures of ΔrafSMsmc M. smegmatis. 
70S and 50S ribosomal species are indicated with black arrows. Strains were 
cultured in LBT and cells were pelleted. Cell pellets were lysed by cell disruption into 
associative ribosomal buffer using a cell disruptor and clarified by ultracentrifugation 
to remove cellular debris. Ribosomes were pelleted by ultracentrifugation on a 
sucrose cushion. Ribosome sub-species were separated by centrifugation on 
associative sucrose gradients. Fractions were collected manually and absorbance of 
fractions was measured at 254 nm. Direction of sedimentation is from right to left. 
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